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ABSTRACT 
Aluminum or Calcium-Catalyzed Electrophilic Cyclizations of 
Alkynes via Vinyl Cations 
In the research projects presented in my PhD thesis, the environmentally friendly 
aluminum or calcium-catalyzed electrophilic cyclizations of alkynes via vinyl cations were 
investigated. In these reactions, trisubstituted highly reactive vinyl cations were generated by 
the nucleophilic addition of alkynes to the carbocations that were produced from alcohols by 
aluminum or calcium catalysis. Subsequently, it was intercepted by hydroxyl groups or 
aromatic nucleophiles, leading to the formation of 4H-chromenes and all-carbon 
tetrasubstituted olefins respectively. Furthermore, the first transition-metal free alkyne 
insertion reaction through unstrained C-C σ bond activation was efficiently promoted by the 
trisubstituted highly reactive vinyl cations in the presence of 10 mol% Al(OTf)3 as a catalyst, 
which provided a novel protocol for the straightforward and efficient synthesis of structurally 
diverse 1,2-dihydroquinolines and 2H-chromenes. 
In a first project, an unprecedented inverse electron demand hetero-Diels-Alder reaction 
(IED/HDA) of alkynes with in situ generated ortho-quinone methides was described. The 
reaction itself features low catalyst loading, wide substrate scope and high functional group 
tolerance. In addition, it offers a new protocol for the straightforward and efficient synthesis 
of structurally diverse multi-substituted 4H-chromenes from readily available starting 
materials under very mild reaction conditions. Furthermore, either a concerted mechanism or 
a stepwise mechanism via vinyl cations was proposed for the reaction. In the stepwise 
mechanism, the trisubstituted highly reactive vinyl cations would be trapped by the tethered 
phenolic hydroxyl group. 
In a second project, the first transition-metal free carboarylation of alkynes with readily 
available alcohols was realized in the presence of non-toxic and abundant calcium catalysts, 
which allowed for the one-step synthesis of all-carbon tetrasubstituted olefins from alkynes. A 
trisubstituted highly reactive vinyl cation was generated in the carboarylation process, which 
was intercepted even by deactivated arenes as the tethered nucleophiles. 
In a third project, a new concept for a redox-neutral C-C bond functionalization based on 
intramolecular 1,3-aryl migration was demonstrated. The redox-neutral C-C σ bond activation 
  
reaction was selectively and efficiently promoted by trisubstituted highly reactive vinyl 
cations in the presence of 10 mol% Al(OTf)3 as a catalyst. Importantly, a plausible retro 
Friedel-Crafts/Povarov reaction mechanism was clearly excluded from this transformation by 
reacting acetals with alkynes. Furthermore, an unsaturated constrained four-membered spiro 
ring intermediate leading to the rearrangement products was proposed in the reaction. 
In the last project, a novel approach to 2H-chromenes through Al(OTf)3-catalyzed 
unstrained C-C σ bond activation was developed. The first transition-metal free process of 
insertion of an unactivated alkyne into an unstrained C-C σ bond was selectively and 
efficiently promoted by trisubstituted highly reactive vinyl cations in the presence of 10 mol% 
Al(OTf)3 as a catalyst. In addition, this alkyne insertion reaction proceeding through the C-C 
σ bond cleavage of benzylic alcohols features operational simplicity and allows for the direct 
and efficient synthesis of structurally diverse multi-substituted 2H-chromenes under very mild 
reaction conditions. 
  
Abbreviations 
Å Angstrom 
Ar Aryl 
Ac Acetyl 
Bn Benzyl 
Bu Butyl 
n-BuLi n-Butyllithium 
CI Chemical ionization  
DTBP Di-tert-butyl peroxide 
dr Diastereoselectivity 
DCE 1,2-Dichloroethane 
DCM Dichloromethane 
DMF N,N-dimethylformamide 
DMSO Dimethyl sulfoxide 
DMSO-d6 Dimethyl sulfoxide-d6 
DIAD Diisopropyl azodicarboxylate 
dppp 1,3-Bis(diphenylphosphino)propane 
Eq. Equivalent 
ESI Electrospray ionization 
EI                Electronic impact (in mass spectroscopy) 
Et Ethyl 
EE Ethyl acetate 
HMPA            Hexamethylphosphoramide 
Hz Hertz 
HPLC High-performance liquid chromatography 
HRMS High-resolution mass spectrometer 
IR Infrared spectroscopy 
KHMDS Potassium bis(trimethylsilyl)amide 
LAH Lithium aluminum hydride 
Me Methyl 
NBS N-Bromosuccinimide 
NIS N-Iodosuccinimide 
Nu Nucleophile 
PCC              Pyridinium chlorochromate 
Py Pyridine 
Ph Phenyl 
PMP 4-Methoxyphenyl 
  
ppm Parts per million 
Pr Propyl 
δ Chemical shift 
s                 Singlet (NMR signal) 
d Doublet (NMR signal) 
t Triplet (NMR signal) 
q Quartet (NMR signal) 
m Multiplet (NMR signal) 
TLC              Thin layer chromatography 
THF Tetrahydrofuran 
TMS Trimethylsilyl 
TIPS Tri-isopropylsilyl 
Ts Tosyl 
Tf                Trifluoromethyl 
p-Tolyl 4-Methylpheny 
hv                Irradiation with light 
 Table of Contents 
 
 
Table of Contents 
1. Introduction 1 
1.1. Reactions via Vinyl Cations 1 
1.1.1. Vinyl Cations 1 
1.1.2. Electrophilic Cyclizations of Alkynes via Vinyl Cations 1 
1.1.2.1 Halogen and Organoselenium as Electrophiles 2 
1.1.2.2 Brønsted Acids as Electrophiles 5 
1.1.2.3 Carbocations and Iodonium Salts as Electrophiles 6 
1.1.3. Vinyl Cation-Promoted Hydride Shift Reactions 10 
1.2.4. Vinyl Cation-Promoted Aryl Shift Reactions 12 
1.2.5. Conclusions and Perspectives 13 
1.2. Calcium-Catalyzed Reactions 13 
1.2.1. Why Developing Calcium-Catalyzed Reactions? 13 
1.2.2. Reactions of Alcohols 14 
1.2.3. Reactions of Olefins 18 
1.2.4. Reactions of Carbonyl Compounds 19 
1.2.5. Conclusions and Perspectives 20 
2. Aims of My Research Projects 21 
3. Results and Discussion 25 
3.1. Calcium-Catalyzed Synthesis of 4H-Chromenes 25 
3.1.1. Background 25 
3.1.2. Aims 26 
3.2.3. Optimization of the [4+2] Cycloaddition Reaction of Alkynes 26 
3.1.4. Synthesis of Substrates 27 
3.1.5. Scope of the Calcium-Catalyzed [4+2] Cycloaddition Reaction 28 
3.2.6. Mechanistic Discussion 29 
3.1.7. Conclusion 30 
3.2. Calcium-Catalyzed Carboarylation of Alkynes 30 
3.2.1. Background 30 
3.2.2. Aims 31 
3.2.3. Optimization of the Calcium-Catalyzed Carboarylation of Alkynes 32 
3.2.4. Synthesis of Substrates 33 
3.2.5. Scope of the Calcium-Catalyzed Carboarylation of Alkynes 35 
3.2.6. Mechanistic Study 38 
 Table of Contents 
 
 
3.2.7. Conclusion 38 
3.3. Al(OTf)3-Catalyzed Insertion of an Unactivated Alkyne into an Unstrained C-C σ 
Bond 38 
3.3.1. Background 38 
3.3.2. Aims 39 
3.3.3. Optimization of the 1,3-Aryl Shift Reaction 39 
3.3.4. Synthesis of Substrates 41 
3.3.5. Scope of the Al(OTf)3-Catalyzed 1,3-Aryl Shift Reaction 42 
3.3.6. Mechanistic Study 43 
3.3.7. Conclusion 46 
3.4. A Novel Approach to 2H-Chromenes through Al(OTf)3-Catalyzed Unstrained 
C-C σ Bond Activation 46 
3.4.1. Background 46 
3.4.2. Aims 48 
3.4.3. Optimization of the Unstrained C-C σ Bond Activation Reaction 48 
3.4.4. Synthesis of Substrates 50 
3.4.5. Scope of the Al(OTf)3-Catalyzed Unstrained C-C σ bond activation reaction 50 
3.4.6. Mechanistic Study 51 
3.4.7. Conclusion 52 
4. Summary and Outlook 53 
5. Experimental Part 55 
5.1. General Techniques 55 
5.2. Solvents 55 
5.3. Methods for Determination of Synthesized Compounds 55 
5.3.1. NMR Spectroscopy 55 
5.3.2. Mass Spectroscopy 55 
5.3.3. Infrared Spectroscopy 55 
5.4. Chromatography 55 
5.5. Experiments for Calcium-Catalyzed Synthesis of 4H-Chromenes 56 
5.5.1. Experiments for Preparation of Substrates 56 
5.5.2. General Experiment for the Calcium-Catalyzed Synthesis of 4H-Chromenes 62 
5.6. Experiments for Calcium-Catalyzed Carboarylation of Alkynes 67 
5.6.1. Experiments for Preparation of Substrates 67 
5.6.2. General Experiment for the Calcium-Catalyzed Carboarylation of Alkynes 77 
 Table of Contents 
 
 
5.7. Experiments for Al(OTf)3-Catalyzed Insertion of an Unactivated Alkyne into an 
Unstrained C-C σ Bond 92 
5.7.1. Experiments for Preparation of Substrates 92 
5.7.2. General Experiment for the Al(OTf)3-Catalyzed Insertion of an Unactivated 98 
Alkyne into an Unstrained C-C σ Bond 
5.8. Experiments for a Novel Approach to 2H-Chromenes through Al(OTf)3- 
Catalyzed Unstrained C-C σ Bond Activation 104 
5.8.1. General Experiment for the synthesis of 2H-Chromenes through Al(OTf)3- 104 
Catalyzed Unstrained C-C σ Bond Activation                                 
Literatures 112 
 
 Introduction  1 
 
 
1. Introduction 
1.1. Reactions via Vinyl Cations 
1.1.1 Vinyl Cations 
Although vinyl cations as well as the well-known alkyl cations possess a positively 
charged carbon atom, their chemical properties are very different from each other, because of 
different orbital hybridizations of the carbon atoms bearing the positive charge (Scheme 1). 
For the vinyl cation, it is located on sp carbon atoms, there is 50% of s orbital, while the alkyl  
 
 
 
Scheme 1. Differences between alkyl cations and vinyl cations. 
cation is located on sp2 carbon atoms, there is only 33% of s orbital. Because the sp carbon 
has more s-character than the sp2 carbon, the vinyl cation is much less stable than the alkyl 
cation. Over the past a few decades, as the alkyl cation is very reactive and easily accessed, it 
has broad applications in natural product total synthesis, materials science and medicinal 
chemistry.[1] In contrast, the vinyl cations have been less developed. In fact, several 
challenging reactions can be promoted by vinyl cations, which are impossible for alkyl 
cations,[2] such as activation of unreactive sp3 C-H bonds.[16,17,18] 
In the following part, representative examples of synthetic applications of vinyl cations 
will be shown. In order to make reading easier, the introduction will be organized with respect 
to different types of reactions via vinyl cations including electrophilic cyclization reactions of 
alkynes, vinyl cation-promoted 1,5-hydride shift reactions and vinyl cation-promoted 1,4-aryl 
shift reactions. 
1.1.2 Electrophilic Cyclizations of Alkynes via Vinyl Cations 
Alkynes have nucleophilic characteristics, because the C-C triple bond has regions of 
high electron density. Therefore, the addition of electrophilic sources to alkynes proceeding 
through the coordination of an electrophilic source with π bonds offers the simplest protocol 
for the generation of vinyl cations (Scheme 2). The R group that is adjacent to the positively 
charged carbon atom significantly affects vinyl-cation formation. For example, aryl groups 
and heteroatoms (such as oxygen and nitrogen atoms) can stabilize the highly reactive vinyl 
cations through a p-π conjugated system and thus induce the formation of vinyl cations. 
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Scheme 2. Concept of electrophilic activation of alkynes. 
In recent years, because of the high reactivity of vinyl cations, different electrophiles and 
alkynes have been used to efficiently construct carbocycles, heterocycles and 
multi-substituted alkenes.[2] 
1.1.2.1 Halogen and Organoselenium as Electrophiles 
In 2007, Larock et al. reported electrophilic cyclizations of substituted propargylic aryl 
ethers 1 by using I2, ICl or PhSeBr as the electrophiles (Figure 1).[3] This transition-metal free 
reaction provided an efficient access to 3,4-disubstituted 2H-benzopyrans 2 under mild 
reaction conditions. Notably, the reaction is quite tolerant with respect to functional groups, 
such as methoxy, hydroxyl, aldehyde and nitro groups. Furthermore, the propargylic aryl 
ethers 1 containing an unactivated alkyne moiety (R4 = alkyl groups) can be employed as the 
reaction substrates when using PhSeBr as the electrophile. 
 
 
 
 
 
  Figure 1 
A plausible reaction mechanism for the electrophilic cyclizations of substituted 
propargylic aryl ethers 1 was proposed by the authors (Scheme 3). The reaction was initiated 
by the activation of the C-C triple bond with ICl or PhSeBr as the electrophiles, producing an  
 
 
 
 
 
Scheme 3. Possible mechanism for the electrophilic cyclizations of propargylic aryl ethers. 
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iodonium or selenonium intermediate 3. Subsequently, Friedel-Crafts type reactions occurred 
in the presence of NaHCO3 as a base, leading to the eventual cyclization product 2. 
Furthermore, the 3-iodo-2H-chromene adducts 2 obtained by this methodology have other 
advantages. The introduced iodo atom can be easily functionalized by Sonogashira reaction to 
produce alkynyl chromenes 7 and a Pd-catalyzed CO insertion reaction to provide lactones 9 
(Figure 2). 
 
 
 
 
 
Figure 2 
Electrophilic cyclizations of alkynes with a 5-endo cyclization by using I2, ICl or Br2 as 
the electrophiles have also been developed by the same group. Larock et al. found that spiro 
[4.5] trienones 11 were exclusively produced by intramolecular 5-endo halocyclization of 
4-(p-methoxyaryl)-1-alkynes 10, but none of the expected product 12 via a 6-endo cyclization 
was observed (Scheme 4).[4] Importantly, an electron-rich substituent such as methoxyl group  
 
 
 
 
Scheme 4. 5-endo Electrophilic cyclization of alkynes. 
and N,N-dimethylamino group on the aromatic ring at the para-position is crucial to the 
reaction. The author proposed a mechanism to explain the formation of the product 11 (Figure 
3). Initially, a highly reactive vinyl iodonium intermediate 13 was produced by the activation 
of the C-C triple bond by halogen electrophiles. Subsequently, a 5-ipso cyclization occurred 
on the benzene ring, leading to intermediates 14, which then underwent the removal of methyl 
group by nucleophilic displacements to afford the product 11. 
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Figure 3 
Not only arenes but also alkenes can be regarded as good nucleophiles for halogen 
electrophile-induced electrophilic cyclizations of alkynes. In 2010 Kirsch et al. demonstrated 
the iodonium-mediated electrophilic cyclizations of 1,5-enynes 15. This transition-metal free 
reaction allowed for the direct and efficient synthesis of highly valuable six-membered ring 
products, such as 1,4-cyclohexadienes 17, 4-fluorocyclohexenes 18 and highly substituted 
benzenes 19 (Scheme 5).[5] 
 
 
 
 
 
 
Scheme 5. Electrophilic cyclizations of 1,5-enynes. 
The nucleophilic oxygen atom of esters and carboxylic acids can be used as excellent 
nucleophiles as well for halogen electrophile-induced electrophilic cyclizations of alkynes. 
 
 
 
 
Scheme 6. Iodolactonization of 3-alkynoate esters and acids. 
R1
CO2R4
R2
R3 E
+
CH2Cl2 or MeCN, rt
O
E
R1
R2
R3
O
50-98% yields
R1 = Et, Ph, PMP
R2 = R3 = H, Me, allyl
R4 = H, Me, Et, n-Bu
E+ = I2, ICl, PhSeCl
20
21
NIS
1
3
5
I
1
3
5
I
I
Nu
NuH
-H+
I
-H+
Nu = F, OCOR
[O]
15 16 17
18
19
R1
R2
R3
R4
R5
R5
R1
R2R3
R4
R5
R1
R2R3
R4
R3
R2
R1
R5
R4
R5
R1
R2
R3
R4
 Introduction  5 
 
 
Therefore, Larock et al. developed the electrophilic cyclizations of 3-alkynoate esters and 
acids by using I2, ICl or PhSeBr as the electrophiles, which provided a novel protocol for the 
straightforward and efficient synthesis of highly substituted 2(3H)-furanones 21 (Scheme 
6).[6] 
1.1.2.2 Brønsted Acids as Electrophiles 
 Brønsted acid is the simplest and smallest electrophile in nature, which played an 
important role in the development of chemistry. In 1997, Swager et al. reported the 
trifluoroacetic acid (TFA)-mediated electrophilic cyclizations of alkynes, which provided an 
efficient access to fused polycyclic aromatics 23 that can’t be obtained by other existing 
methods (Figure 4).[7] The synthesis of such a complex framework proceeded through two 
synthetic steps. First, the preparation of nonfused ring systems was realized by 
transition-metal catalyzed coupling reactions. Second, Brønsted acid-induced electrophilic 
cyclizations of alkynes were crucial to the ring-forming step in quantitative yields. 
 
 
 
 
 
Figure 4 
In 2004, Kozmin et al. developed the Tf2NH-promoted electrophilic carbocyclizations 
of siloxyalkynes 24, which provided a novel platform for the direct and efficient synthesis of 
a variety of structurally diverse enol silyl ethers 27, tetralones and cyclohexenones.[8] 
Importantly, the oxygen atom is the key to stabilize vinyl cations. A proposed mechanism 
for this transformation is outlined in Scheme 7. Highly reactive ketenium ions 25 were  
 
 
 
 
 
Scheme 7. HNTf2-promoted carbocyclizations of siloxyalkynes. 
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produced upon the protonation of the siloxyalkynes 24, which can be subsequently 
intercepted by both arenes and alkenes as the tethered carbon nucleophiles to afford the 
eventual adducts 27. 
Not only the oxygen atom but also the heteroatoms selenium and tellurium are able to 
enhance the stability of intermediary vinyl cations by positive charge delocalization. 
Therefore, recently triflic acid-catalyzed intramolecular hydroarylation of alkynyl selenides 
28 and tellurides 31 was described by the Lee group, which provided an efficient access to a 
variety of structurally diverse cycloalkenyl selenides 29 and tellurides 32.[9] Furthermore, the 
cycloalkenyl selenides and tellurides can be easily functionalized by transition-metal 
catalyzed coupling reactions (Scheme 8). 
 
 
 
 
 
 
 
Scheme 8. Electrophilic carbocyclizations of alkynyl selenides and tellurides. 
1.1.2.3 Carbocations and Iodonium Salts as Electrophiles 
Carbocations are excellent electrophiles and common reactive intermediates that can be 
easily accessed in laboratories. Therefore, considerable effort of chemists has been directed 
toward applications of the carbocations over the past decades. For example, in 2010 Tian et al. 
described an iron-catalyzed electrophilic [3+2] cycloaddition reaction of N-benzylic 
sulphonamides 34 with internal alkynes 35, which allowed for the direct and efficient 
synthesis of structurally diverse indene derivatives 36 (Scheme 9).[10] A proposed mechanism 
for the iron-catalyzed electrophilic [3+2] cycloaddition reaction is depicted in Scheme 9. The 
reaction began with the iron-catalyzed C-N bond cleavage of the N-benzylic sulphonamides 
34, producing stable benzylic carbocations 37. Subsequently, trisubstituted highly reactive 
vinyl cations 38 were generated by the nucleophilic addition of the alkyne 35 to the benzylic 
carbocation 37, which were then trapped by the tethered aryl nucleophiles to give the eventual 
adducts 36. 
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Scheme 9. Electrophilic [3+2] cycloaddition of alkynes with benzylic carbocations. 
Several similar electrophilic [3+2] cycloaddition reactions of alkynes with benzylic 
carbocations have been developed by other groups as well.[11] The only difference is the ways 
of generating the benzylic carbocations. In 2011, Li et al. demonstrated that benzylic 
carbocations 41 can be formed through iron-catalyzed C-C σ bond cleavage with 
1,3-dicarbonyl groups as a leaving group (Figure 5, a).[11a] In the same year, Zhou et al. 
disclosed that benzylic alcohols 42 were efficiently converted into the corresponding benzylic 
carbocations 43 through the iron-catalyzed dehydroxylation process of the benzylic alcohol 
42 (Figure 5, b).[11b] In 2013, Chen et al. utilized an oxidative strategy to produce the benzylic 
carbocations 43 by iron catalysis (Figure 5, c).[11c] 
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Figure 5 
Spirocyclic hydrocarbon frameworks are important structural motifs with a broad range 
of biological activities, which are frequently found in natural isolates and pharmaceuticals.[12] 
Therefore, in 2009 Yamamoto and co-workers developed intramolecular electrophilic 
cyclizations of alkynyl cyclic tertiary alcohols 45, which offered a novel protocol for the 
straightforward and efficient synthesis of spirocycles 46 with rings of different sizes and 
bridged bicyclic compounds (Scheme 10).[13] Tertiary carbocations were produced from the 
corresponding tertiary alcohol 45 in the presence of 10 mol% TfOH. Subsequently, 
trisubstituted highly reactive vinyl cations 47 were generated by the intramolecular 
nucleophilic addition of the alkyne moiety to the tertiary carbocation, which were then 
intercepted by water produced in the reaction system to provide the eventual spirocycles 46. 
 
 
 
 
Scheme 10. Tertiary carbocation-induced electrophilic cyclizations of alkynes. 
Phenyl electrophiles 50 which are generated through oxidative addition of copper (I) to 
the C-I bond of diaryliodonium salts 48 (Figure 6) can be used as carbon electrophiles as well 
for electrophilic cyclizations of alkynes. Recently, Gaunt et al. developed copper (I)-catalyzed 
carboarylation of alkynes 51 by using diaryliodonium salts 52 as carbon electrophile  
 
 
 
Figure 6 
equivalent, which provided an easy access to all-carbon tetrasubstituted alkenes 53 containing 
dihydronaphthalene motifs (Figure 7).[14] Notably, the reaction features high functional group 
tolerance and wide substrate scope in both the aryl alkyne and diaryliodonium salt 
components. Furthermore, the intermolecular carboarylation of alkynes 54 was also feasible, 
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Figure 7 
leading to the formation of acyclic all-carbon tetrasubstituted alkenes 56 (Scheme 11). 
 
 
 
 
Scheme 11. Intermolecular carboarylation of alkynes via vinyl cations. 
The reagent of Togni 58 is a kind of iodonium salts with a trifluoromethyl group. In 
2014, Ding and co-workers described copper (II) acetate-catalyzed trifluoromethylation of 
propiolates 57 by using the Togni’s reagent 58 as carbon electrophile equivalent, which 
allowed for the straightforward and efficient synthesis of trifluoromethylated coumarins 59.[15] 
A proposed mechanism for the Togni’s reagent-induced electrophilic cyclizations of alkynes 
is outlined in Scheme 12. Radical addition of trifluoromethyl radicals generated from the 
Togni’s reagent and copper (II) acetate to the alkyne 57 provided vinyl radicals 60, which 
were then further oxidized by copper (III) via single electron transfer (SET) to produce 
trisubstituted highly reactive vinyl cations 62. Subsequently, the trisubstituted highly reactive 
vinyl cations 62 were intercepted by the tethered aryl nucleophiles, leading to the formation 
of the eventual adducts 59 (Scheme 12, path b). 
 
 
 
 
 
 
 
 
 
 
Scheme 12. Togni’s reagent-induced carboarylation of alkynes via vinyl cations. 
I
TfO
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1.1.3 Vinyl Cation-Promoted Hydride Shift Reactions 
 There are a few examples of vinyl cation-promoted hydride shift reactions, which 
involve concerted 1,5-hydride shift processes. In 2006, Metzger et al. reported the first 
example of intramolecular insertion of vinyl cations into C-H bonds. At the beginning, the 
author designed processes of hydroalkylation of alkynes 66 by reducing highly reactive vinyl 
cations 67 with Et3SiH as an additional hydride donor. To their surprise, they just obtained the 
expected hydroalkylation adduct 68 as a by-product (< 5%), but cyclopentanes 71 as the 
major product in good yield (Scheme 13).[16] The formation of the cyclopentane 71 can be 
explained as follows: the highly reactive vinyl cations 67 were formed by the nucleophilic 
addition of the alkyne 66 to alkyl carbocations 65 produced from alkyl chloroformates 64 and 
ethylaluminum sesquichlorides (Et3Al2Cl3). If a C-H bond was available at the C5 position, 
intramolecular 1,5-hydride shift processes would occur, leading to cyclopentyl cations 70. 
Subsequently, the cyclopentyl carbocation 70 was reduced by Et3SiH to afford the eventual 
cyclopentane 71 (Scheme 13). Furthermore, calculations demonstrated that insertion of the 
highly reactive vinyl cations 67 into sp3 C-H bonds proceeded in a concerted manner. 
 
 
 
 
 
Scheme 13. The first example of 1,5-hydrogen shift reactions via vinyl cations. 
In 2010, Yamamoto and co-workers developed Brønsted acid TfOH or NHTf2-catalyzed 
activation of unreactive sp3 C-H bonds based on vinyl cation-promoted 1,5-hydride shift 
reactions, which allowed for the direct and efficient synthesis of complex bridged multi-cyclic  
 
 
 
 
 
Scheme 14. Tertiary carbocation-induced 1,5-hydride shift reactions via vinyl cations. 
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molecules 74 from versatile enynes (Scheme 14).[17] Vinyl cations 78 produced by the 
intramolecular nucleophilic addition of the alkyne moiety to tertiary carbocations 77 can 
efficiently promote 1,5-hydride shift processes and the formation of new C-C bonds. 
A plausible mechanism for the 1,5-hydride shift reaction is outlined in Figure 8. Initially, 
tertiary carbocations 77 were produced from the corresponding alkenes in the presence of 
Brønsted acids. Subsequently, the trisubstituted highly reactive vinyl cations 78 were 
generated by the intramolecular nucleophilic addition of the alkyne moiety to the tertiary 
carbocation 77. There are two possible pathways for the 1,5-hydride shift processes. A 
concerted pathway was promoted by the anion of deprotonated Brønsted acids and the highly 
reactive vinyl cations 78, thus directly leading to the eventual adduct 76 (Figure 8, path A). 
Meanwhile, a stepwise mechanism can not be ruled out. Because the 1,5-hydride shift 
processes occurred, leading to the formation of alkyl carbocations 80, which then underwent 
the addition/elimination sequences to provide the same adduct 76 (Figure 8, path B). 
 
 
 
 
 
 
 
 
 
 
Figure 8 
In 2014, Gaunt and co-workers have demonstrated that vinyl cations 84 produced by the 
intermolecular nucleophilic addition of alkynes 82 to aromatic electrophile equivalent 48 can 
promote 1,5-hydride shift reactions as well, which allowed for the straightforward and 
efficient synthesis of cyclopentenes 83 from readily available starting materials. Furthermore, 
it was the first time for them to demonstrate the concerted mechanism for insertion of vinyl 
cations into sp3 C-H bonds by experiments (Scheme 15).[18] 
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Scheme 15. Experimental proofs for the concerted 1,5-hydride shift mechanism. 
1.1.4 Vinyl Cation-Promoted Aryl Shift Reactions 
The electrons in a C-H σ bond can transfer to the vacant p-orbital of a vinyl cation, thus 
leading to hydride shift processes, such as vinyl cation-promoted 1,5-hydride shift reactions 
as already discussed in chapter 1.1.3. Similar to the hydride shift processes, the cleavage of a 
C-C σ bond via electron transfer to the empty p-orbital of a vinyl cation would lead to carbon 
transfer processes. Recently, Liang and co-workers have demonstrated the feasibility of the 
carbon transfer processes by vinyl cation-promoted 1,4-aryl shift reactions.[19] A proposed 
mechanism for the cascade reaction is outlined in Scheme 16. Initially, radical addition of 
trifluoromethyl radicals generated from the Togni’s reagent 58 and CuI to alkynes 86 
provided vinyl radicals 87. There are two possible pathways for the generation of 
intermediates 90. In the first pathway, a 5-ipso cyclization would occur on the phenyl ring,  
 
 
 
 
 
 
 
 
Scheme 16. One example of aryl shift reactions via vinyl cations. 
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leading to radicals 88, which were then oxidized by Cu2+ via single electron transfer (SET) to 
produce the intermediate 90 (Scheme 16, path a). In the other pathway, the vinyl radicals 87 
would be oxidized directly by Cu2+ via single electron transfer (SET), producing trisubstituted 
highly reactive vinyl cations 89, which can also lead to the intermediate 90 via a 5-endo 
cyclization (Scheme 16, path b). Finally, the intermediate 90 underwent intramolecular 
1,4-aryl migration, leading to the rearrangement product 91. 
1.1.5 Conclusions and Perspectives 
Recent advances in reactions via vinyl cations were illustrated and summarized. 
Different electrophiles and alkynes have been used to efficiently construct carbocycles, 
heterocycles and multi-substituted alkenes.[2] Particularly, halogen atom-induced electrophilic 
cyclizations of alkynes provided an efficient access to a variety of heterocycles that can be 
further functionalized by transition-metal catalysis to give the highly substituted heterocycles. 
Despite advances, electrophilic sources for the activation of the alkyne moiety are often 
limited to halogen, organoselenium, carbon electrophiles (carbocations and iodonium salts) 
and Brønsted acids. Among these electrophilic sources, the carbon electrophile seems to be 
privileged, for the reactions by using the carbon electrophiles serve as a rapid and 
atom-economic approach for constructing at least one new C-C bond. Therefore, developing 
the new reactions by using the carbon electrophiles is highly desirable in the future, especially 
for vinyl cation-promoted hydride shift reactions and vinyl cation-promoted aryl shift 
reactions. 
1.2. Calcium-Catalyzed Reactions 
1.2.1 Why Developing Calcium-Catalyzed Reactions? 
Over the past few decades, transition-metal catalysis has become the most powerful tool 
for the creation of C-C bonds and carbon-heteroatom bonds in organic synthesis, which 
played an important role in natural product total synthesis, pharmaceuticals and materials.[20] 
Nevertheless, there are some inherent disadvantages for transition-metal catalysts. First, the 
transition-metal catalysts are oftentimes highly toxic, thus to remove metallic impurities from 
the final pharmaceutical products is a major purification problem from transition-metal 
catalyzed reactions. Second, they are expensive, most transition metals such as palladium, 
gold, rhodium and ruthenium are precious metals. Third, in most transition-metal catalyzed 
reactions, the combination of transition metals and the complex ligands is required to improve 
the reaction efficiency. Finally, the availability of the transition metals is more and more 
restricted, as our limited natural resources are used up. Therefore, wherever possible, the 
creation of more sustainable alternatives is in strong demand. In this regard, the reactions 
catalyzed by inexpensive, non-toxic and abundant metals open a new avenue for 
sustainability. 
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Calcium is the fifth most abundant elements in the earth’s crust and essentially non-toxic 
even in substantial amounts, which perfectly meets the requirements for sustainability. 
Therefore, it is highly desirable to develop the calcium-catalyzed reactions in synthetic 
organic chemistry, from the viewpoint of ecological and economic benefits. 
In the following part, representative examples of calcium-catalyzed reactions will be 
shown. In order to make reading easier, the introduction will be organized with respect to 
different types of the calcium-catalyzed reactions based on alcohols, olefins and carbonyl 
compounds as the reaction substrates. 
1.2.2 Reactions of Alcohols 
An easily accessible calcium-based inorganic salt that was synthesized from calcium 
carbonate and HNTf2 acid in water can efficiently convert many different alcohols into the 
corresponding carbocations. Therefore, highly interesting organic reactions were designed and 
realized based on these reactive intermediates. A plausible activation model of hydroxyl 
groups for the generation of carbocations is depicted in Figure 9. Wherein, a real reactive 
species, CaNTfPF6 was proposed for the dehydroxylation process, which was in situ 
generated by anion exchange between calcium salts and ammonium additives (Figure 9). 
 
 
 
 
 
Figure 9 
 When this highly efficient protocol for the generation of carbocations was first 
discovered, electron-rich arenes were used to trap these highly reactive carbocations, and thus  
 
 
 
 
 
Scheme 17. The first example of calicum-catalyzed Friedel-Crafts alkylation reactions. 
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providing an environmentally benign protocol for the alkylation of electron-rich arenes under 
mild reaction conditions (Scheme 17).[21] Notably, not only π-activated secondary alcohols 
but also tertiary alcohols can be transformed into the corresponding carbocations by calcium 
catalysis, which were subsequently intercepted by aromatic nucleophiles. Furthermore, a 
variety of electron-rich heteroarenes reacted smoothly with allylic and tertiary alcohols in the 
presence of calcium catalysts. 
Amines have good nucleophilic characteristics, a series of nitrogen nucleophiles 100 
such as carbamates, tosylamides and anilines can be used to trap the highly reactive 
carbocations. Therefore, in 2011 the calcium-catalyzed direct amination of π-activated 
alcohols was developed. For tertiary, allylic and propargyl alcohols, they were successfully 
aminated by this methodology (Scheme 18).[22] 
 
 
 
 
Scheme 18. Calcium-catalyzed direct amination of π-activated alcohols. 
Allyltrimethylsilanes 103 are good nucleophiles that are widely used as coupling partners 
in transition-metal catalyzed reactions. Thus, in 2011 the calcium-catalyzed direct coupling 
reaction of π-activated alcohols 92/105 with organosilanes 103/106 was described. The highly 
reactive carbocations produced from π-activated alcohols by calcium catalysis were smoothly 
intercepted by the organosilanes 103 or 106 (Scheme 19).[23] In addition, tertiary, allylic and 
propargyl alcohols were quite suitable for the coupling reaction as well. 
 
 
 
 
 
Scheme 19. Calcium-catalyzed coupling reactions of π-activated alcohols with organosilanes. 
Silanes are excellent nucleophiles that have broad applications in reduction reactions, 
such as the reduction of carbonyl groups and imines. In 2012, the calcium-catalyzed 
deoxygenation of π-activated alcohols by using triethylsilanes 109 as an inexpensive and 
environmentally benign reductant was therefore developed (Scheme 20).[24] The tiethylsilane 
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109 successfully reduced not only secondary alcohols 108, but also tertiary alcohols 111. 
Normally, the elimination of tertiary carbocations leading to alkenes is always preferred over 
the reduction of tertiary carbocations. However, in this case, the elimination products were 
significantly prevented by using CH3NO2 as the solvent or N,N-dimethylanilinium 
tetra(pentafluorophenyl)borate as the additive. 
 
 
 
 
 
Scheme 20. Calcium-catalyzed deoxygenation of alcohols. 
In 2013, the first calcium-catalyzed carbocation cascade reaction was demonstrated, 
which provided a highly elegant protocol for the diastereoselective synthesis of cyclopropanes 
114 containing heterocycles  that were essential structural motifs found in a myriad of 
natural isolates and pharmaceuticals.[25] A proposed mechanism for the cascade reaction is 
outlined in Scheme 21. The reaction began with the calcium-catalyzed dehydroxylation 
process of compounds 113, producing propargylic cations 115 and carbocations 116 bearing 
the positive charge on the allenic position. Subsequently, cyclopropanation started when the 
carbocations 116, which were stabilized by the through-space cation-π interaction of the 
positive charge with alkenes, formed in the pool of random conformers. Importantly, DFT 
calculations demonstrated that the successive two C-C and one C-X bond-forming events, 
eventually leading to the cyclopropanes 114, were merged in a concerted manner. 
Furthermore, two different geometries of olefins were found to have great effect on the 
reaction efficiency. 
 
 
 
 
 
 
Scheme 21. The first example of calcium-catalyzed carbocation cascade reactions. 
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In 2015, the first calcium-catalyzed formal [2+2+2] cycloaddition reaction of enynes 119 
with aldehydes 120 was disclosed, which allowed for a one-step synthesis of highly valuable 
bicyclic building blocks 121 with excellent chemo, region- and diastereoselectivity from 
readily available starting materials (Scheme 22).[26] A highly reactive homoallenyl cation 122 
and its cyclopropyl form 123, which were trapped by the tethered nucleophiles in the 
calcium-catalyzed cyclopropanation, can also be intercepted by the aldehyde 120. 
 
 
 
 
 
 
Scheme 22. Formal [2+2+2] cycloaddition reactions of enynes with aldehydes. 
Typically, [2+2+2] cycloaddition reactions of enynes with aldehydes rely on 
transition-metal catalyzed reactions via Co-, Rh-, Ru- and Ni metallacycles 126 or C-gold 
bond species 130 and 131 (Scheme 23).[27] Therefore, the similar type of reactions 
demonstrates that calcium catalysts can replace transition-metal catalysts in synthetic organic 
chemistry. 
 
 
 
 
 
Scheme 23. Transition-metal catalyzed [2+2+2] cycloaddition reactions of enynes with 
aldehydes. 
The alkyne moiety has nucleophilic characteristics, which can trap highly reactive 
carbocations to produce highly reactive vinyl cations. Therefore, in 2015 the 
calcium-catalyzed intermolecular carbohydroxylation of alkynes was developed (Scheme 
24).[28] Notably, cyclopentanones 135 can significantly improve the yields for the 
intermolecular carbohydroxylation of alkynes. The role of the cyclopentanone 135 is to 
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stabilize transient reactive carbocations produced from π-activated alcohols 133 by calcium 
catalysis and vinyl cations 137. 
 
 
 
Scheme 24. Cyclopentanone-promoted carbohydroxylation of alkynes. 
1.2.3 Reactions of Olefins 
 Not only alcohols but also alkenes can be efficiently transformed into the corresponding 
carbocations by calcium catalysis, which are subsequently trapped by aromatic nucleophiles. 
Therefore, in 2010 the first calcium-catalyzed hydroarylation of alkenes was described 
(Scheme 25).[29] In addition, a wide array of trisubstituted olefins and dienes were 
successfully hydroarylated in the presence of the calcium catalyst. 
 
 
 
 
 
Scheme 25. Calcium-catalyzed hydroarylation of alkenes. 
Hydroxyl groups are regarded as excellent nucleophiles, which can trap these highly 
reactive carbocations as well. In 2012 the calcium-catalyzed intramolecular hydroalkoxylation 
of alkenes was developed here, which offered an elegant protocol for the direct and efficient 
synthesis of structurally diverse cyclic tetrahydropyrans 146 and tetrahydrofurans 148 under 
mild reaction conditions (Scheme 26).[30] 
 
 
 
 
Scheme 26. Calcium-catalyzed hydroalkoxylation of alkenes. 
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1.2.4 Reactions of Carbonyl Compounds 
In 2008, Stambuli and co-workers developed the first example of the calcium-catalyzed 
regioselective Pictet-Spengler reactions of m-tyramines 149 with aldehydes 150 (Scheme 
27).[31] The Pictet-Spengler reaction is a classic synthetic route to prepare 
tetrahydroisoquinolines and β-carbonyl alkaloids. However, it was generally promoted by 
stoichiometric amounts of strong Brønsted acids, and thus resulting in many disadvantages 
caused by the harsh reaction conditions, such as limited functional group tolerance. Therefore, 
Stambuli and co-workers developed the Pictet-Spengler reaction catalyzed by 
environmentally benign calcium salts to overcome these disadvantages.[31a] The role of 
calcium catalysts is to activate the aldehyde 150 and imines 152. Two years later, Stambuli et 
al. found that unreactive ketones were quite suitable for the calcium-catalyzed Pictet-Spengler 
reaction as well.[31b] 
 
 
 
 
 
 
Scheme 27. Calcium-catalyzed Pictet-Spengler reactions. 
In 2009, Pandiarajan described the calcium-catalyzed Biginelli reaction among 
aldehydes 154, 1,3-dicarbonyl compounds 155 and urea/thiourea 156 (Scheme 28),[32] which 
provided an elegant protocol for the straightforward and efficient synthesis of 
dihydropyrimidones 157. In addition, a variety of metal-halides and metal-triflates have been  
 
 
 
 
 
 
Scheme 28. Calcium-catalyzed Biginelli reactions. 
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explored for the optimization of the Biginelli reaction. Among these inorganic salts, calcium 
fluoride was identified to exhibit superior levels of catalytic activities. The role of the Lewis 
acidic calcium catalyst is to facilitate the formation of acyl iminium intermediates 158, which 
is the rate-determining step in the Biginelli reaction (Scheme 28). In addition, the calcium 
catalyst can increase the nucleophilicity of 1,3-dicarbonyl compounds 155 by enolization 
(Scheme 28). 
In 2012, Fuchter and co-workers demonstrated the Ca(OTf)2-promoted regioselective 
Luche-type reduction of α,β-unsaturated ketones 159 with NaBH4 (Scheme 29).[33] Before this 
approach, the 1,2-reduction of α,β-unsaturated ketones 159 was generally promoted by CeCl3, 
thus it was not eco-friendly. The challenging 2-cyclopentenone was quite suitable for the 
calcium-promoted Luche-type reduction reaction. In addition, aziridinyl ketones 162 were 
also smoothly reduced by this methodology to give the stereoselective reduction adducts 163. 
 
 
 
 
 
Scheme 29. Calcium-mediated Luche-type reduction reactions. 
1.2.5 Conclusions and Perspectives 
Recent advances in calcium-catalyzed reactions were illustrated and summarized. Lewis 
acidic calcium salts have exhibited excellent activities toward alcohols, olefins and carbonyl 
compounds. Particularly, the Ca(NTf2)2 catalyst can transform not only alcohols but also 
alkenes into the corresponding carbocations. Importantly, calcium-catalyzed carbocation 
cascade reactions provide a powerful platform for the construction of molecular complexity, 
from readily available starting materials. Furthermore, [2+2+2] cycloaddition reactions of 
enynes with aldehydes demonstrate that non-toxic and abundant calcium catalysts can replace 
transition-metal catalysts in synthetic organic chemistry. 
Future developments in this area will involve the screening of suitable chiral ligands to 
realize calcium-catalyzed asymmetric reactions. In addition, calcium-catalyzed and vinyl 
cation-promoted hydride shift reactions and aryl shift reactions may be discovered by 
designing reasonable substrates.
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2. Aims of My Research Projects 
The first goal of the presented work was to develop an efficient and sustainable approach 
for the synthesis of 4H-chromenes. The established methods for the preparation of 
4H-chromenes are dependent on organocatalytic reactions that are often limited to 
salicylaldehyde derivatives and α,β-unsaturated carbonyl compounds as the reaction 
substrates, and transition-metal catalyzed reactions. Thus, the approaches are not general and 
eco-friendly. Therefore, the development of more efficient and sustainable alternatives is 
highly desirable. In this regard, inverse electron demand hetero-Diels-Alder reactions 
(IED/HDA) of alkynes with in situ generated ortho-quinone methides 165 are investigated in 
this project, which provides an elegant protocol for the straightforward synthesis of 
multi-substituted 4H-chromenes 166 (Scheme 30). 
 
 
 
Scheme 30. Calcium-catalyzed synthesis of 4H-chromenes. 
In principle, there are two different types of cyclization of alkynes with the in situ 
generated ortho-quinone methides 165, leading to 4H-chromenes 166 and 2H-chromenes 169 
respectively (Scheme 31). Electron-donating groups are therefore introduced on the aromatic 
ring in the aryl alkyne component, which are able to stablize highly reactive vinyl cations 167 
and are thus beneficial to the inverse electron demand hetero-Diels-Alder reaction (IED/HDA) 
(Scheme 31, path A). 
 
 
 
 
 
 
Scheme 31. Two different types of cyclization of alkynes with ortho-quinone methides. 
As a second part of my work, investigations of the calcium-catalyzed carboarylation of 
alkynes were undertaken. Although there are several catalytic protocols for the one-step 
synthesis of all-carbon tetrasubstituted olefins from alkynes, transition-metal catalysts, such 
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as nickel,[49] palladium,[50] copper[14] and iron salts,[51] and air and moisture sensitive 
stoichiometric organometallic reagents are required for these processes. Therefore, the 
development of more sustainable alternatives is certainly highly desirable. 
Inspired by Brønsted acid-mediated hydroarylation of alkynes (Scheme 32, path A),[52] 
the first transition-metal free approach for the one-step synthesis of all-carbon tetrasubstituted 
olefins 174 from alkynes is investigated in this project. It involves the activation of the alkyne 
moiety by carbocations followed by the introduction of carbon nucleophiles (Scheme 32, path 
B). In other words, a transient, highly reactive vinyl cation 173 is generated by the 
nucleophilic addition of alkynes to the carbon electrophiles. Subsequently, the highly reactive 
vinyl cation 173 is intercepted by the carbon nucleophiles, leading to the all-carbon 
tetrasubstituted olefins 174 (Scheme 32, path B). 
 
 
 
 
 
 
Scheme 32. Hydroarylation versus carboarylation of alkynes. 
There are several possibilities for the calcium-catalyzed carboarylation of alkynes. First, 
in theory, two different trisubstituted highly reactive vinyl cations 173 and 175 might be 
generated by the nucleophilic addition of alkynes to carbocations, potentially leading to the 
formation of regio-isomeric mixtures of products 174 (Scheme 32, path B) and products 176 
(Scheme 33, path A). Therefore, aryl alkynes and ynamides are selected as the reaction  
 
 
 
 
 
 
Scheme 33. Different calcium-catalyzed electrophilic cyclizations of alkynes. 
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substrates to selectively induce the formation of the trisubstituted highly reactive vinyl cations 
173. Alternatively, Lewis acid-bound vinyl cations 177 might be produced by the direct 
activation of alkynes by the calcium catalyst. Subsequently, protodemetallation of the Lewis 
acid-bound vinyl cations 177 would lead to the formation of hydroarylation products 178 
(Scheme 33, path B). Hence, many factors such as solvents, additives and reaction 
temperature must be considered to prevent the generation of the Lewis acid-bound vinyl 
cations 177. 
As a third part of my work, the development of a new concept for a redox-neutral C-C 
bond functionalization was projected. In 2005, Sames described redox-neutral C-H bond 
functionalizations based on intramolecular 1,5-hydrogen transfer processes (Scheme 34).[54]  
 
 
Scheme 34. Redox-neutral C-H bond functionalizations presented by Sames. 
Inspired by his pioneering work, the new concept for the redox-neutral C-C bond 
functionalization based on intramolecular 1,3-aryl migration is investigated in this project 
(Scheme 35). 
 
 
 
Scheme 35. New concept for a redox-neutral C-C bond functionalization. 
As an extension of the redox-neutral C-C bond activation reaction, the development of 
more efficient and sustainable approaches for the synthesis of 2H-chromenes was also 
projected. Although a variety of methods for the synthesis of 2H-chromenes are documented 
in the literature,[61c] the approaches suffer from multi-step reaction sequences, limited 
functional group tolerance and formation of regio-isomeric mixtures. Particularly, 
transition-metal catalysts and complex prefunctionlized fragments are required in most cases. 
Therefore, the first transition-metal free alkyne insertion reaction proceeding through the C-C  
 
 
 
Scheme 36. Synthesis of 2H-chromenes through unstrained C-C σ bond activation. 
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σ bond cleavage of benzylic alcohols 164 is investigated in this project, which provides an 
elegant protocol for the direct synthesis of multi-substituted 2H-chromenes 169 (Scheme 36). 
Theoretically, there are two different types of cyclization of alkynes with in situ 
generated ortho-azaquinone methides or ortho-quinone methides, leading to the 
rearrangement products 189 and the direct [4+2] cyclization products 191 (Scheme 37). Many 
factors such as metal catalysts, additives, solvents and reaction temperature must be taken into 
account to avoid the formation of the [4+2] cyclization products 191. Among these factors, 
metal catalysts seem to be particularly interesting, for the coordination between the metal 
catalysts and the ortho-azaquinone methides or ortho-quinone methides might play an 
important role in the selectivity of these two different reactions. 
 
 
 
 
 
Scheme 37. [2+2] Cyclization versus [4+2] cyclization of alkynes.
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3. Results and Discussion 
3.1. Calcium-Catalyzed Synthesis of 4H-Chromenes 
3.1.1 Background 
4H-Chromenes belong to the privileged structural motifs frequently found in both natural 
isolates and pharmaceutically active compounds (such as these molecules shown in Figure 
10).[34] Therefore, considerable effort of chemists has been directed toward the synthesis of 
such a framework over the past decade. The established methods for the preparation of 
4H-chromenes include: (1) ruthenium-catalyzed cycloaddition reactions of propargylic 
alcohols with phenol derivatives via allenylidene intermediates;[35] (2) ruthenium-catalyzed 
 
 
 
 
 
Figure 10 
RCM reactions of aryl vinyl ethers;[36] (3) CuI-catalyzed intramolecular O-arylation of aryl 
bromides with 1,3-dicarbonyl groups;[37] (4) the tetrahydrothiophene-catalyzed tandem 
annulation reactions by Michael addition/elimination/substitution sequences;[38] (5) tandem 
reactions of 1,3-dicarbonyls with salicylaldehyde derivatives;[39] (6) organocatalytic tandem 
annulation reactions of α,β-unsaturated alkynes with salicylaldehyde derivatives;[40] (7) 
organocatalytic tandem annulation reactions of allenic esters or ketones with salicylaldehyde 
derivatives;[41,42] (8) metal-free reactions of chalcones with kojic acids, indoles or phenols 
through intermolecular Michael addition/intramolecular condensation sequences;[43] (9) 
further synthetic transformations of benzopyrans.[44] However, the approaches suffer from the 
limited diversity of readily available starting materials, multi-step reaction sequences or the 
use of transition-metal catalysts. Therefore, the development of more general and sustainable 
alternatives is highly desirable. 
Based on previous studies here, ortho-quinone methides 165 can be in situ generated 
from benzylic alcohols 164 by calcium catalysis. Subsequently, inverse electron demand 
hetero-Diels-Alder reactions (IED/HDA) of the ortho-quinone methides 165 with alkynes 
allow for the straightforward synthesis of 4H-chromenes 166 (Scheme 30). 
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3.1.2 Aims 
The goal of this work was to develop an efficient and sustainable approach for the 
synthesis of 4H-chromenes. The established methods for the preparation of 4H-chromenes are 
dependent on organocatalytic reactions that are often limited to salicylaldehyde derivatives 
and α,β-unsaturated carbonyl compounds as the reaction substrates, and transition-metal 
catalyzed reactions. Thus, the approaches are not general and eco-friendly. Therefore, the 
development of more efficient and sustainable alternatives is highly desirable. In this regard, 
inverse electron demand hetero-Diels-Alder reactions (IED/HDA) of alkynes with in situ 
generated ortho-quinone methides 165 are investigated in this project, which provides an 
elegant protocol for the straightforward synthesis of multi-substituted 4H-chromenes 166 
(Scheme 30). 
In principle, there are two different types of cyclization of alkynes with the in situ 
generated ortho-quinone methides 165, leading to 4H-chromenes 166 and 2H-chromenes 169 
respectively (Scheme 31). Therefore, electron-donating groups are introduced on the aromatic 
ring in the aryl alkyne component, which are able to stablize highly reactive vinyl cations 167 
and are thus beneficial to the inverse electron demand hetero-Diels-Alder reaction (IED/HDA) 
(Scheme 31, path A). 
3.1.3 Optimization of the [4+2] Cycloaddition Reaction of Alkynes 
Initially, the reaction of 5-chloro-2-(1-hydroxyethyl)phenol 164a with 
1-p-methoxyphenyl-1-hexyne 183a in DCE, in the presence of 5 mol% Ca(NTf2)2 and 5 mol% 
Bu4NPF6 at 40 oC for 12 h was examined. Gratifyingly, the desired product 166a was 
obtained in 92% isolated yield (table 1, entry 1). The reaction also worked well in CH3NO2 as 
media (table 1, entry 2) or when using other additives such as Bu4NBF4 and Bu4NSbF6 (table 
1, entry 3-4). Notably, the desired adduct 166a was obtained in excellent yield even when 2.5 
mol% Ca(NTf2)2 and 2.5 mol% Bu4NPF6 were used (table 1, entry 5, 91%). However, the 
reaction didn’t work in the absence of additives (table 1, entry 6) and 5 mol% HNTf2 
exhibited lower catalytic activities compared to 2.5 mol% Ca(NTf2)2/2.5 mol% Bu4NPF6 
(table 1, entry 5 versus entry 7-8). From these optimization results, 2.5 mol% Ca(NTf2)2 and 
2.5 mol% Bu4NPF6 in DCE at 40 oC for 12 h were selected as the standard reaction conditions 
(table 1, entry 5). 
Table 1. Optimization of the calcium-catalyzed [4+2] cycloaddition reaction. 
    
    
    
+
X mol% Ca(NTf2)2/
Y mol% additive
Solvent
40 oC, 12 h
OH
OHCl
H3CO C4H9
OCl
CH3
C4H9
PMP
164a 183a 166a
 Results and Discussion  27 
 
 
Entry [a] Ca(NTf2)2 (X mol%) Additive (Y mol%) Solvent Yield (%)[b]
1 5 Bu4NPF6 (5) DCE 92 
2 5 Bu4NPF6 (5) CH3NO2 73 
3 5 Bu4NBF4 (5) DCE 84 
4 5 Bu4NSbF6 (5) DCE 79 
5 2.5 Bu4NPF6 (2.5) DCE 91 
6 2.5 ------ DCE ------ 
7c ------ Bu4NPF6 (2.5) DCE 84 
8c ------ ------ DCE 83 
[a] Additives and Ca(NTf2)2 were added to 164a (0.4 mmol) and 183a (0.6 mmol) in 4 mL solvent and the 
reaction was then stirred at 40 oC for 12 h. [b] The isolated yield. [c] 5 mol% HNTf2 was used. 
3.1.4 Synthesis of Substrates 
 Benzylic alcohols 164 were synthesized from the corresponding commercial ketones 
196 and aldehydes 197 according to the known methods.[39a] For example, reduction of the 
ketones 196 by NaBH4 provided the benzylic alcohols 164a-164d directly (Figure 11). The 
nucleophilic addition of organometallic reagents 198 to the aldehydes 197 allowed for the 
continuation of synthesis of the benzylic alcohols 164e-164i (Figure 12). 
 
 
 
 
 
Figure 11 
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Figure 12 
For the synthesis of alkynes 183, they can be obtained by the Sonogashira coupling 
reaction of terminal alkynes 199 with aryl iodides 200 (Figure 13).[45] In addition, it can also 
be prepared from terminal alkynes 201 and methyl iodides 202 in the presence of 
n-butyllithium as a strong base (Figure 13).[46] 
 
 
 
 
 
Figure 13 
3.1.5 Scope of the Calcium-Catalyzed [4+2] Cycloaddition Reaction 
With the optimal reaction conditions in hand, the scope of the inverse electron demand 
hetero-Diels-Alder reaction of alkynes 183 with in situ generated ortho-quinone methides was 
next examined. Bromo atom and chloro atom, which not only can prevent polymerization of 
benzylic alcohols 164 by decreasing the electron density on the benzene ring, but also are 
regarded as excellent coupling functional groups in transition-metal catalyzed reactions, can 
be introduced on the 2-(1-hydroxyethyl)phenol at the C4 and C5 positions without loss in 
reaction efficiency (table 2, 166a-166b). Importantly, a wide variety of structurally diverse 
secondary benzylic alcohols 164, which bear sterically hindered groups, can be employed as 
the reaction substrates and the reactions afforded the desired [4+2] cycloaddition adducts in 
moderate to excellent yields (table 2, 166c-166e). Furthermore, the aryl framework of the  
Table 2. Scope of the calcium-catalyzed [4+2] cycloaddition reaction. 
      
      
      
+
I
Ar
5 mol% Pd(PPh)4
10 mol% CuI, Et3N, 60 oC
C4H9
Ar
C4H9
H3CO C4H9
S
C4H9
H3C + CH3I
n-BuLi, HMPA
THF, -78 oC to rt
H3C CH3
183a 183b
183g
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199 200
202
OH
OH
Ph
Br
OH
OH
Cl
OH
OH
Cl
OH
Ph OH
OH
OH
Ph
H3C
164e 164f 164g 164h 164i
 Results and Discussion  29 
 
 
   
 
 
 
  
   
[a] 2.5 mol% Bu4NPF6 and 2.5 mol% Ca(NTf2)2 were added to benzylic alcohols 164 (0.4 mmol) and 
alkynes 183 (0.6 mmol) in 4 mL DCE and the reaction was then stirred at 40 oC for 12 h. [b] Isolated yields. 
[c] 5 mol% Al(OTf)3/NH4PF6/Bu4NSbF6 were used and the reaction was stirred at 80 oC. 
benzylic alcohols 164 can be successfully extended to electron-rich aromatic and 
naphthalene-derived systems (table 2, 166f-166h). More importantly, structural variation in 
the aryl alkyne component can also be realized. Both the aryl and heteroaromatic alkynes 
reacted smoothly with 164a and 164b under the standard reaction conditions (table 2, 
166i-166k). 
3.1.6 Mechanistic Discussion 
Based on previous studies here, plausible reaction mechanisms for the inverse electron 
demand hetero-Diels-Alder reaction of alkynes with the in situ generated ortho-quinone 
methides are outlined in Scheme 38. The reaction started with the calcium-catalyzed 
dehydroxylation process of 164a, generating ortho-quinone methides 203 and carbocations 
204. There are two possible pathways for the [4+2] cycloaddition processes. In the first 
pathway, the inverse electron demand hetero-Diels-Alder reaction (IED/HDA) proceeded in a 
concerted manner (Scheme 38, path a), thus directly leading to the eventual product 166a. In 
 
 
 
 
 
 
 
 
Scheme 38. Proposed pathways for the [4+2] cycloaddition reaction of alkynes. 
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the other pathway, a stepwise mechanism can’t be ruled out. A trisubstituted highly reactive 
vinyl cation 205 was produced by the nucleophilic addition of alkynes 183a to the 
electrophilic intermediates 203/204, which was subsequently intercepted by the tethered 
phenolic hydroxyl group to afford the same product 166a (Scheme 38, path b). 
3.1.7 Conclusion 
In summary, the first [4+2] cycloaddition reaction of alkynes with in situ generated 
ortho-quinone methides has been developed, which provides an elegant protocol for the 
straightforward and efficient synthesis of structurally diverse multi-substituted 4H-chromenes 
166. In addition, eleven representative adducts were readily obtained by this methodology in 
moderate to excellent yields (40-93%) under very mild reaction conditions. 
The reaction proceeded through either a concerted inverse electron demand 
hetero-Diels-Alder reaction (IED/HDA) or a stepwise mechanism via trisubstituted highly 
reactive vinyl cations. In the stepwise mechanism, the trisubstituted highly reactive vinyl 
cation would be trapped by the tethered phenolic hydroxyl group. 
3.2. Calcium-Catalyzed Carboarylation of Alkynes 
3.2.1 Background 
All-carbon tetrasubstituted olefins are ubiquitous structural motifs that widely occur in 
not only natural isolates, but also pharmaceuticals and materials.[47] In addition, they are 
versatile starting materials for the synthesis of complex fine chemicals through hydrogenation, 
dihydroxylation and epoxidation. However, their synthesis is very difficult by conventional 
olefination methods such as olefin metathesis and carbonyl olefination,[47a] because of the 
congested nature of densely substituted olefins. Over the past decade, transition-metal 
catalysis has became a powerful tool for the introduction of substituents to the alkyne moiety. 
Nevertheless, most transition-metal catalyzed reactions proceeded through vinyl-metal 
species 207, which subsequently underwent protodemetallation, leading to the formation of 
trisubstituted olefins (Scheme 39, path A). Although a few methods have been demonstrated 
to obtain all-carbon tetrasubstituted olefins from alkynes in a stepwise reaction 
 
 
 
 
Scheme 39. Synthesis of olefins through hydroarylation of alkynes. 
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sequence,[47a, 48] the development of catalytic protocols for the one-step synthesis of all-carbon 
tetrasubstituted olefins from alkynes still remains one of the major challenges in synthetic 
organic chemistry. Particularly, transition-metal catalysts, such as nickel,[49] palladium,[50] 
copper[14] and iron salts,[51] and air and moisture sensitive stoichiometric organometallic 
reagents are required for these processes. Therefore, the development of more efficient and 
sustainable alternatives is highly desirable. 
Inspired by Brønsted acid-mediated hydroarylation of alkynes (Scheme 39, path B),[52] 
an ideal strategy for the synthesis of all-carbon tetrasubstituted olefins is envisaged, which 
involves the activation of the alkyne moiety by carbon electrophiles such as carbocations 
followed by the subsequent introduction of carbon nucleophiles (Scheme 32, path B). In other 
words, a transient, highly reactive vinyl cation 173 is generated by the nucleophilic addition 
of alkynes 170 to the carbon electrophiles. Subsequently, the highly reactive vinyl cation 173 
is trapped by the carbon nucleophiles, and thus leading to the formation of all-carbon 
tetrasubstituted olefins 174 (Scheme 32, path B). Therefore, this strategy is able to avoid the 
formation of the vinyl-metal species 207, and two carbon substituents are concomitantly 
introduced to the C-C triple bond. 
3.2.2 Aims 
As a second part of my work, investigations of the calcium-catalyzed carboarylation of 
alkynes were undertaken. Although there are several catalytic protocols for the one-step 
synthesis of all-carbon tetrasubstituted olefins from alkynes, transition-metal catalysts, such 
as nickel,[49] palladium,[50] copper[14] and iron salts,[51] and air and moisture sensitive 
stoichiometric organometallic reagents are required for these processes. Therefore, the 
development of more sustainable alternatives is highly desirable. 
Inspired by Brønsted acid-mediated hydroarylation of alkynes (Scheme 32, path A),[52] 
the first transition-metal free approach for the one-step synthesis of all-carbon tetrasubstituted 
olefins from alkynes is investigated in this project. It involves the activation of the alkyne 
moiety by carbocations followed by the introduction of carbon nucleophiles (Scheme 32, path 
B). In other words, a transient, highly reactive vinyl cation 173 is generated by the 
nucleophilic addition of alkynes to the carbon electrophiles. Subsequently, the highly reactive 
vinyl cation 173 is trapped by the carbon nucleophiles, leading to the formation of all-carbon 
tetrasubstituted olefins 174 (Scheme 32, path B). 
There are several possibilities for the calcium-catalyzed carboarylation of alkynes. First, 
in theory, two different trisubstituted highly reactive vinyl cations 173 and 175 might be 
generated by the nucleophilic addition of alkynes to carbocations, potentially leading to the 
regio-isomeric mixtures of products 174 (Scheme 32, path B) and products 176 (Scheme 33, 
path A). Aryl alkynes and ynamides are therefore chosen as the reaction substrates to 
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selectively induce the formation of the trisubstituted highly reactive vinyl cations 173. 
Alternatively, Lewis acid-bound vinyl cations 177 might be produced by the direct activation 
of alkynes by the calcium catalyst. Subsequently, protodemetallation of the Lewis acid-bound 
vinyl cations 177 would lead to the formation of hydroarylation products 178 (Scheme 33, 
path B). Hence, many factors such as solvents, additives and reaction temperature must be 
considered to prevent the generation of the Lewis acid-bound vinyl cations 177. 
3.2.3 Optimization of the Calcium-Catalyzed Carboarylation of Alkynes 
In the initial investigation, the reaction of 4-hydroxyphenylethanol 209a with acetylene 
210a in DCE, in the presence of 5 mol% Ca(NTf2)2 and 5 mol% Bu4NPF6 at 40 °C for 12 h 
was examined. Gratifyingly, the reaction did occur and the desired carboarylation adduct 
211a was obtained in 56% isolated yield (table 3, entry 1). Inspired by this result, further 
optimization of reaction conditions was then explored. It was pleased to find that solvents had 
great effect on the reaction efficiency, and the reaction yield was significantly improved when 
using CH3NO3 as media (table 3, entry 2). In addition, decreasing the additive Bu4NPF6 
loading to 2.5 mol% slightly improved the reaction yield (Table 3, entry 3). The reaction also 
worked well when using other additives such as NH4PF6 and Bu4NSbF6 (table 3, entry 4-5). 
Furthermore, mixed solvents and two equivalents of 209a were investigated as well in order 
to improve the reaction efficiency further, but no better results were obtained (table 3, entry 
6-7). Notably, the reaction didn’t work in the absence of additives (table 3, entry 8) and 10 
mol% HNTf2 exhibited lower catalytic activities than 5 mol% Ca(NTf2)2/2.5 mol% Bu4NPF6 
(Table 3, entry 3 versus entry 9-10). From these optimization results, 5 mol% Ca(NTf2)2 and 
2.5 mol% Bu4NPF6 in CH3NO2 at 40 °C for 12 h were selected as the standard reaction 
conditions (Table 3, entry 3). 
Table 3. Optimization of the calcium-catalyzed carboarylation of alkynes. 
    
    
    
Entry [a] Additive (X mol%) Solvent Yield (%)[b] 
1 Bu4NPF6 (5) DCE 56 
2 Bu4NPF6 (5) CH3NO2 83 
3 Bu4NPF6 (2.5) CH3NO2 85 
4 NH4PF6 (2.5) CH3NO2 80 
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5 Bu4NSbF6 (2.5) CH3NO2 81 
6 Bu4NPF6 (2.5) CH3NO2/DCE (1:1) 77 
7c Bu4NPF6 (2.5) CH3NO2 82 
8 ------ CH3NO2 ------ 
9d Bu4NPF6 (2.5) CH3NO2 70 
10d ------ CH3NO2 71 
[a] Additives and Ca(NTf2)2 were added to 210a (0.48 mmol) and 209a (0.4 mmol) in 2 mL solvent and the 
reaction was then stirred at 40 °C for 12 h. [b] The isolated yield. [c] Two equivalents of 209a were used. 
[d] 10 mol% HNTf2 was used. 
3.2.4 Synthesis of Substrates 
π-Activated alcohols were sythesized from the corresponding ketones 212 and aldehydes 
213 according to the known methods (Figure 14 and 15).[39a] Notably, cyclic allylic alcohols 
209f and 209g were obtained by the Ca(OTf)2-promoted selective 1,2-reduction of 
α,β-unsaturated ketones with NaBH4.[33] 
 
 
 
 
 
Figure 14 
 
 
 
 
 
Figure 15 
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 For the synthesis of alkynes 210, they can be obtained by the Sonogashira coupling 
reaction of terminal alkynes 214 with aryl iodides 200 (Figure 16).[45] In addition, the 
nucleophilic displacement reactions of bromides 215 with 4-ethynylanisoles 216 allowed for  
 
 
 
 
 
 
 
 
Figure 16 
the concise synthesis of other different alkynes 210 (Figure 17).[14] Furthermore, 
copper-catalyzed aerobic oxidative C-N bond coupling of terminal alkynes 214 with 
oxazolidin-2-ones 217 provided an efficient access to ynamides 210l (Figure 18).[14] 
 
 
 
 
 
 
 
Figure 17 
 
 
Figure 18 
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The rest of alkynes 210 containing the oxygen atom and nitrogen atom were prepared by 
classic reactions from readily available starting materials (Figure 19 and 20).[14] 
 
 
 
 
Figure 19 
 
 
 
 
Figure 20 
3.2.5 Scope of the Calcium-Catalyzed Carboarylation of Alkynes 
With the optimized reaction conditions in hand, the scope of the calcium-catalyzed 
carboarylation of alkynes was next investigated. As revealed in table 4, π-activated alcohols 
as carbon electrophiles were first examined. The reaction is quite general with respect to the 
electronic nature of substituents on the aromatic ring of benzylic alcohols (table 4, 211a-211f). 
For example, OH, MeO, Me, Cl and NHTs can be introduced on the 1-phenylethanol at the 
C2 and C4 positions without loss in reaction efficiency. Furthermore, the reaction seems quite 
tolerant with respect to functional groups in the π-activated alcohol component, such as C-C 
double bonds and C-C triple bonds (table 4, 211g-211i). More importantly, sterically hindered 
secondary benzylic alcohols and cyclic allylic alcohols can be employed as the reaction 
substrates and the reactions provided the desired carboarylation adducts in good to excellent 
yields (table 4, 211j-211m). 
Table 4. Scope of the π-activated alcohols as carbon electrophiles. 
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[a] 2.5 mol% Bu4NPF6 and 5 mol% Ca(NTf2)2 were added into 210a (0.48 mmol) and 209 (0.4 mmol) in 2 
mL CH3NO2 and the reaction was then stirred at 40 oC for 12 h. [b] Isolated yields after column 
chromatography. [c] 2 mL DCE/CH3NO2 (1:1) was used. [d] 2 mL DCE was used. 
Next the substituents on the C-C triple bond were examined, both aryl and 
heteroaromatic groups gave the corresponding carboarylation adducts in excellent yields 
(table 5, 211n-211q). Notably, an axial scaffold that has broad applications in asymmetric 
catalysis was successfully installed by this methodology (table 5, 211o-211p), although 
obtaining the racemic compounds. Furthermore, ynamides 210l reacted smoothly with 209a, 
providing more complex dihydronaphthalene derivatives (table 5, 211r). 
The linkage between aryl nucleophiles and the C-C triple bond was investigated as well. 
Not only an ethylene linking unit but also oxygen and nitrogen substituents can be 
incorporated into the substrates (table 5, 211a’-211c’), which allowed for the direct and 
efficient synthesis of multi-substituted 2H-chromenes and 1,2-dihydroquinolines. In addition, 
the 1,2-dihydroquinoline 211b’ was obtained in 73% isolated yield through simple filtration 
after reaction completion (table 5, 211b’). Furthermore, the diastereoselectivity of the reaction 
was examined by introducing an additional substituent in the linkage (table 5, 211c’), 
although the result was moderate. More importantly, a seven-membered carbocyclic ring can 
be formed by this methodology, which further expands the substrate scope (table 5, 211d’). 
Table 5. Scope of alkyne substituents and linking units. 
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[a] 2.5 mol% Bu4NPF6 and 5 mol% Ca(NTf2)2 were added into 210 (0.48 mmol) and 209a (0.4 mmol) in 2 
mL CH3NO2 and the reaction was then stirred at 40 oC for 12 h. [b] Isolated yields after column 
chromatography. [c] Reactions stirred at 80 oC for 12 h and the dr was determined by 1H NMR analysis of 
the crude mixture. 
Finally, the scope of aryl nucleophiles was examined. The reaction seems quite general 
with respect to the electronic nature of substituents on the nucleophilic aromatic ring, both 
electron-donating and electron-withdrawing groups can be introduced without loss in reaction 
efficiency (table 6, 211s-211v). Furthermore, the aryl framework can be successfully 
extended to heteroaromatic and naphthalene-derived systems (table 6, 211w-211x). 
Table 6. Scope of aromatic nucleophiles. 
   
   
   
   
   
   
   
   
   
[a] 2.5 mol% Bu4NPF6 and 5 mol% Ca(NTf2)2 were added into 210 (0.48 mmol) and 209a (0.4 mmol) in 2 
mL CH3NO2 and the reaction was then stirred at 40 oC for 12 h. [b] Isolated yields after column 
chromatography. 
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3.2.6 Mechanistic Study 
To gain insight into a plausible reaction mechanism, dihydronaphtalenes 226 that were 
seperated as a by-product in the reaction mixture reacted with 209a and 209b under the 
standard reaction conditions (eqn(1) and eqn(2)). The desired products 211a and 211b were 
obtained in 8% and 21% yields respectively together with the unreacted dihydronaphtalene 
226. Therefore, trisubstituted highly reactive vinyl cations generated by the nucleophilic 
addition of alkynes to the carbocations that were produced from π-activated alcohols by 
calcium catalysis were clearly demonstrated in the calcium-catalyzed carboarylation of 
alkynes. 
 
 
 
 
 
3.2.7 Conclusion 
In conclusion, the first transition-metal free carboarylation of alkynes with readily 
available alcohols was realized in the presence of non-toxic and abundant calcium catalysts, 
which provides a novel protocol for the one-step synthesis of all-carbon tetrasubstituted 
olefins from alkynes. A trisubstituted highly reactive vinyl cation 173 was generated by the 
nucleophilic addition of alkynes to carbocations, which was subsequently intercepted even by 
deactivated arenes as the tethered nucleophiles. In addition, twenty eight representative 
adducts were readily obtained by this methodology in moderate to excellent yields (56-97%) 
under very mild reaction conditions. 
3.3. Al(OTf)3-Catalyzed Insertion of an Unactivated Alkyne into an 
Unstrained C-C σ Bond 
3.3.1 Background 
Over the past decade, considerable effort of chemists has been devoted to addressing the 
long-standing problem of the direct functionalization of unactivated C-H bonds, and therefore 
remarkable progress has been made in this area.[53] Complementing the more classical, 
directing group/transition metal-triggered strategies, in 2005 Sames revived an alternative 
approach to C-H bond activation based on intramolecular 1,5-hydrogen transfer processes.[54] 
As opposed to the aforementioned transition-metal catalyzed C-H bond transformations, no 
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terminal oxidants were required for the C-H bond activation reaction, thus this strategy was 
called as the “redox-neutral C-H bond functionalizations” (Scheme 34). 
Despite advances in the field of the direct C-H functionalizations, the cleavage and 
activation of C-C σ bonds still remains one of the major challenges in modern synthetic 
chemistry, from the viewpoint of practicability and mechanistic understanding.[55] Reactions 
generally rely on the C-C σ bond cleavage of constrained small-ring molecules by the release 
of strain energy.[55k] In recent years, notable achievements have been made by transition-metal 
catalyzed reactions, which are limited to nitriles, acylquinolines and carbonyl compounds as 
the unconstrained reaction substrates.[55l] In addition, several transition-metal free C-C σ bond 
cleavage reactions have been recently demonstrated, which were enabled by oxidative 
processes.[56] Therefore, in analogy to the redox-neutral C-H bond functionalization presented 
by Sames, a new concept for a redox-neutral C-C bond functionalization based on the first 
transition-metal free alkyne insertion reaction through unstrained C-C σ bond activation has 
been developed here, such as the one described in Scheme 40. 
 
 
 
 
 
Scheme 40. New concept for a redox-neutral C-C bond functionalization. 
3.3.2 Aims 
As a third part of my work, the development of a new concept for a redox-neutral C-C 
bond functionalization was projected. In 2005, Sames described redox-neutral C-H bond 
functionalizations based on intramolecular 1,5-hydrogen transfer processes (Scheme 34).[54] 
Inspired by his pioneering work, the new concept for the redox-neutral C-C bond 
functionalization based on intramolecular 1,3-aryl migration is investigated in this project 
(Scheme 40). 
3.3.3 Optimization of the 1,3-Aryl Shift Reaction 
Initially, the reaction of N-(2-(1-hydroxyethyl)phenyl)-4-methylbenzenesulfonamide 
182a with 1-phenyl-1-propyne 229 in DCE, in the presence of 10 mol% Ca(NTf2)2 and 10 
mol% Bu4NPF6 at room temperature for 12 h was investigated. Gratifyingly, the reaction did 
occur and gave both the desired rearrangement product 184a and the direct [4+2] 
cylcoaddition product 184a’ in 65% isolated yield, albeit with poor selectivity (table 7, entry 
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1, 184a/184a’ = 68:32). In addition, the structure of the rearrangement product 184a was 
confirmed by X-ray diffraction analysis unambiguously. Thus, further optimization of 
reaction conditions was then explored. Notably, the reaction efficiency was slightly improved 
Table 7. Optimization of the unstrained C-C σ bond activation reaction. 
   
   
   
Entry [a] Catalyst (10 
mol%) 
Additive (X 
mol%) 
Solvent Yield (%)[b] Ratio[c] 
184a/184a’
1 Ca(NTf2)2 Bu4NPF6 (10) DCE 65 68:32 
2 Ca(NTf2)2 Bu4NPF6 (5) DCE 69 77:23 
3 LiNTf2 Bu4NPF6 (5) DCE 60 64:36 
4 Mg(NTf2)2 Bu4NPF6 (5) DCE 84 73:27 
5 Al(OTf)3 Bu4NPF6 (5) DCE 91 88:12 
6 Al(NTf2)3 Bu4NPF6 (5) DCE 81 74:26 
7 Al(OTf)3 ------ DCE ------ ------ 
8 TfOH (10) Bu4NPF6 (5) DCE 39 83:17 
9 TfOH (10) ------ DCE 43 86:14 
10 Al(OTf)3 Bu4NPF6 (5) CH3NO2 89 82:18 
11 Al(OTf)3 Bu4NPF6 (5) DCM 84 95:5 
12 Al(OTf)3 Bu4NSbF6 (5) DCE 50 95:5 
13 Al(OTf)3 Bu4NBF4 (5) DCE 71 95:5 
14d Al(OTf)3 Bu4NPF6 (5) DCE 87 95:5 
15e Al(OTf)3 Bu4NPF6 (5) DCE 86 95:5 
16f Al(OTf)3 Bu4NPF6 (5) DCE 83 91:9 
[a] Alcohols 182a (0.3 mmol) and alkynes 229 (0.36 mmol) were added at room temperature to additives 
and catalysts in 1.5 mL solvent and the reaction was then stirred for 12h at rt. [b] The isolated and 
combined yield of 184a and 184a’. [c] Ratio for 184a/184a’ determined by 1H NMR spectroscopy of the 
crude mixture. [d] Reaction at 40 oC. [e] Reaction at 80 oC. [f] Reaction in 3 mL DCE. 
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by deceasing the additive Bu4NPF6 loading to 5 mol% (table 7, entry 2), and  Al(OTf)3 (10 
mol%) was identified to exhibit excellent selectivity toward the formation of the 
rearrangement product 184a (table 7, entry 5, 91%, 184a/184a’ = 88:12) after the 
investigations of a series of environmentally benign catalysts (table 7, entry 3-6). However, 
the reaction didn’t work in the absence of additives (table 7, entry 7), and 10 mol% TfOH 
gave low yield for the rearrangement product 184a with good selectivity (table 7, entry 8-9). 
The rearrangement reaction also worked well in DCM or CH3NO2 as media (table 7, entry 
10-11). Furthermore, the influence of several other additives such as Bu4NSbF6 and Bu4NBF4 
were examined as well, but no better results were obtained (table 7, entry 12-13). After the 
further investigations of the reaction temperature and reaction concerntrations (table 7, entry 
14-16), 10 mol% Al(OTf)3/5 mol% Bu4NPF6 in 0.2 M DCE at 40 oC for 12 h were selected as 
the standard reaction conditions (table 7, entry 14). 
3.3.4 Synthesis of Substrates 
Benzylic alcohols 182 were obtained from the corresponding commercial ketones 233 
and alcohols 236 according to the known methods.[57] For example, protection of amines 233 
by tosyl group and subsequent reduction of ketones 235 with NaBH4 gave the substrates 182a 
and 182b (Figure 21).[57a] 
 
 
 
 
 
Figure 21 
Aldehydes 238 were prepared from the commercial benzylic alcohols 236 through amino 
protection by tosyl group and subsequent oxidation of hydroxyl groups by PCC (Figure 22). 
Then, the nucleophilic addition of organometallic reagents 198 to the aldehyde 238 provided 
an easy access to the benzylic alcohols 182c-182e (Figure 22).[57b] 
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Figure 22 
For the synthesis of alkynes 183, they can be obtained by the Sonogashira coupling 
reaction of terminal alkynes 239 with aryl iodides 200 (Figure 23).[45] In addition, it can also 
be prepared from terminal alkynes 240 and methyl iodides 202 in the presence of 
n-butyllithium as a strong base (Figure 24).[46] 
 
 
 
 
Figure 23 
 
 
Figure 24 
3.3.5 Scope of the Al(OTf)3-Catalyzed 1,3-Aryl Shift Reaction 
With the optimal reaction conditions in hand, the scope of this Al(OTf)3-catalyzed 
unstrained C-C σ bond activation reaction was next investigated. As revealed in table 8, not 
only the aryl alkynes with long carbon chains (table 8, 184b), the carbon chain containing 
bromo atom (table 8, 184c), but also the aryl alkynes with both electron-donating (table 8, 
184d-184e) and electron-withdrawing groups (table 8, 184f-184g) on the aromatic ring, 
reacted smoothly with 182a under the standard reaction conditions. Furthermore, the reaction 
seems quite tolerant with respect to functional groups in both the aryl alkyne and benzylic 
alcohol components, such as acetyl group (table 8, 184g) and unsaturated C-C bonds (table 8, 
184h-184i). More importantly, a wide variety of structurally diverse secondary benzylic 
alcohols, which bear alkynyl group, allyl group and phenyl group, can be employed as the 
reaction substrates and the reactions provided the desired rearrangement products in good to 
O
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excellent yields (table 8, 184h-184j). However, an electron-withdrawing chloro atom on the 
N-(2-(1-hydroxyethyl)phenyl)-4-methylbenzenesulfonamide at the C4 position was not 
beneficial to this transformation (table 8, 184k). 
Table 8. Scope of the Al(OTf)3-catalyzed 1,3-aryl shift reaction. 
   
   
   
   
   
   
   
   
[a] Alcohols 182 (0.3 mmol) and alkynes 229/183 (0.36 mmol) were added at room temperature to 
Bu4NPF6 and Al(OTf)3 in 1.5 mL DCE and the reaction was then stirred at 40 oC for 12h. [b] Isolated 
yields of 184. [c] Alkynes 183 (0.9 mmol) were used and the reaction was stirred at 80 oC. [d] 20 mol% 
Al(OTf)3/10 mol% Bu4NPF6 were used. [e] Alkynes 229 (0.9 mmol) were used. 
3.3.6 Mechanistic Study 
To gain insight into a plausible reaction mechanism, more experiments have been done 
to understand the Al(OTf)3-catalyzed unstrained C-C σ bond activation reaction. Further 
analysis of the reaction mixture at various reaction time revealed that the ratio for 184a/184a’ 
was rising from beginning to end with the increasing conversion of the starting materials 
(Figure 25). 
 
Figure 25 
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 Dimers 241 as well as small amounts of asymmetric dimers 242 were obtained by 
preparative HPLC when the model reaction was quenched after 10 minutes (eqn(3)). Because 
the isolation of the asymmetric dimer 242 was very difficult, its analogue 245 was prepared  
 
 
 
 
 
 
 
according to the literature (eqn(4)).[58] Then, 241 and 245 reacted with 229 under the standard 
reaction conditions. The rearrangement product 184a was exclusively obtained when using 
the dimer 241 (eqn(5)). However, the selectivity decreased for the compound 245, 
presumably because of the more difficult ionization of C-N bonds (eqn(6)). 
 
 
 
 
 
 
 
There is an alternative reaction pathway to explain the formation of the rearrangement 
product 184a. The reaction might proceed through retro Friedel-Crafts/Povarov reaction 
sequences, such as these illustrated in Scheme 41. To prove the hypothesis, acetals 251 that 
can be easily converted into iminiums 248 under the acidic reaction conditions were prepared 
according to the literature (eqn(7)).[59] Then, the acetal 251 reacted with 229 under the 
standard reaction conditions, whereas none of the desired product 184a was observed, 
unsaturated ketones 252 were obtained by alkyne-carbonyl metathesis reactions in high yield 
(eqn(8)).[60] Therefore, the retro Friedel-Crafts/Povarov reaction mechanism was clearly 
excluded from this transformation. 
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O
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CH3
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+
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CH3
NTs
H3C
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Scheme 41. Retro Friedel-Crafts reaction/Povarov reaction pathways. 
 
 
 
 
 
While a precise reaction mechanism for the Al(OTf)3-catalyzed unstrained C-C σ bond 
activation reaction awaits further study, a plausible reaction mechanism is outlined in Scheme 
42. The reaction began with the Al(OTf)3-catalyzed dehydroxylation process of 182a to 
generate dimers 241, which were then further transformed into ortho-azaquinone methides 
227 and carbocations 228. Subsequently, trisubstituted highly reactive vinyl cations 230 were  
 
 
 
 
 
 
 
 
 
Scheme 42. Possible mechanism for the Al(OTf)3-catalyzed 1,3-aryl shift reaction. 
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produced by the nucleophilic addition of alkynes 229 to the electrophilic intermediates 
227/228, which were then trapped by the tethered nitrogen nucleophiles to give the direct 
[4+2] cycloaddition product 184a’. Meanwhile, a 4-ipso cyclization would occur on the 
phenyl ring, providing highly unstable four-membered spiro ring intermediates 231. 
Thereupon, the highly unstable four-membered spiro ring intermediate 231 underwent 
intramolecular 1,3-aryl migration, leading to a stable allylic carbocation intermediate 232, 
which was subsequently intercepted by the tethered nitrogen nucleophiles to afford the 
eventual rearrangement product 184a. The excellent selectivity toward the formation of the 
rearrangement product 184 seems to be derived from the Al-coordination at the nitrogen 
atom. 
3.3.7 Conclusion 
In summary, a new concept for a redox-neutral C-C bond functionalization based on 
intramolecular 1,3-aryl migration has been developed. The redox-neutral C-C σ bond 
activation reaction was selectively and efficiently promoted by trisubstituted highly reactive 
vinyl cations in the presence of 10 mol% Al(OTf)3 as a catalyst. Furthermore, a plausible 
retro Friedel-Crafts/Povarov reaction mechanism was clearly excluded from this novel 
transformation by reacting acetals 251 with alkynes, and a highly unstable four-membered 
spiro ring intermediate 231 leading to the rearrangement product 184a was proposed in the 
reaction. 
3.4. A Novel Approach to 2H-Chromenes through Al(OTf)3-Catalyzed 
Unstrained C-C σ Bond Activation 
3.4.1 Background 
2H-Chromenes are ubiquitous structural motifs frequently found in not only natural 
isolates (such as tannins and polyphenols found in teas, fruits, and vegetables), but also 
pharmaceuticals and materials (such as sex-pheromones, breast cancer treatment and 
photochromic materials, and selected examples shown in Figure 26).[61] Therefore, the 
synthesis of such a framework has intrigued and inspired synthetic organic chemists over the 
past decade, and a variety of methods are documented in the literature.[61c] Most of them are 
dependent on transition-metal catalyzed reactions, such as CoII-catalyzed radical reactions of 
salicyl N-tosylhydrazones with phenylacetylenes,[62] Au-catalyzed cyclization of aryl 
propargyl ethers,[63] Ru-catalyzed ring-closing methathesis (RCM) reactions of styrenyl 
ethers[64] and Ni-catalyzed functional group transformations between chromene acetals and 
boronic acids.[65] In recent years, organocatalysis has become an ideal tool for the synthesis of 
2H-chromenes.[61c] Despite advances, the approaches suffer from multi-step reaction 
sequences, limited functional group tolerance and formation of regio-isomeric mixtures.[61c,14] 
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Particularly, transition-metal catalysts or complex prefunctionlized fragments are required in 
most cases.[61c] Therefore, the development of more efficient and sustainable alternatives is 
certainly highly desirable. 
 
 
 
 
 
 
 
 
Figure 26 
Ever-increasing demand for “green chemistry” urges to develop highly economical and 
eco-friendly C-C bond-forming reactions.[66] In this regard, cleavage of a C-C σ bond 
followed by insertion of an unsaturated C-C bond unit, namely, simultaneous formation of 
two new C-C bonds should have extremely great synthetic potentials.[67] Nevertheless, 
reported examples with regard to success of these processes rely on the C-C σ bond cleavage 
of constrained small-ring molecules by the release of strain energy.[68,69] In addition, 
remarkable progress has recently been made in transition-metal catalyzed reactions, which are 
limited to nitriles 258[70,71] (Scheme 43, a), acylquinolines 261[72] (Scheme 43, b) and  
 
 
 
 
 
 
 
 
Scheme 43. Insertion of an unsaturated C-C bond into an unstrained C-C σ bond. 
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β-keto sulfones 263[73] (Scheme 43, c) as the unconstrained reaction substrates. Consequently, 
they lack generality and are not environmentally friendly. On the contrary, no such 
transition-metal free reactions through unstrained C-C σ bond activation are documented to 
date. Therefore, the first Al(OTf)3-catalyzed process of insertion of an unactivated alkyne into 
an unstrained C-C σ bond has been developed here (Scheme 43, d). This alkyne insertion 
reaction proceeds through the C-C σ bond cleavage of benzylic alcohols 164 and allows for 
the direct and efficient synthesis of structurally diverse multi-substituted 2H-chromenes 169 
under very mild reaction conditions. 
3.4.2 Aims 
As an extension of the redox-neutral C-C bond activation reaction, the development of 
more efficient and sustainable approaches for the synthesis of 2H-chromenes was also 
projected. Although a variety of methods for the synthesis of 2H-chromenes are documented 
in the literature,[61c] the approaches suffer from multi-step reaction sequences, limited 
functional group tolerance and formation of regio-isomeric mixtures. Particularly, 
transition-metal catalysts and complex prefunctionlized fragments are required in most cases. 
Therefore, the first transition-metal free alkyne insertion reaction proceeding through the C-C 
σ bond cleavage of benzylic alcohols 164 is investigated in this project, which provides an 
elegant protocol for the direct synthesis of multi-substituted 2H-chromenes 169 (Scheme 43, 
d). 
3.4.3 Optimization of the Unstrained C-C σ Bond Activation Reaction 
Initially, the reaction of 4-bromo-2-(1-hydroxyethyl)phenol 164b with 
1-phenyl-1-propyne 229 in DCE, in the presence of 10 mol% Al(OTf)3 and 5 mol% Bu4NPF6 
at 40 oC for 12 h was investigated. Gratifyingly, the alkyne insertion reaction did occur and 
gave both the rearrangement adduct 169a and the direct [4+2] cylcoaddition product 166k in 
78% isolated yield, albeit with poor selectivity (table 9, entry 1, 169a/166k = 60:40). In 
addition, the structure of the adduct 169a was confirmed by X-ray diffraction analysis 
unambiguously. Thus, the influence of several additives was then investigated (table 9, entry 
2-4), and it was pleased to find that the additives had great effect on the reaction efficiency. 
For example, the additive NH4PF6 afforded an excellent yield for the products with poor 
selectivity (table 9, entry 3, 169a/166k = 61:39), while the additive Bu4NSbF6 provided 
improved selectivity but low yields (table 10, entry 4, 169a/166k = 80:20). Based on these 
observations, the mixed additives by the combination of 15 mol% NH4PF6 and 5 mol% 
Bu4NSbF6 were therefore examined for the reaction. Gratifyingly, the product 169a was 
obtained in 70% yield with excellent selectivity (table 9, entry 5, 169a/166k = 92:8). 
Furthermore, other environmentally benign catalysts were explored as well in order to 
improve the reaction efficiency further (table 9, entry 6-9), but no better results were obtained. 
Notably, the reaction didn’t work in the absence of additives (table 9, entry 10) and 30 mol% 
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TfOH provided poor selectivity for the reaction without additives (table 9, entry 11, 
169a/166k = 65:35). From these optimization results, 10 mol% Al(OTf)3/15 mol% NH4PF6/5 
mol% Bu4NSbF6 in DCE at 40 oC for 12 h were selected as the standard reaction conditions 
(table 9, entry 5). 
Table 9. Optimization of reaction conditions. 
    
    
    
Entry [a] Catalyst (10 
mol%) 
Additive (X mol%) Yield (%) Ratio 
(169a/166k) 
1 Al(OTf)3 Bu4NPF6 (5) 78 60:40 
2 Al(OTf)3 Bu4NBF4 (5) 82  62:38 
3 Al(OTf)3 NH4PF6 (5) 89 61:39 
4 Al(OTf)3 Bu4NSbF6 (5) 46 80:20 
5 Al(OTf)3 NH4PF6 (15)/Bu4NSbF6 (5) 70 92:8 
6 Al(NTf2)3 NH4PF6 (15)/Bu4NSbF6 (5) 74 84:16 
7 Ca(NTf2)2 NH4PF6 (15)/Bu4NSbF6 (5) 72 81:19 
8 Mg(NTf2)2 NH4PF6 (15)/Bu4NSbF6 (5) 69 86:14 
9 Zn(OTf)2 NH4PF6 (15)/Bu4NSbF6 (5) 75 88:12 
10 Al(OTf)3 none NR ------ 
11 TfOH (30) none 87 65:35 
12 TfOH (30) NH4PF6 (15)/Bu4NSbF6 (5) 68 92:8 
[a] Reaction conditions: to a suspension of 10 mol% catalysts in 4 mL dried DCE, 164b (86.8 mg, 0.4 
mmol), 229 (69.7 mg, 0.6 mmol) and additives were added, the reaction was then stirred at 40 oC for 12 h. 
[b] Yields of the isolated and combined products. [c] Ratio for 169a/166k was determined by 1H NMR 
spectroscopy of the crude mixture. 
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3.4.4 Synthesis of Substrates  
Benzylic alcohols 164 were obtained according to the aforementioned methods.[39a] The 
nucleophilic addition of organometallic reagents 198 to aldehydes 197 allowed for the 
straightforward synthesis of the benzylic alcohols 164j-164o (Figure 27). 
 
 
 
 
 
 
 
Figure 27 
3.4.5 Scope of the Al(OTf)3-Catalyzed Unstrained C-C σ bond activation reaction 
With the optimized reaction conditions in hand, the substrate scope of this 
Al(OTf)3-catalyzed unstrained C-C σ bond activation reaction was next investigated. Bromo 
atom and chloro atom, which not only can prevent polymerization of benzylic alcohols by 
decreasing the electron density on the benzene ring, but also are regarded as excellent 
coupling functional groups in transition-metal catalyzed reactions, can be introduced on the 
2-(1-hydroxyethyl)phenol at both the C4 and C5 positions without loss in reaction efficiency 
(table 10, 169a-d). Importantly, a wide variety of structurally diverse secondary benzylic 
alcohols, which bear n-butyl group, allyl group, alkynyl group and even sterically hindered 
groups, can be employed as the reaction substrates and the reactions afforded the desired 
2H-chromene adducts in good to excellent yields with excellent selectivity (table 10, 
169e-169k), except for the products 169i and 169j with poor selectivity. Although the 
reaction of 2-(1-hydroxyethyl)phenol 164c gave the corresponding product 169l in 31% yield, 
due to its polymerization (table 10, 169l), the reactivity was restored by changing the R2 
group from methyl group to phenyl group (table 10, 169m). Furthermore, an electron- 
donating methyl group can be introduced on the 2-(hydroxy(phenyl)methyl)phenol at the C4 
position by the same strategy (table 10, 169n). More importantly, structural variation in the 
aryl alkyne component can also be realized. Not only the aryl alkynes with long carbon chains 
(table 10, 169o), the carbon chain containing bromo atom (table 10, 169p), but also the aryl 
alkynes with electron-donating groups on the aromatic ring (table 10, 169q-169r) reacted 
successfully with 164b under the standard reaction conditions. 
OH
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Br OH
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Table 10. Scope of the unstrained C-C σ bond activation reaction. 
     
     
     
   
 
 
 
 
 
 
 
 
  
   
[a] Reaction conditions: to a suspension of 10 mol% Al(OTf)3 (19.0 mg, 0.04 mmol) in 4 mL dried DCE, 
164 (0.4 mmol), 183/229 (0.6 mmol), NH4PF6 (9.8 mg, 0.06 mmol) and Bu4NSbF6 (9.6 mg, 0.02 mmol) 
were added, the reaction was then stirred at 40 oC for 12 h. [b] Yields of isolated products. [c] 10 mol% 
Al(OTf)3 and 5 mol% NH4PF6 were used. [d] 10 mol% Mg(OTf)2/5 mol% NH4PF6 and 4 mL 
DCE/CH3NO2 (1:1) were used. [e] Ratio for 169/169’ determined by 1H NMR spectroscopy of the crude 
mixture. 
3.4.6 Mechanistic Study 
To gain insight into a plausible reaction mechanism for the Al(OTf)3-catalyzed 
unstrained C-C σ bond activation reaction, the model reaction was stopped after 5 minutes 
and dimers 266 were obtained in 89% isolated yield (eqn (9)). The dimer 266 then reacted 
with 229 under the standard reaction conditions, both the yield and selectivity were slightly 
improved compared to the model reaction (eqn (10)). Moreover, further analysis of the model 
reaction mixture at various reaction time revealed that the ratio for 169a/166k was rising from 
beginning to end. At the beginning of the reaction, the ratio was very low, but it was 
remarkably improved within two hours (up to 87:13). Therefore, based on these experiments, 
a proposed reaction mechanism is described as these shown in Scheme 42. 
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3.4.7 Conclusion 
In conclusion, the first transition-metal free process of insertion of an unactivated alkyne 
into an unstrained C-C σ bond has been developed. This alkyne insertion reaction proceeds 
through the C-C σ bond cleavage of benzylic alcohols 164 and provides an efficient access to 
potentially biologically active multi-substituted 2H-chromenes 169 from readily available 
starting materials. Eighteen representative adducts were obtained by this methodology in 
moderate to excellent yields (31-91%) under very mild reaction conditions. In addition, 10 
mol% Al(OTf)3/15 mol% NH4PF6/5 mol% Bu4NSbF6 were identified to exhibit excellent 
selectivity toward the formation of the rearrangement products 169. Furthermore, a highly 
unstable four-membered spiro ring intermediate 186 leading to the rearrangement products 
169 was proposed in the reaction. 
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4. Summary and Outlook 
In conclusion, the environmentally friendly aluminum or calcium-catalyzed electrophilic 
cyclizations of alkynes via vinyl cations have been developed. In these reactions, 
trisubstituted highly reactive vinyl cations were generated by the nucleophilic addition of 
alkynes to the carbocations that were produced from alcohols by aluminum or calcium 
catalysis. Subsequently, it was intercepted by hydroxyl groups or aromatic nucleophiles, 
leading to the formation of 4H-chromenes and all-carbon tetrasubstituted olefins respectively. 
Furthermore, the first transition-metal free alkyne insertion reaction through unstrained C-C σ 
bond activation was efficiently promoted by the trisubstituted highly reactive vinyl cations in 
the presence of 10 mol% Al(OTf)3 as a catalyst, which provided a novel protocol for the 
straightforward and efficient synthesis of structurally diverse 1,2-dihydroquinolines and 
2H-chromenes. 
In a first project, an unprecedented inverse electron demand hetero-Diels-Alder reaction 
(IED/HDA) of alkynes with in situ generated ortho-quinone methides has been described, 
which offers a new protocol for the straightforward and efficient synthesis of structurally 
diverse multi-substituted 4H-chromenes from readily available starting materials under very 
mild reaction conditions. Either a concerted mechanism or a stepwise mechanism via vinyl 
cations was proposed for the reaction. In the stepwise mechanism, the trisubstituted highly 
reactive vinyl cations would be trapped by the tethered phenolic hydroxyl group. 
In a second project, the first transition-metal free carboarylation of alkynes with readily 
available alcohols has been realized in the presence of non-toxic and abundant calcium 
catalysts, which allows for the one-step synthesis of all-carbon tetrasubstituted olefins from 
alkynes. A trisubstituted highly reactive vinyl cation was generated in the carboarylation 
process, which was intercepted even by deactivated arenes as the tethered nucleophiles. 
In a third project, a new concept for a redox-neutral C-C bond functionalization based on 
intramolecular 1,3-aryl migration has been demonstrated. The redox-neutral C-C σ bond 
activation reaction was selectively and efficiently promoted by trisubstituted highly reactive 
vinyl cations in the presence of 10 mol% Al(OTf)3 as a catalyst. 
In the last project, a novel approach to 2H-chromenes through Al(OTf)3-catalyzed 
unstrained C-C σ bond activation has been developed. The first transition-metal free process 
of insertion of an unactivated alkyne into an unstrained C-C σ bond was selectively and 
efficiently promoted by trisubstituted highly reactive vinyl cations in the presence of 10 mol% 
Al(OTf)3 as a catalyst. This alkyne insertion reaction proceeds through the C-C σ bond 
cleavage of benzylic alcohols and allows for the direct and efficient synthesis of structurally 
diverse multi-substituted 2H-chromenes from readily available starting materials under very 
mild reaction conditions. 
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Future developments in the redox-neutral C-C bond activation reaction will involve the 
screening of suitable chiral ligands to realize a catalytic asymmetric version of alkyne 
insertion reactions. In addition, other different nucleophiles such as alkenes and 
cyclopropanes might react with in situ generated ortho-azaquinone methides or ortho-quinone 
methides, giving the different [4+2] cycloaddition products and the [4+3] cycloaddition 
products respectively. Furthermore, aluminum or calcium-catalyzed 1,5-hydride shift 
reactions might be realized and promoted by a vinyl cation generated by the nucleophilic 
addition of alkynes to the carbocations produced from π-activated alcohols.
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5. Experimental Part 
5.1. General Techniques 
All the experimetal operations were carried out in a well ventilated hood according to the 
standard requirements for experimental safety in our institute. All reactions were performed in 
standard glassware with no special precautions taken for the exclusion of moisture or air. For 
air and moisture sensitive reactions, they were performed in Schlenk flasks under an inert 
atmosphere of argon. 
5.2. Solvents 
Solvents for anhydrous reactions were dried and distilled before used, DCM was dried 
over calcium hydride and THF was distilled from sodium/benzophenone. Ethyl acetate 
(EtOAc) and n-pentane/hexane were distilled before used for flash column chromatography. 
DMF, DMSO, acetonitrile, methanol and ethanol were HPLC grade solvents and they were 
used directly as received. DCE and CH3NO2 were filtered through neutral alumina before 
used. 
5.3. Methods for Determination of Synthesized Compounds 
5.3.1 NMR Spectroscopy 
NMR spectra was collected on a Varian Mercury 300 spectrometer (300 MHz), a Varian 
Inova 400 spectrometer (400 MHz), or a Varian VNMRS 600 spectrometer (600 MHz). For 
1H NMR, CHCl3 (7.26 ppm) or DMSO-d6 (2.50 ppm) are used as internal standard in the 
same solvent; for 13C NMR, CDCl3 (77.00 ppm) or DMSO-d6 (39.50 ppm) are used as 
internal standard in the same solvent; integrals in accordance with assignments, coupling 
constants are measured in Hz and always constitute JH,H coupling constants.  
5.3.2 Mass Spectroscopy 
Low-resolution and high-resolution mass spectra were obtained by using electron impact 
ionisation (EI) and chemical ionisation (CI) techniques, or positive and/or negative 
electrospray ionisation (ESI) on Finnigan SSQ or 7000 Thermo Deca XP mass spectrometers. 
5.3.3 Infrared Spectroscopy 
IR Spectra was recorded on a Perkin-Elmer 1760 series FT-IR as neat films on KBr 
plates.  
5.4. Chromatography 
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Column chromatography was performed in glass columns (10-50 mm diameter) on 
Merck silica gel 60, particle size 0.035-0.070 mm. Analytical thin layer chromatography 
(TLC) was conducted with precoated aluminium-backed plates (silica gel 60 F254) and 
visualized with UV radiation at 254 nm. 
5.5. Experiments for Calcium-Catalyzed Synthesis of 4H-Chromenes 
5.5.1 Experiments for Preparation of Substrates 
To a solution of ketones 196 (5 mmol) in 20 mL EtOH at 0 oC was added NaBH4 (15 
mmol) in portions, the reaction was then warmed to room temperature and stirred for 2 h. 
After reaction completion, EtOH solvent was removed under reduced pressure and the residue 
was washed by 20 mL saturated brine. The aqueous phase was extracted with Et2O (3×20 mL), 
the combined organic phases were dried over Na2SO4 and concentrated under reduced 
pressure. The crude product was purified by column chromatography. 
5-Chloro-2-(1-hydroxyethyl)phenol (164a) 
 
Colorless oil, Rf (pentane: EtOAc 5:1) = 0.32. 1H NMR (600 MHz, CDCl3): δ = 8.21–8.13 (m, 
1H), 6.88 (d, J = 8.1, 1H), 6.86 (s, 1H), 6.80 (dd, J = 8.1, 2.1, 1H), 5.04 (d, J = 3.6, 1H), 2.72 
(s, 1H), 1.60–1.54 (m, 3H); 13C NMR (150 MHz, CDCl3): δ = 156.17, 134.06, 127.28, 126.81, 
119.99, 117.38, 71.21, 23.49; m/z (EI)(%): 172.1 (M, 78.8), 157.0 (39.3), 155.1 (100), 154.0 
(74.1), 91.2 (63.8); [M+Na] HRMS calcd. for C8H9O2ClNa: 195.01833, found: 195.01804; IR 
(KBr): = 3297, 2978, 1593 1485, 1414, 1233, 1072, 897 cm-1. 
4-Bromo-2-(1-hydroxyethyl)phenol (164b) 
 
White solid, Rf (pentane: EtOAc 10:1) = 0.14. 1H NMR (400 MHz, CDCl3): δ = 8.06 (s, 1H), 
7.22 (dd, J = 8.6, 2.5, 1H), 7.07 (d, J = 2.4, 1H), 6.70 (d, J = 8.6, 1H), 4.97 (q, J = 6.6, 1H), 
3.04 (s, 1H), 1.53 (d, J = 6.6, 3H); 13C NMR (100 MHz, CDCl3): δ = 154.28, 131.52, 130.42, 
129.12, 118.78, 111.83, 70.78, 23.30; m/z (EI)(%): 217.9 (M+2, 61.1), 229.9 (M, 60.6), 200.9 
(94.6), 199.9 (75.5), 199.0 (100), 197.9 (75.7), 120.0 (42.2), 91.1 (63.3); IR (KBr): = 3348, 
2977, 1586, 1477, 1361, 1234, 1071, 814, 551 cm-1. 
2-(1-Hydroxyethyl)phenol (164c) 
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White solid, Rf (hexane: EtOAc 5:1) = 0.27. 1H NMR (400 MHz, CDCl3): δ = 8.04–7.84 (m, 
1H), 7.15 (td, J = 8.2, 1.6, 1H), 6.97 (dd, J = 7.5, 1.4, 1H), 6.83 (ddd, J = 14.9, 7.3, 1.0, 2H), 
5.04 (d, J = 6.2, 1H), 2.76 (s, 1H), 1.56 (dd, J = 6.6, 1.9, 3H); 13C NMR (100 MHz, CDCl3): δ 
= 155.31, 128.90, 128.36, 126.43, 119.87, 117.04, 71.56, 23.39; m/z (EI)(%): 138.1 (M, 56.7), 
121.1 (26.2), 120.1 (100), 119.1 (29.6), 92.1 (24.6), 91.1 (81.5), 77.2 (25.1); IR (KBr): = 
3327, 2976, 2929, 1593 1491, 1455, 1372, 1238, 1072, 893, 755 cm-1. 
2-(Hydroxy(phenyl)methyl)phenol (164d) 
 
White solid, Rf (hexane: EtOAc 5:1) = 0.29. 1H NMR (400 MHz, CDCl3): δ = 7.98 (s, 1H), 
7.41–7.27 (m, 5H), 7.22–7.14 (m, 1H), 6.84 (dt, J = 14.6, 7.8, 3H), 5.96 (s, 1H), 3.27 (s, 1H); 
13C NMR (100 MHz, CDCl3): δ = 155.25, 141.77, 129.23, 128.66, 128.21, 128.14, 126.76, 
119.93, 119.92, 117.15, 76.85; m/z (EI)(%): 200.1 (M, 4.1), 183.1 (8.1), 182.1 (50.4), 181.1 
(100), 152.1 (10.3), 77.1 (10.1); IR (KBr): = 3500, 3185, 1598, 1456, 1227, 1009, 883, 748, 
694 cm-1. 
To a solution of organometallic reagents R-M 198 (10.5 mmol) in 20 mL THF at 0 oC 
was added aldehydes 197 (5 mmol) slowly under an argon protective atmosphere, the reaction 
was then heated under reflux for 30 minutes. After the reaction cooled down to room 
temperature, it was quenched by 20 mL saturated NH4Cl solution and the aqueous phase was 
extracted with Et2O (2×30 mL). The combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography. 
4-Chloro-2-(1-hydroxy-2-methylpropyl)phenol (164e) 
 
Yellow oil, Rf (pentane: EtOAc 3:1) = 0.60. 1H NMR (400 MHz, CDCl3): δ = 8.04 (s, 1H), 
7.09 (dd, J = 8.7, 2.6, 1H), 6.86 (d, J = 2.6, 1H), 6.77 (d, J = 8.6, 1H), 4.47 (dd, J = 6.8, 2.2, 
1H), 2.63 (s, 1H), 2.06 (dq, J = 13.1, 6.6, 1H), 1.02 (d, J = 6.7, 3H), 0.86 (d, J = 6.8, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 154.40, 128.54, 127.78, 127.36, 124.06, 118.52, 81.52, 34.37, 
19.18, 17.89; m/z (EI)(%): 202.1 (M+2, 19.8), 200.0 (M, 58.5), 183.0 (100), 182.0 (52.7), 
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167.0 (37.1), 157.0 (69.4), 141.0 (39.8), 129.0 (23.6); IR (KBr): = 3352, 2954, 1596 1470, 
1234, 1009, 814, 708 cm-1. 
4-Chloro-2-(cyclohexyl(hydroxy)methyl)phenol (164f) 
 
Light yellow solid, Rf (pentane: EtOAc 5:1) = 0.58. 1H NMR (400 MHz, CDCl3): δ = 8.06 (s, 
1H), 7.08 (dd, J = 8.6, 2.6, 1H), 6.83 (d, J = 2.6, 1H), 6.75 (d, J = 8.6, 1H), 4.45 (dd, J = 7.1, 
2.9, 1H), 2.77 (d, J = 3.2, 1H), 1.98–1.87 (m, 1H), 1.81–1.57 (m, 4H), 1.50–1.36 (m, 1H), 
1.28–0.87 (m, 5H); 13C NMR (100 MHz, CDCl3): δ = 154.30, 128.46, 127.81, 127.36, 124.05, 
118.41, 80.75, 43.70, 29.39, 28.40, 26.15, 25.88, 25.79; m/z (EI)(%): 242.0 (M+2, 21.5), 
240.0 (M, 63.3), 224.9 (34.6), 224.0 (27.9), 223.0 (100), 222.0 (40.7), 156.9 (18.0), 81.1 
(34.3); IR (KBr): = 3427, 3073, 2921, 2726, 1594, 1430, 1236, 1097, 1010, 891, 816, 727 
cm-1. 
4-Bromo-2-(hydroxy(phenyl)methyl)phenol (164g) 
OH
OH
Ph
Br
164g  
White solid, Rf (hexane: EtOAc 10:1) = 0.15. 1H NMR (600 MHz, CDCl3): δ = 8.02 (s, 1H), 
7.42–7.30 (m, 5H), 7.26 (dd, J = 8.7, 2.3, 1H), 6.97 (d, J = 2.3, 1H), 6.75 (d, J = 8.7, 1H), 
5.91 (d, J = 2.7, 1H), 3.10 (d, J = 3.1, 1H); 13C NMR (150 MHz, CDCl3): δ = 154.45, 141.04, 
131.95, 130.69, 128.90, 128.58, 128.48, 126.77, 119.06, 111.90, 76.49; m/z (EI)(%): 279.9 
(M+2, 12.1), 277.9 (M, 10.8), 261.9 (61.8), 260.9 (100), 259.9 (60.4), 258.9 (85.2), 151.9 
(20.4); [M+Na] HRMS calcd. for C13H11O2BrNa: 300.98346, found: 300.98309; IR (KBr): 
= 3439, 3216, 1580, 1478, 1368, 1228, 1101, 1025, 820, 692 cm-1. 
1-(Hydroxy(phenyl)methyl)naphthalen-2-ol (164h) 
 
Light yellow solid, Rf (hexane: EtOAc 10:1) = 0.18. 1H NMR (400 MHz, CDCl3): δ = 9.32 (s, 
1H), 7.80–7.68 (m, 2H), 7.61 (d, J = 8.4, 1H), 7.43–7.37 (m, 2H), 7.37–7.24 (m, 5H), 7.16 (d, 
J = 8.9, 1H), 6.71 (d, J = 2.7, 1H), 3.23 (d, J = 2.9, 1H); 13C NMR (100 MHz, CDCl3): δ = 
154.39, 141.19, 131.41, 130.11, 128.85, 128.73, 128.67, 128.42, 127.14, 126.76, 123.00, 
121.42, 119.90, 115.74, 74.61; m/z (EI)(%): 250.0 (M, 25.8), 232.0 (67.7), 231.0 (100), 202.0 
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(15.4); IR (KBr): = 3368, 3027, 1604, 1464, 1405, 1326, 1216, 1157, 1062, 935, 812, 739 
cm-1. 
2-(Hydroxy(phenyl)methyl)-4-methylphenol (164i) 
 
White solid, Rf (hexane: EtOAc 10:1) = 0.19. 1H NMR (400 MHz, CDCl3): δ = 7.88 (s, 1H), 
7.42–7.26 (m, 5H), 6.97 (dd, J = 8.2, 2.0, 1H), 6.76 (d, J = 8.2, 1H), 6.68 (s, 1H), 5.88 (s, 1H), 
3.58 (s, 1H), 2.21 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 152.72, 142.00, 129.56, 129.09, 
128.61, 128.56, 127.95, 126.71, 126.54, 116.85, 76.67, 20.42; m/z (EI)(%): 213.9 (M, 8.2), 
196.9 (9.9), 195.9 (59.4), 194.9 (100), 180.9 (6.9), 151.9 (7.0), 76.9 (13.2); IR (KBr): = 
3331, 3035, 2925, 1607, 1493, 1377, 1232, 1011, 921, 817, 709 cm-1. 
5-Bromo-2-(1-hydroxyethyl)phenol (164j) 
 
Colorless oil, Rf (pentane: EtOAc 5:1) = 0.27. 1H NMR (600 MHz, CDCl3): δ = 8.21 (s, 1H), 
6.99 (d, J = 1.9, 1H), 6.95 (dd, J = 8.1, 1.9, 1H), 6.82 (d, J = 8.2, 1H), 5.07–4.95 (m, 1H), 
2.97 (s, 1H), 1.54 (d, J = 6.6, 3H); 13C NMR (150 MHz, CDCl3): δ = 156.06, 127.60, 127.39, 
122.98, 121.81, 120.17, 71.02, 23.36; m/z (EI)(%): 218.0 (M+2, 83.5), 216.0 (M, 79.3), 201.0 
(64.1), 200.0 (99.0), 199.0 (55.5), 198.0 (100), 94.1 (28.0), 91.2 (83.9); [M+Na] HRMS calcd. 
for C8H9O2BrNa: 238.96781, found: 238.96741; IR (KBr): = 3345, 2976, 1589, 1482, 1413, 
1224, 1068, 878 cm-1. 
4-Chloro-2-(1-hydroxypentyl)phenol (164l) 
 
Light yellow oil, Rf (pentane: EtOAc 5:1) = 0.51. 1H NMR (400 MHz, CDCl3): δ = 7.97 (s, 
1H), 7.09 (dd, J = 8.6, 2.6, 1H), 6.89 (d, J = 2.6, 1H), 6.77 (d, J = 8.6, 1H), 4.75 (t, J = 5.8, 
1H), 2.66 (s, 1H), 1.92–1.81 (m, 1H), 1.80–1.69 (m, 1H), 1.48–1.22 (m, 4H), 0.89 (t, J = 7.1, 
3H); 13C NMR (100 MHz, CDCl3): δ = 154.12, 128.86, 128.55, 126.83, 124.35, 118.50, 75.78, 
36.78, 27.71, 22.41, 13.94; m/z (EI)(%): 216.1 (M+2, 38.8), 214.1 (M, 100), 199.1 (33.4), 
198.1 (31.6), 197.1 (90.2), 196.1 (64.0), 169.0 (21.9), 167.0 (66.3), 157.0 (26.0), 141.0 (61.6), 
132.1 (26.6); HRMS calcd. for C11H15O235Cl: 214.07551, found: 214.07583; IR (KBr): = 
3344, 2936, 1598, 1469, 1235, 1009, 844, 811 cm-1. 
4-Chloro-2-(1-hydroxybut-3-en-1-yl)phenol (164m) 
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Colorless oil, Rf (pentane: EtOAc 3:1) = 0.50. 1H NMR (400 MHz, CDCl3): δ = 8.27 (s, 1H), 
7.06 (dd, J = 8.6, 2.6, 1H), 6.93 (d, J = 2.6, 1H), 6.73 (d, J = 8.7, 1H), 5.84–5.69 (m, 1H), 
5.15–5.11 (m, 1H), 5.05–4.94 (m, 1H), 4.77 (t, J = 6.6, 1H), 3.68 (s, 1H), 2.53 (ddd, J = 7.9, 
4.5, 1.0, 2H); 13C NMR (100 MHz, CDCl3): δ = 153.78, 133.51, 128.43, 126.75, 124.36, 
119.12, 118.16, 116.17, 73.56, 41.81; m/z (EI)(%): 200.1 (M+2, 8.9), 198.1 (M, 23.3), 159.1 
(17.4),157.0 (54.5), 85.0 (63.5), 83.0 (100); IR (KBr): = 3333, 2922, 1608, 1481, 1426, 
1239, 1105, 1015, 905, 814 cm-1. 
4-Chloro-2-(1-hydroxyprop-2-yn-1-yl)phenol (164n) 
 
Yellow solid, Rf (pentane: EtOAc 3:1) = 0.30. 1H NMR (600 MHz, CDCl3): δ = 7.37 (d, J = 
2.5, 1H), 7.24–7.17 (m, 2H), 6.82 (dd, J = 8.6, 2.1, 1H), 5.64 (d, J = 3.1, 1H), 3.22 (s, 1H), 
2.79 (t, J = 2.0, 1H); 13C NMR (150 MHz, CDCl3): δ = 153.54, 129.96, 127.43, 125.50, 
125.13, 118.37, 80.80, 76.87, 62.94; m/z (EI)(%): 183.9 (M+2, 27.5), 181.9 (M, 87.5), 165.9 
(33.3), 165.0 (33.6), 163.9 (100), 137.9 (29.7), 135.9 (84.8), 128.9 (22.3), 101.0 (33.6); IR 
(KBr): = 3287, 1600, 1484, 1421, 1231, 1109, 1011, 815 cm-1. 
4-Chloro-2-(1-hydroxy-3-phenylprop-2-yn-1-yl)phenol (164o) 
 
Yellow solid, Rf (pentane: EtOAc 3:1) = 0.51. 1H NMR (400 MHz, CDCl3): δ = 7.54–7.44 (m, 
2H), 7.40 (d, J = 2.6, 1H), 7.38–7.29 (m, 4H), 7.19 (dd, J = 8.6, 2.6, 1H), 6.84 (t, J = 9.5, 1H), 
5.86 (d, J = 5.7, 1H), 3.01 (d, J = 5.8, 1H); 13C NMR (100 MHz, CDCl3): δ = 153.96, 131.86, 
129.88, 129.10, 128.41, 127.48, 125.85, 124.94, 121.62, 118.51, 88.69, 85.72, 63.96; m/z 
(EI)(%): 258.0 (M, 12.9), 241.0 (56.6), 240.0 (69.3), 239.0 (100), 239.0 (35.3), 205.0 (98.3), 
177.0 (19.2), 176.0 (33.2); IR (KBr): = 3296, 1596, 1484, 1412, 1235, 1111, 907, 743 cm-1. 
To a solution of aryl iodides 200 (5 mmol) and terminal alkynes 199/239 (10 mmol) in 5 
mL degassed Et3N were added Pd(PPh3)4 (0.25 mmol) and CuI (0.5 mmol) under an argon 
protective atmosphere, the reaction was then stirred at 60 oC for 3 hours. After the reaction 
cooled down to room temperature, the mixture was diluted with 30 mL EE and washed by 20 
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mL 1N HCl and 10 mL saturated NaHCO3 solution. The aqueous phase was extracted with 
EE (2×30 mL), the combined organic phases were dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by column chromatography. 
1-(p-Methoxyphenyl)-1-hexyne (183a) 
 
Colorless oil, Rf (hexane) = 0.41. 1H NMR (400 MHz, CDCl3): δ = 7.36–7.27 (m, 2H), 
6.83–6.73 (m, 2H), 3.78 (s, 3H), 2.37 (t, J = 7.0, 2H), 1.62–1.52 (m, 2H), 1.51–1.41 (m, 2H), 
0.93 (t, J = 7.3, 3H); 13C NMR (100 MHz, CDCl3): δ = 158.93, 132.81, 116.24, 113.76, 88.72, 
80.18, 55.22, 30.95, 22.01, 19.08, 13.65; m/z (EI)(%): 188.0 (M, 100), 172.9 (38.3), 158.9 
(38.2), 144.9 (84.2), 114.9 (23.4), 101.8 (28.8); IR (KBr): = 2933, 2867, 1605, 1506, 1458, 
1287, 1243, 1173, 1032, 829 cm-1. 
1-(2-Thienyl)-1-hexyne (183b) 
 
Colorless oil, Rf (pentane) = 0.43. 1H NMR (600 MHz, CDCl3): δ = 7.16 (dd, J = 5.2, 1.1, 1H), 
7.12–7.09 (m, 1H), 6.93 (dd, J = 5.2, 3.6, 1H), 2.43 (t, J = 7.1, 2H), 1.63–1.56 (m, 2H), 
1.51–1.42 (m, 2H), 0.94 (t, J = 7.3, 3H); 13C NMR (150 MHz, CDCl3): δ = 130.83, 126.71, 
125.78, 124.22, 94.48, 73.59, 30.63, 22.02, 19.35, 13.62; m/z (EI)(%): 165.0 (M+1, 20.4), 
164.0 (M, 100), 149.0 (63.7), 135.0 (59.1), 121.0 (85.4), 115.1 (23.3); IR (KBr): = 2936, 
1519, 1441, 1189, 832, 694 cm-1. 
1-Phenyl-1-heptyne (183c) 
 
Brown oil, Rf (hexane) = 0.53. 1H NMR (400 MHz, CDCl3): δ = 7.41–7.35 (m, 2H), 
7.30–7.20 (m, 3H), 2.39 (t, J = 7.1, 2H), 1.60 (dt, J = 11.4, 7.1, 2H), 1.48–1.19 (m, 4H), 0.90 
(dd, J = 12.9, 5.8, 3H); 13C NMR (100 MHz, CDCl3): δ = 131.52, 128.15, 127.42, 124.10, 
90.47, 80.53, 31.13, 28.48, 22.24, 19.39, 14.00; m/z (EI)(%): 165.1 (14.9), 117.1 (15.4), 105.1 
(21.6), 91.1 (52.8), 57.1 (63.9), 55.1 (100); IR (KBr): = 3058, 2931, 2862, 1598, 1489, 
1458, 755, 691 cm-1. 
4-(hept-1-yn-1-yl)-1,1'-biphenyl (183e) 
 
Brown oil, Rf (hexane) = 0.32. 1H NMR (400 MHz, CDCl3): δ = 7.58 (dt, J = 3.0, 1.8, 2H), 
7.55–7.49 (m, 2H), 7.49–7.39 (m, 4H), 7.37–7.30 (m, 1H), 2.43 (t, J = 7.1, 2H), 1.68–1.58 (m, 
2H), 1.50–1.30 (m, 4H), 0.94 (t, J = 7.2, 3H); 13C NMR (100 MHz, CDCl3): δ = 140.50, 
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140.15, 131.92, 128.78, 127.41, 126.94, 126.84, 123.05, 91.20, 80.38, 31.14, 28.48, 22.25, 
19.47, 14.01; m/z (EI)(%): 249.3 (M+1, 27.9), 248.3 (M, 100), 219.3 (29.1), 206.3 (14.0), 
193.2 (23.0), 191.2 (25.8), 189.2 (17.5), 165.2 (12.6); IR (KBr): = 3038, 2932, 2320, 2100, 
1597, 1476, 836, 754, 701 cm-1. 
1-(4-(Hept-1-yn-1-yl)phenyl)propan-2-one (183f) 
 
Brown oil, Rf (Hex: EtOAc 5:1) = 0.45. 1H NMR (600 MHz, CDCl3): δ = 7.34 (d, J = 8 Hz, 2 
H), 7.10 (d, J = 8 Hz, 2 H), 3.65 (s, 2 H), 2.37 (t, J = 7 Hz, 2 H), 2.12 (s, 3 H), 1.58 (q, J = 7 
Hz, 2 H), 1.41 (m, 2 H), 1.34 (m, 2 H), 0.90 (t, J = 7 Hz, 3 H); 13C NMR (150 MHz, CDCl3): 
δ = 206.0, 133.5, 131.9, 129.2, 123.0, 90.7, 80.1, 50.8, 31.1, 29.3, 28.4, 22.2, 19.4, 14.0; m/z 
(EI)(%): 228.3 (M-1); IR (KBr): = 3853, 3746, 3615, 3530, 3336, 3100, 3013, 2933, 2670, 
2324, 2091, 1995, 1901, 1739, 1541, 1453, 1364, 1217, 1098, 990, 897, 839, 782, 696 cm-1. 
To a solution of terminal alkynes 201/240 (5 mmol) in 10 mL THF at -78 oC was slowly 
added n-BuLi (7 mmol) under an argon protective atmosphere, the reaction was stirred at -78 
oC for one hour, then a iodomethane solution (10 mmol CH3I in 10 mL THF) was added 
dropwise into the flask. The reaction was warmed to room temperature and stirred overnight. 
After reaction completion, the mixture was quenched by 20 mL saturated brine and the 
aqueous phase was extracted with Et2O (3×20 mL). The combined organic phases were dried 
over Na2SO4 and concentrated under reduced pressure. The crude product was purified by 
column chromatography. 
1- (p-Tolyl)-1-propyne (183g) 
 
Colorless oil, Rf (hexane) = 0.50. 1H NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.1, 2H), 
7.10–7.04 (m, 2H), 2.32 (s, 3H), 2.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 137.43, 
131.32, 128.93, 120.91, 84.91, 79.72, 21.36, 4.29; m/z (EI)(%): 130.7 (M, 14.7), 129.8 (33.3), 
128.8 (63.9), 128.1 (32.4), 127.1 (100), 102.5 (23.7), 54.7 (27.2); IR (KBr): = 3028, 2919, 
2859, 1509, 1445, 1382, 1107, 1031, 816, 526 cm-1. 
5.5.2 General Experiment for the Calcium-Catalyzed Synthesis of 4H-Chromenes 
To a solution of 5-chloro-2-(1-hydroxyethyl)phenols 164a (0.4 mmol) and 
1-(p-Methoxyphenyl)-1-hexynes 183a (0.6 mmol) in 4 mL DCE were added Bu4NPF6 (0.01 
mmol) and Ca(NTf2)2 (0.01 mmol), the reaction was then stirred at 40 oC for 12 h. For the 
isolation of the product 166a, 5 mL saturated NaHCO3 solution was added, and the aqueous 
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phase was extracted with dichloromethane (2×10 mL). The combined organic phases were 
dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column 
chromatography. 
3-Butyl-7-chloro-2-(4-methoxyphenyl)-4-methyl-4H-chromene (166a) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.35. 1H NMR (400 MHz, CDCl3): δ = 7.38–7.29 
(m, 2H), 7.05 (d, J = 8.1, 1H), 7.02–6.94 (m, 2H), 6.94–6.88 (m, 2H), 3.83 (s, 3H), 3.44 (q, J 
= 6.9, 1H), 2.23 (ddd, J = 14.0, 9.9, 6.7, 1H), 2.11 (ddd, J = 14.2, 9.7, 4.8, 1H), 1.53–1.40 (m, 
1H), 1.39–1.10 (m, 6H, 1/2-CH2, -CH2 and -CH3), 0.80 (t, J = 7.3, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 159.44, 152.48, 144.90, 131.94, 130.31, 128.81, 127.58, 125.67, 123.04, 116.18, 
114.50, 113.48, 55.27, 32.01, 30.18, 29.27, 23.92, 22.44, 13.88; m/z (CI)(%): 345.2(28.6), 
344.3(27.1), 343.3 (M+1, 100), 342.3 (16.0), 327.2 (11.7), 307.2 (1.4), 135.3 (0.9); [M+1] 
HRMS calcd. for C21H24O235Cl: 343.14593, found: 343.14496; IR (KBr): = 2944, 1671, 
1593, 1485, 1242, 1175, 1083, 898, 830, 729 cm-1. 
6-Bromo-3-butyl-2-(4-methoxyphenyl)-4-methyl-4H-chromene (166b) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.41. 1H NMR (600 MHz, CDCl3): δ = 7.37–7.32 
(m, 2H), 7.26 (d, J = 2.5, 1H), 7.23 (dd, J = 8.6, 2.4, 1H), 6.94–6.90 (m, 2H), 6.83 (d, J = 8.6, 
1H), 3.84 (s, 3H), 3.44 (q, J = 6.9, 1H), 2.23 (ddd, J = 14.1, 9.9, 6.7, 1H), 2.11 (ddd, J = 14.3, 
9.8, 4.8, 1H), 1.51–1.42 (m, 1H), 1.38–1.30 (m, 4H, 1/2-CH2 and -CH3), 1.30–1.15 (m, 2H), 
0.82 (t, J = 7.3, 3H); 13C NMR (150 MHz, CDCl3): δ = 159.46, 151.08, 145.06, 130.54, 
130.30, 129.76, 129.27, 127.66, 117.75, 114.78, 114.12, 113.50, 55.28, 32.36, 30.20, 29.25, 
23.90, 22.43, 13.88; m/z (EI)(%): 388.1 (M+2, 2.1), 386.1 (M, 2.4), 373.1 (12.4), 371.1 (12.2), 
268.0 (8.3), 266.0 (8.8), 136.1 (8.5), 135.0 (100), 77.1 (7.3); [M+1] HRMS calcd. for 
C21H24O279Br: 387.09542, found: 387.09528; IR (KBr): = 2942, 1710, 1603, 1475, 1238, 
1179, 1099, 1038, 823, 665, 551 cm-1. 
6-Chloro-4-isopropyl-3-methyl-2-phenyl-4H-chromene (166c) 
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Colorless oil, Rf (pentane: EtOAc 40:1) = 0.75. 1H NMR (400 MHz, CDCl3): δ = 7.51–7.43 
(m, 2H), 7.43–7.36 (m, 2H), 7.36–7.30 (m, 1H), 7.14 (dd, J = 8.6, 2.5, 1H), 7.05 (d, J = 2.5, 
1H), 6.95 (d, J = 8.6, 1H), 3.10 (d, J = 3.6, 1H), 2.04 (dtd, J = 13.8, 6.9, 3.7, 1H), 1.88 (s, 3H), 
1.00 (d, J = 6.9, 3H), 0.80 (d, J = 6.9, 3H); 13C NMR (100 MHz, CDCl3): δ = 151.99, 146.19, 
135.01, 128.93, 128.46, 128.25, 128.04, 127.10, 126.95, 124.84, 116.99, 108.85, 48.18, 33.66, 
20.23, 18.50, 18.01; m/z (CI)(%): 301.1 (37.1), 300.1 (27.7), 299.1 (M+1, 100), 298.0 (9.6), 
257.1 (29.1), 256.1 (14.7), 255.1 (84.5), 105.1 (10.3); HRMS calcd. for C19H19O35Cl: 
298.11189, found: 298.11138; IR (KBr): = 3056, 2954, 1581, 1473, 1241, 1088, 1006, 897, 
814, 704 cm-1. 
6-Chloro-4-cyclohexyl-3-methyl-2-phenyl-4H-chromene (166d) 
 
Colorless oil, Rf (pentane) = 0.40. 1H NMR (400 MHz, CDCl3): δ = 7.47 (dt, J = 8.2, 1.8, 2H), 
7.42–7.35 (m, 2H), 7.35–7.30 (m, 1H), 7.13 (dd, J = 8.6, 2.5, 1H), 7.03 (d, J = 2.5, 1H), 6.94 
(d, J = 8.6, 1H), 3.06 (d, J = 3.7, 1H), 1.89 (s, 3H), 1.82–1.55 (m, 6H), 1.26–1.09 (m, 3H), 
1.02 (ddt, J = 16.2, 12.6, 6.2, 1H), 0.73 (qd, J = 12.4, 3.4, 1H); 13C NMR (100 MHz, CDCl3): 
δ = 152.02, 146.34, 134.98, 128.92, 128.42, 128.23, 128.02, 127.09, 126.86, 125.65, 116.95, 
108.89, 48.13, 44.05, 30.80, 28.58, 26.74, 26.62, 26.30, 18.64; m/z (CI)(%): 341.2 (28.2), 
340.2 (26.2), 339.2 (M+1, 100), 338.1 (M, 17.4), 337.1 (11.4), 257.1 (18.8), 255.1 (47.1); 
HRMS calcd. for C22H23O35Cl: 338.14319, found: 338.14311; IR (KBr): = 2923, 2859, 
1726, 1595, 1473, 1240, 1084, 1009, 902, 815, 709 cm-1. 
6-Bromo-3-butyl-2-(4-methoxyphenyl)-4-phenyl-4H-chromene (166e) 
 
Light yellow oil, Rf (pentane: EtOAc 40:1) = 0.38. 1H NMR (400 MHz, CDCl3): δ = 
7.44–7.38 (m, 2H), 7.34–7.28 (m, 4H), 7.25–7.18 (m, 2H), 7.15 (d, J = 2.3, 1H), 6.97–6.91 (m, 
2H), 6.88 (d, J = 8.7, 1H), 4.59 (s, 1H), 3.84 (s, 3H), 2.14 (ddd, J = 14.0, 9.9, 6.6, 1H), 1.80 
(ddd, J = 14.2, 9.6, 4.7, 1H), 1.51–1.36 (m, 1H), 1.32–1.05 (m, 3H), 0.76 (t, J = 7.3, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 159.60, 150.07, 145.42, 145.18, 131.78, 130.36, 130.24, 128.76, 
127.93, 127.41, 126.85, 126.55, 118.10, 114.97, 113.55, 112.12, 55.28, 43.98, 29.63, 29.43, 
22.30, 13.81; m/z (EI)(%): 450.0 (M+2, 100), 449.1 (25.7), 448.0 (M, 97.5), 406.8 (22.4), 
392.8 (66.9), 390.9 (56.5), 372.9 (73.7), 371.0 (68.8), 134.9 (20.4); HRMS calcd. for 
C26H25O279Br: 448.10324, found: 448.10328; IR (KBr): = 2955, 2864, 1731, 1604, 1510, 
1475, 1242, 1170, 1032, 831, 731, 701 cm-1. 
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3-Butyl-2-(4-methoxyphenyl)-4-phenyl-4H-chromene (166f) 
 
Colorless oil, Rf (pentane: EtOAc 50:1) = 0.25. 1H NMR (600 MHz, CDCl3): δ = 7.48–7.42 
(m, 2H), 7.38–7.33 (m, 2H), 7.31 (dd, J = 10.4, 4.9, 2H), 7.23–7.18 (m, 1H), 7.15–7.11 (m, 
1H), 7.08–7.03 (m, 1H), 7.03–6.99 (m, 1H), 6.98–6.91 (m, 3H), 4.67 (s, 1H), 3.86 (s, 3H), 
2.17 (ddd, J = 14.0, 10.0, 6.7, 1H), 1.84 (ddd, J = 14.3, 9.8, 4.7, 1H), 1.52–1.43 (m, 1H), 
1.35–1.27 (m, 1H), 1.27–1.19 (m, 1H), 1.18–1.09 (m, 1H), 0.78 (t, J = 7.3, 3H); 13C NMR 
(150 MHz, CDCl3): δ = 159.47, 150.92, 146.19, 145.22, 130.40, 129.23, 128.59, 127.99, 
127.86, 127.24, 126.52, 124.47, 123.03, 116.22, 113.51, 112.23, 55.28, 44.10, 29.71, 29.53, 
22.34, 13.84; m/z (EI)(%): 371.1 (M+1, 13.2), 370.1 (M, 51.7), 313.0 (44.5), 293.1 (58.1), 
250.0 (20.8), 134.9 (100); HRMS calcd. for C26H26O2: 370.19273, found: 370.19259; IR 
(KBr): = 2946, 2864, 1725, 1600, 1494, 1461, 1241, 1170, 1031, 836, 749, 703 cm-1. 
3-Butyl-2-(4-methoxyphenyl)-6-methyl-4-phenyl-4H-chromene (166g) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.32. 1H NMR (400 MHz, CDCl3): δ = 7.43–7.37 
(m, 2H), 7.35–7.25 (m, 4H), 7.21–7.15 (m, 1H), 6.95–6.86 (m, 4H), 6.82 (d, J = 0.8, 1H), 
4.58 (s, 1H), 3.83 (s, 3H), 2.20 (s, 3H), 2.16–2.07 (m, 1H), 1.79 (ddd, J = 14.1, 9.6, 4.7, 1H), 
1.49–1.37 (m, 1H), 1.34–1.03 (m, 3H), 0.74 (t, J = 7.3, 3H); 13C NMR (100 MHz, CDCl3): δ 
= 159.44, 148.91, 146.34, 145.30, 132.33, 130.40, 129.35, 128.57, 127.98, 126.47, 124.11, 
115.97, 113.49, 112.10, 55.28, 44.19, 29.75, 29.51, 22.33, 20.70, 13.84; m/z (EI)(%): 384.1 
(M, 1.9), 347.0 (4.4), 346.0 (9.3), 265.0 (7.0), 264.0 (20.9), 135.9 (10.7), 134.9 (100), 76.9 
(12.0); HRMS calcd. for C27H28O2: 384.20838, found: 384.20839; IR (KBr): = 2939, 1723, 
1603, 1500, 1241, 1169, 1033, 824, 727 cm-1. 
2-Butyl-3-(4-methoxyphenyl)-1-phenyl-1H-benzo[f]chromene (166h) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.32. 1H NMR (400 MHz, CDCl3): δ = 7.92 (d, J = 
8.4, 1H), 7.76 (d, J = 7.4, 1H), 7.71 (d, J = 8.9, 1H), 7.41 (ddd, J = 8.2, 5.4, 2.9, 5H), 
7.35–7.27 (m, 2H), 7.24 (dd, J = 10.3, 4.9, 2H), 7.16–7.09 (m, 1H), 6.97–6.88 (m, 2H), 5.17 
(s, 1H), 3.83 (s, 3H), 2.22 (ddd, J = 14.0, 9.9, 6.8, 1H), 2.05–1.96 (m, 1H), 1.61 (tdd, J = 9.9, 
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6.4, 4.7, 1H), 1.46–1.35 (m, 1H), 1.32–1.13 (m, 2H), 0.80 (t, J = 7.3, 3H); 13C NMR (100 
MHz, CDCl3): δ = 159.49, 149.28, 145.59, 144.29, 131.52, 130.80, 130.47, 128.42, 128.37, 
128.27, 127.67, 126.43, 126.39, 123.77, 122.98, 117.89, 115.70, 113.60, 113.51, 55.28, 41.23, 
29.73, 29.08, 22.42, 13.88; m/z (EI)(%): 421.2 (M+1, 10.5), 420.1 (M, 39.0), 363.0 (33.1), 
344.1 (21.8), 343.1 (100), 299.0 (6.3); [M+1] HRMS calcd. for C30H29O2: 421.21621, found: 
421.21634; IR (KBr): = 2955, 2927, 1603, 1511, 1460, 1234, 1175, 1087, 906, 833, 737, 
701 cm-1. 
7-Chloro-3,4-dimethyl-2-(p-Tolyl)-4H-chromene (166i) 
 
Colorless oil, Rf (pentane) = 0.30. 1H NMR (400 MHz, CDCl3): δ = 7.37–7.30 (m, 2H), 
7.23–7.15 (m, 2H), 7.04 (d, J = 8.1, 1H), 7.00–6.94 (m, 2H), 3.33 (q, J = 6.9, 1H), 2.37 (s, 
3H), 1.82 (s, 3H), 1.36 (d, J = 6.9, 3H); 13C NMR (100 MHz, CDCl3): δ = 152.15, 144.00, 
138.05, 132.11, 132.03, 128.86, 128.84, 128.70, 124.86, 123.05, 116.20, 109.85, 35.30, 23.50, 
21.31, 17.18; m/z (CI)(%): 287.2 (38.6), 286.2 (22.7), 285.2 (M+1, 100), 284.2 (13.5), 249.2 
(15.6), 199.1 (41.1), 181.1 (10.5), 121.2 (11.3), 119.2 (19.9); [M-CH3] HRMS calcd. for 
C17H14O35Cl: 269.07277, found: 269.07229; IR (KBr): = 2937, 1715, 1589, 1479, 1420, 
1265, 1088, 1010, 817, 728, 587 cm-1. 
3-Butyl-7-chloro-4-methyl-2-(thiophen-2-yl)-4H-chromene (166j) 
 
Colorless oil, Rf (pentane) = 0.42. 1H NMR (600 MHz, CDCl3): δ = 7.35 (dd, J = 5.1, 0.9, 1H), 
7.23 (dd, J = 3.6, 0.9, 1H), 7.08–7.04 (m, 2H), 7.03 (d, J = 1.9, 1H), 7.01 (dd, J = 8.0, 2.0, 
1H), 3.44 (q, J = 6.9, 1H), 2.52 (ddd, J = 14.2, 10.5, 6.2, 1H), 2.28–2.22 (m, 1H), 1.58–1.50 
(m, 1H), 1.50–1.40 (m, 1H), 1.40–1.28 (m, 5H, -CH2 and -CH3), 0.89 (t, J = 7.3, 3H); 13C 
NMR (150 MHz, CDCl3): δ = 152.14, 139.65, 136.76, 132.09, 128.54, 126.64, 126.62, 125.68, 
125.53, 123.34, 117.18, 116.26, 33.44, 30.27, 30.13, 23.81, 22.67, 13.93; m/z (CI)(%): 321.1 
(32.0), 320.1 (22.0), 319.1 (M+1, 100), 318.1 (13.0), 303.1 (5.9), 283.2 (5.8); [M-CH3] 
HRMS calcd. for C17H16O35Cl32S: 303.06049, found: 303.06021; IR (KBr): = 2945, 2320, 
2097, 1725, 1587, 1476, 1416, 1233, 1081, 836, 702, 593 cm-1. 
6-Bromo-3,4-dimethyl-2-phenyl-4H-chromene (166k) 
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Colorless oil, Rf (pentane: EtOAc 40:1) = 0.8. 1H NMR (600 MHz, CDCl3): δ = 7.46 (dd, J = 
5.1, 3.3, 2H), 7.40 (dd, J = 10.1, 4.7, 2H), 7.37–7.32 (m, 1H), 7.26 (d, J = 2.4, 1H), 7.24 (dd, J 
= 8.5, 2.4, 1H), 6.84 (d, J = 8.5, 1H), 3.35 (q, J = 6.9, 1H), 1.83 (s, 3H), 1.40 (d, J = 7.0, 3H); 
13C NMR (150 MHz, CDCl3): δ = 150.69, 144.13, 135.05, 130.59, 129.93, 128.96, 128.38, 
128.21, 128.03, 117.80, 114.86, 109.90, 35.59, 23.48, 17.13; m/z (CI)(%): 317.0 (66.4), 315.9 
(36.6), 315.0 (68.0), 314.0 (18.6), 301.0 (18.3), 298.9 (17.1), 236.1 (28.6), 123.1 (43.4), 105.2 
(100), 85.2 (21.8), 83.2 (30.2); [M-CH3] HRMS calcd. for C16H12O79Br: 299.00660, found: 
299.00671; IR (KBr): = 3053, 2964, 1581, 1473, 1241, 1092, 807, 763, 695 cm-1. 
5.6 Experiments for Calcium-Catalyzed Carboarylation of Alkynes 
5.6.1 Experiments for Preparation of Substrates 
To a solution of ketones 212 (5 mmol) in 20 mL EtOH at 0 oC was added NaBH4 (15 
mmol) in portions, the reaction was then warmed to room temperature and stirred for 2 h. 
After reaction completion, EtOH solvent was removed under reduced pressure and the residue 
was washed by 20 mL saturated brine. The aqueous phase was extracted with Et2O (3×20 mL), 
the combined organic phases were dried over Na2SO4 and concentrated under reduced 
pressure. The crude product was purified by column chromatography. 
4-(1-Hydroxyethyl)phenol (209a) 
 
White solid, Rf (hexane: EtOAc 1:1) = 0.39. 1H NMR (400 MHz, DMSO-d6): δ = 9.17 (s, 1H), 
7.10 (d, J=5.8, 2H), 6.67 (d, J=5.8, 2H), 4.91 (s, 1H), 4.58 (s, 1H), 1.25 (s, 3H); 13C NMR 
(100 MHz, DMSO-d6): δ = 155.96, 137.68, 126.44, 114.66, 67.80, 25.95; m/z (EI)(%): 138.1 
(M, 42.5), 123.1 (100), 121.1 (26.4), 95.1 (52.7), 77.2 (33.8); IR (KBr): = 3388, 3097, 3022, 
2971, 1600, 1511, 1458, 1371, 1232, 1072, 1007, 895, 825, 731 cm-1. 
1-(p-Tolyl)ethanol (209b) 
 
Colorless oil, Rf (hexane: EtOAc 5:1) = 0.32. 1H NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 
8.2, 2H), 7.15 (d, J = 7.9, 2H), 4.85 (q, J = 6.4, 1H), 2.34 (s, 3H), 1.83 (s, 1H), 1.47 (d, J = 6.4, 
3H); 13C NMR (100 MHz, CDCl3): δ = 142.84, 137.10, 129.12, 125.31, 70.21, 25.05, 21.06; 
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m/z (EI)(%): 136.0 (M, 73.2), 121.0 (100), 119.0 (69.4), 93.0 (68.3), 91.1 (47.9), 77.1 (22.1); 
IR (KBr): = 3358, 2973, 1513, 1449, 1200, 1078, 1009, 897, 815, 725 cm-1. 
N-(2-(1-Hydroxyethyl)phenyl)-4-methylbenzenesulfonamide (209c) 
 
White solid, Rf (hexane: EtOAc 3:1) = 0.20. 1H NMR (600 MHz, CDCl3): δ = 8.43 (s, 1H), 
7.72–7.66 (m, 2H), 7.43 (dd, J = 8.1, 1.0 Hz, 1H), 7.24–7.20 (m, 2H), 7.20–7.16 (m, 1H), 
7.08 (dd, J = 7.7, 1.7 Hz, 1H), 7.04 (td, J = 7.5, 1.2 Hz, 1H), 4.84 (q, J = 6.6 Hz, 1H), 2.42 (s, 
1H), 2.37 (s, 3H), 1.36 (d, J = 6.7 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.71, 136.88, 
135.66, 133.99, 129.59, 128.48, 127.12, 126.97, 124.60, 121.79, 69.75, 22.81, 21.50; m/z 
(EI)(%): 293.3 (3.5), 292.2 (9.8), 291.2 (53.5), 136.2 (63.8), 118.1 (100), 91.1 (40.2); HRMS 
calcd. for C15H17NO3SNa: 314.08214, found: 314.08121; IR (KBr): = 3488, 3243, 2977, 
2972, 1549, 1496, 1330, 1159, 1091, 932, 759, 665, 564 cm-1. 
1-(4-Chlorophenyl)ethanol (209e) 
 
Colorless oil, Rf (hexane: EtOAc 3:1) = 0.45. 1H NMR (400 MHz, CDCl3): δ = 7.31–7.21 (m, 
4H), 4.81 (q, J = 6.5, 1H), 2.48 (s, 1H), 1.42 (d, J = 6.5, 3H); 13C NMR (100 MHz, CDCl3): δ 
= 144.15, 132.93, 128.49, 126.73, 69.60, 25.15; m/z (EI)(%): 156.2 (M, 17.2), 155.0 (42.8), 
140.8 (83.4), 138.7 (100), 112.3 (14.8), 77.3 (40.3); IR (KBr): = 3342, 2973, 1592, 1486, 
1406, 1080, 1009, 896, 825 cm-1. 
Cyclohex-2-enol (209f) 
 
Colorless oil, Rf (hexane: EtOAc 3:1) = 0.29. 1H NMR (400 MHz, CDCl3): δ = 5.77–5.84 (m, 
1H,), 5.69–5.75 (m, 1H), 4.13–4.21 (m, 1H), 1.78–2.08 (m, 4H), 1.65–1.78 (m, 1H), 
1.50–1.65 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 130.5, 129.9, 65.6, 32.1, 25.2, 19.1; m/z 
(EI)(%): 81 (15), 70 (32), 69 (37), 63 (12), 57 (66), 55 (78), 54 (11), 53 (51), 52 (46), 51 (93), 
50 (100); IR (KBr): = 3353, 3025, 2929, 2864, 2657, 1650, 1578, 1541, 1438, 1385, 1284, 
1160, 1131, 1057, 1002, 957, 896, 853, 810, 726, 671, 561 cm-1. 
Cyclopent-2-enol (209g) 
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Colorless oil, Rf (hexane: EtOAc 5:1) = 0.19. 1H NMR (400 MHz, CDCl3): δ = 5.94 (dtd, J = 
5.6, 2.2, 1.0, 1H), 5.82–5.77 (m, 1H), 4.87–4.79 (m, 1H), 2.54–2.38 (m, 1H), 2.30–2.15 (m, 
1H), 1.83 (s, 1H), 1.75–1.45 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 135.01, 133.24, 
77.48, 33.21, 30.91; m/z (EI)(%): 84.9 (M, 64.7), 82.9 (100), 48.1 (17.6), 47.1 (31.9); IR 
(KBr): = 2961, 1408, 1258, 1017, 866, 797, 694 cm-1. 
To a solution of organometallic reagents R-M 198 (7.5 mmol) in 20 mL THF at 0 oC was 
added aldehydes 213 (5 mmol) slowly under an argon protective atmosphere, the reaction was 
then heated under reflux for 30 minutes. After the reaction cooled down to room temperature, 
it was quenched by 20 mL saturated NH4Cl solutuion and the aqueous phase was extracted 
with Et2O (2×30 mL). The collected organic phases were dried over Na2SO4 and concentrated 
under reduced pressure. The crude product was purified by column chromatography. 
1-(4-Methoxyphenyl)-2-methylpropan-1-ol (209h) 
 
Colorless oil, Rf (hexane: EtOAc 5:1) = 0.26. 1H NMR (400 MHz, CDCl3): δ = 7.24–7.16 (m, 
2H), 6.88–6.81 (m, 2H), 4.27 (d, J = 7.2, 1H), 3.78 (s, 3H), 1.91 (dq, J = 13.6, 6.8, 1H), 1.84 
(s, 1H), 0.99 (d, J = 6.7, 3H), 0.75 (d, J = 6.8, 3H); 13C NMR (100 MHz, CDCl3): δ = 158.86, 
135.82, 127.66, 113.51, 79.70, 55.21, 35.24, 18.92, 18.48; m/z (EI)(%): 180.1 (M, 13.1), 
163.0 (11.7), 137.0 (100), 109.0 (15.5), 94.0 (8.1), 77.0 (6.8); IR (KBr): = 3428, 2957, 
1609, 1510, 1461, 1241, 1173, 1025, 938, 828 cm-1. 
Cyclohexyl(4-methoxyphenyl)methanol (209i) 
 
White solid, Rf (hexane: EtOAc 5:1) = 0.31. 1H NMR (400 MHz, CDCl3): δ = 7.23–7.15 (m, 
2H), 6.91–6.80 (m, 2H), 4.29 (d, J = 7.5, 1H), 3.79 (s, 3H), 2.00 (d, J = 12.7, 1H), 1.76 (dd, J 
= 10.0, 6.6, 2H), 1.69–1.50 (m, 3H), 1.34 (d, J = 12.8, 1H), 1.28–0.94 (m, 4H), 0.87 (qd, J = 
12.4, 3.5, 1H); 13C NMR (100 MHz, CDCl3): δ = 158.91, 135.80, 127.74, 113.55, 79.02, 
55.25, 44.96, 29.26, 29.09, 26.43, 26.07, 25.99; m/z (EI)(%): 220.1 (M, 8.8), 138.1 (7.1), 
137.0 (100), 109.0 (8.9); IR (KBr): = 3447, 2939, 2856, 1609, 1510, 1448, 1244, 1172, 
1001, 820 cm-1. 
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1-(4-Methoxyphenyl)but-3-en-1-ol (209j) 
 
Colorless oil, Rf (hexane: EtOAc 5:1) = 0.24. 1H NMR (400 MHz, CDCl3): δ = 7.30–7.22 (m, 
2H), 6.91–6.83 (m, 2H), 5.78 (ddt, J = 17.2, 10.2, 7.1, 1H), 5.19–5.07 (m, 2H), 4.67 (t, J = 6.5, 
1H), 3.79 (s, 3H), 2.48 (dt, J = 7.9, 1.1, 2H), 2.02 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 
158.97, 136.02, 134.58, 127.03, 118.17, 113.74, 72.94, 55.24, 43.72; m/z (EI)(%): 177.9 
(M+1, 1.1), 137.0 (100), 136.1 (99.6), 135.3 (40.0), 108.8 (69.3), 94.4 (25.1), 93.4 (24.6), 
77.4 (35.3); IR (KBr): = 3400, 2933, 2906, 1610, 1511, 1299, 1242, 1175, 1033, 915, 830 
cm-1. 
1-(4-Methoxyphenyl)hept-2-yn-1-ol (209k) 
 
Colorless oil, Rf (hexane: EtOAc 5:1) = 0.24. 1H NMR (400 MHz, CDCl3): δ = 7.50–7.37 (m, 
2H), 6.95–6.79 (m, 2H), 5.38 (dd, J = 4.0, 1.9, 1H), 3.79 (s, 3H), 2.26 (td, J = 7.0, 2.0, 2H), 
2.14 (d, J = 2.5, 1H), 1.58–1.47 (m, 2H), 1.46–1.35 (m, 2H), 0.90 (t, J = 7.3, 3H); 13C NMR 
(100 MHz, CDCl3): δ = 159.48, 133.62, 128.00, 113.81, 87.40, 80.04, 64.39, 55.27, 30.64, 
21.95, 18.48, 13.57; m/z (EI)(%): 218.1 (M, 100), 217.0 (28.5), 201.1 (27.7), 187.0 (38.9), 
175.0 (28.8), 161.0 (26.5), 109.0 (82.2), 107.9 (23.3); IR (KBr): = 3399, 2934, 2867, 2285, 
2106, 1608, 1509, 1457, 1243, 1026, 833, 768 cm-1. 
1-(4-Methoxyphenyl)-3-phenylprop-2-yn-1-ol (209l) 
 
Yellow oil, Rf (hexane: EtOAc 5:1) = 0.24. 1H NMR (400 MHz, CDCl3): δ = 7.56–7.50 (m, 
2H), 7.49–7.42 (m, 2H), 7.34–7.27 (m, 3H), 6.95–6.87 (m, 2H), 5.63 (d, J = 5.9, 1H), 3.81 (s, 
3H), 2.40 (s, 1H); 13C NMR (100 MHz, CDCl3): δ = 159.65, 132.95, 131.69, 128.51, 128.25, 
128.14, 122.44, 113.96, 88.90, 86.43, 64.66, 55.30; m/z (EI)(%): 238.1 (M, 20.2), 237.1 (23.7), 
236.1 (100), 208.1 (70.6), 193.0 (44.0), 165.0 (23.3), 129.0 (28.2); IR (KBr): = 3384, 2324, 
2108, 1608, 1509, 1245, 1173, 1028, 958, 832, 756, 691 cm-1. 
To a solution of aryl iodides 200 (5 mmol) and but-3-yn-1-ylbenzenes 214 (10 mmol) in 
5 mL degassed Et3N were added Pd(PPh3)4 (0.25 mmol) and CuI (0.5 mmol) under an argon 
protective atmosphere, the reaction was then stirred at 60 oC for 3 hours. After the reaction 
cooled down to room temperature, the mixture was diluted with 30 mL EE and washed by 20 
mL 1N HCl and 20 mL saturated NaHCO3 solution. The aqueous phase was extracted with 
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EE (2×30 mL), the collected organic phases were dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by column chromatography. 
But-1-yne-1,4-diyldibenzene (210a) 
 
Yellow oil, Rf (hexane) = 0.42. 1H NMR (400 MHz, CDCl3): δ = 7.42–7.36 (m, 2H), 
7.36–7.20 (m, 8H), 2.94 (t, J = 7.5, 2H), 2.71 (t, J = 7.5, 2H); 13C NMR (100 MHz, CDCl3): δ 
= 140.67, 131.49, 128.51, 128.35, 128.17, 127.59, 126.28, 123.81, 89.47, 81.29, 35.17, 21.67; 
m/z (EI)(%): 207.2 (M+1, 17.4), 206.2 (M, 92.8), 205.2 (47.7), 191.1 (19.3), 115.1 (73.3), 
91.1 (100); IR (KBr): = 3028, 2925, 2330, 2096, 1597, 1490, 1444, 749, 693, 531 cm-1. 
1-Methoxy-2-(4-phenylbut-1-yn-1-yl)benzene (210c) 
 
Yellow oil, Rf (hexane: EtOAc 30:1) = 0.21. 1H NMR (400 MHz, CDCl3): δ = 7.38–7.19 (m, 
7H), 6.91–6.83 (m, 2H), 3.87 (s, 3H), 2.96 (t, J = 7.5, 2H), 2.77 (t, J = 7.5, 2H): 13C NMR 
(100 MHz, CDCl3): δ = 159.79, 140.79, 133.64, 128.98, 128.55, 128.31, 126.21, 120.37, 
112.89, 110.50, 93.68, 55.74, 35.26, 22.06; m/z (EI)(%): 236.8 (M, 13.5), 235.7 (99.9), 234.7 
(100), 233.7 (72.4), 232.9 (73.0), 145.1 (42.0), 144.2 (44.5), 143.3 (39.2), 116.8 (32.2), 115.8 
(44.0), 114.9 (53.3), 114.0 (35.0), 91.5 (38.5), 90.7 (41.2); [M+Na] HRMS calcd. for 
C17H16ONa: 259.10934, found: 259.10934; IR (KBr): = 3026, 2933, 2325, 2099, 1595, 
1491, 1455, 1258, 1115, 1024, 748, 697 cm-1. 
1-(4-Phenylbut-1-yn-1-yl)naphthalene (210d) 
 
White solid, Rf (hexane) = 0.36. 1H NMR (600 MHz, CDCl3): δ = 8.23–8.13 (m, 1H), 
7.86–7.81 (m, 1H), 7.79 (dd, J = 8.1, 3.2, 1H), 7.62 (dd, J = 8.7, 5.1, 1H), 7.55–7.48 (m, 2H), 
7.44–7.39 (m, 1H), 7.39–7.34 (m, 4H), 7.32–7.26 (m, 1H), 3.05 (ddd, J = 7.3, 6.1, 3.3, 2H), 
2.93–2.87 (m, 2H); 13C NMR (150 MHz, CDCl3): δ = 140.64, 133.44, 133.11, 129.95, 128.62, 
128.44, 128.09, 127.99, 126.43, 126.34, 126.19, 125.17, 121.49, 94.43, 79.37, 35.19, 21.89; 
m/z (EI)(%): 256.1 (M, 29.2), 255.4 (56.5), 254.5 (38.6), 253.7 (57.8), 165.1 (53.7), 164.1 
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(100), 162.6 (88.6); HRMS calcd. for C20H16: 256.12455, found: 256.12425; IR (KBr): = 
3038, 2922, 2325, 1582, 1494, 1447, 760, 700 cm-1. 
2-(4-Phenylbut-1-yn-1-yl)thiophene (210e) 
 
Yellow oil, Rf (hexane) = 0.41. 1H NMR (400 MHz, CDCl3): δ = 7.36–7.20 (m, 5H), 
7.19–7.15 (m, 1H), 7.12 (d, J = 3.6, 1H), 6.94 (dd, J = 5.2, 3.6, 1H), 2.93 (t, J = 7.6, 2H), 2.72 
(t, J = 7.6, 2H); 13C NMR (100 MHz, CDCl3): δ = 140.49, 131.01, 128.47, 128.39, 126.74, 
126.33, 126.01, 123.92, 93.54, 74.45, 34.97, 21.94; m/z (EI)(%): 212.8 (M, 12.6), 211.8 (15.5), 
210.5 (100), 208.3 (36.6), 120.8 (48.4), 119.9 (36.3), 91.5 (19.1), 90.7 (26.4); [M+1] HRMS 
calcd. for C14H13S: 213.07325, found: 213.07309; IR (KBr): = 3027, 2925, 2324, 2099, 
1600, 1495, 1440, 1191, 833, 745, 696 cm-1. 
Pent-1-yne-1,5-diyldibenzene (210d’) 
 
Colorless oil, Rf (hexane: EtOAc 30:1) = 0.44. 1H NMR (400 MHz, CDCl3): δ = 7.46–7.38 (m, 
2H), 7.34–7.26 (m, 5H), 7.26–7.17 (m, 3H), 2.80 (t, J = 7.6, 2H), 2.43 (t, J = 7.0, 2H), 
1.99–1.89 (m, 2H); 13C NMR (100 MHz, CDCl3): δ = 141.61, 131.53, 128.54, 128.34, 128.18, 
127.53, 125.88, 123.95, 89.81, 81.12, 34.82, 30.30, 18.81; m/z (EI)(%): 219.4 (M-1, 50.5), 
218.8 (26.0), 218.0 (44.5), 216.9 (67.2), 189.4 (28.2), 141.3 (83.5), 128.3 (72.6), 127.5 (72.4), 
126.4 (85.9), 115.0 (100), 102.1 (41.6), 91.5 (64.5), 90.6 (58.3); IR (KBr): = 3060, 3027, 
2935, 2858, 2111, 1598, 1490, 1448, 749, 693 cm-1. 
To a solution of 4-ethynylanisoles 216 (3 mmol) in 15 mL THF at -78 oC was slowly 
added n-BuLi (3 mmol) under an argon protective atmosphere, the mixture was stirred at -78 
oC for 30 minutes, then NaI (0.3 mmol) and 2-arylethylbromides 215 (3.6 mmol) were added 
into the flask, the reaction was heated up to reflux overnight. After the reaction cooled down 
to room temperature, the reaction was quenched by 20 mL saturated NH4Cl solution and the 
aqueous phase was extracted with Et2O (2×20 mL). The collected organic phases were dried 
over Na2SO4 and concentrated under reduced pressure. The crude product was purified by 
column chromatography. 
4,4'-(But-1-yne-1,4-diyl)bis(methoxybenzene) (210f) 
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White solid, Rf (hexane: Et2O 9:1) = 0.37. 1H NMR (600 MHz, CDCl3): δ = 7.33 (d, J = 8.8, 
2H), 7.20 (d, J = 8.6, 2H), 6.87 (d, J = 8.6, 2H), 6.82 (d, J = 8.8, 2H), 3.80 (d, J = 1.2, 6H), 
2.87 (t, J = 7.5, 2H), 2.65 (t, J = 7.5, 2H); 13C NMR (150 MHz, CDCl3): δ = 159.02, 158.04, 
132.93, 132.80, 129.44, 115.98, 113.77, 113.71, 87.97, 80.94, 55.21, 55.20, 34.40, 21.97; m/z 
(EI)(%): 266.1 (M, 39.0), 235.1 (11.2), 145.0 (16.9), 121.0 (100); IR (KBr): = 3015, 2951, 
2309, 2060, 1739, 1603, 1502, 1234, 1173, 1028, 824, 752 cm-1. 
1-(4-(4-Methoxyphenyl)but-3-yn-1-yl)-2-methylbenzene (210g) 
 
Colorless oil, Rf (hexane: DCM 7:3) = 0.41. 1H NMR (600 MHz, CDCl3): δ = 7.38–7.31 (m, 
2H), 7.25 (dd, J = 7.0, 1.8, 1H), 7.22–7.10 (m, 3H), 6.89–6.78 (m, 2H), 3.85–3.75 (m, 3H), 
3.00–2.90 (m, 2H), 2.71–2.61 (m, 2H), 2.43–2.36 (m, 3H); 13C NMR (150 MHz, CDCl3): δ = 
159.05, 138.90, 135.95, 132.82, 130.17, 128.97, 126.37, 125.95, 115.95, 113.79, 87.94, 80.81, 
55.20, 32.56, 20.39, 19.30; m/z (EI)(%): 251.3 (M+1, 12.6), 250.2 (M, 55.7), 146.1 (17.5), 
145.1 (100), 121.2 (11.6), 105.2 (32.9), 102.1 (17.4); IR (KBr): = 3011, 2938, 2079, 1605, 
1504, 1456, 1287, 1243, 1172, 1032, 829, 746 cm-1. 
1-Bromo-4-(4-(4-methoxyphenyl)but-3-yn-1-yl)benzene (210h) 
 
White solid, Rf (hexane: DCM 7:1) = 0.51. 1H NMR (600 MHz, CDCl3): δ = 7.46–7.39 (m, 
2H), 7.33–7.27 (m, 2H), 7.14 (t, J = 5.4, 2H), 6.85–6.77 (m, 2H), 3.80 (s, 3H), 2.86 (t, J = 7.4, 
2H), 2.65 (t, J = 7.4, 2H); 13C NMR (150 MHz, CDCl3): δ = 159.11, 139.65, 132.80, 131.35, 
130.32, 120.07, 115.75, 113.81, 87.30, 81.34, 55.22, 34.58, 21.48; m/z (EI)(%): 316.0 (M+2, 
18.1), 314.0 (M, 17.8), 146.1 (13.8), 145.0 (100), 102.0 (15.8); IR (KBr): = 2930, 2305, 
1600, 1494, 1288, 1242, 1168, 1020, 822 cm-1. 
1-Fluoro-4-(4-(4-methoxyphenyl)but-3-yn-1-yl)benzene (210i) 
 
White solid, Rf (hexane: DCM 7:3) = 0.52. 1H NMR (600 MHz, CDCl3): δ = 7.33–7.27 (m, 
2H), 7.25–7.19 (m, 2H), 7.03–6.96 (m, 2H), 6.83–6.78 (m, 2H), 3.80 (s, 3H), 2.88 (t, J = 7.4, 
2H), 2.65 (t, J = 7.4, 2H); 13C NMR (150 MHz, CDCl3): δ = 162.33, 160.72, 159.12, 136.38, 
133.00, 132.60, 129.69, 113.96, 87.51, 81.26, 55.16, 34.40, 21.79; m/z (EI)(%): 255.2 (M+1, 
12.6), 254.2 (M, 61.9), 146.1 (13.9), 145.1 (100), 109.1 (17.4), 102.1 (12.5); IR (KBr): = 
2936, 1605, 1506, 1455, 1288, 1241, 1028, 822 cm-1. 
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1-(4-(4-Methoxyphenyl)but-3-yn-1-yl)naphthalene (210j) 
 
Colorless oil, Rf (hexane: DCM 7:3) = 0.41. 1H NMR (400 MHz, CDCl3): δ = 8.10 (d, J = 8.3, 
1H), 7.90–7.84 (m, 1H), 7.75 (dd, J = 8.5, 3.8, 1H), 7.56–7.46 (m, 2H), 7.43 (d, J = 5.0, 2H), 
7.34–7.27 (m, 2H), 6.88–6.74 (m, 2H), 3.79 (s, 3H), 3.40 (t, J = 7.7, 2H), 2.83 (t, J = 7.7, 2H); 
13C NMR (100 MHz, CDCl3): δ = 159.07, 136.72, 133.84, 132.83, 131.71, 128.81, 127.08, 
126.31, 125.92, 125.49, 123.55, 115.94, 113.79, 87.92, 81.30, 55.22, 32.46, 21.00; m/z 
(EI)(%): 287.2 (M+1, 20.1), 286.2 (M, 90.0), 285.2 (15.3), 255.2 (24.3), 145.1 (100), 141.1 
(75.6), 115.1 (28.7), 102.1 (14.1); IR (KBr): = 3047, 2953, 2322, 2113, 1603, 1507, 1459, 
1288, 1244, 1172, 1029, 829, 788 cm-1. 
3-(4-(4-Methoxyphenyl)but-3-yn-1-yl)thiophene (210k) 
 
Light yellow oil, Rf (hexane: DCM 7:3) = 0.42. 1H NMR (400 MHz, CDCl3): δ = 7.35–7.28 
(m, 2H), 7.28–7.23 (m, 1H), 7.09–7.05 (m, 1H), 7.03 (dd, J = 4.9, 1.2, 1H), 6.85–6.76 (m, 
2H), 3.79 (s, 3H), 2.94 (t, J = 7.4, 2H), 2.68 (t, J = 7.4, 2H); 13C NMR (100 MHz, CDCl3): δ = 
159.08, 141.13, 132.82, 128.14, 125.29, 120.79, 115.92, 113.80, 87.86, 81.00, 55.21, 29.70, 
20.91; m/z (EI)(%): 242.1 (M+1, 22.6), 241.1 (M, 81.9), 146.1 (19.9), 145.0 (100), 102.0 
(17.0), 97.0 (26.4); [M+1] HRMS calcd. for C15H15OS: 242.08381, found: 242.08345; IR 
(KBr): = 2922, 2313, 2090, 1604, 1505, 1452, 1286, 1243, 1172, 1030, 830, 773 cm-1. 
To a solution of 2,2,6,6-tetramethylpiperidines (1.8 mmol) in 10 mL THF at -78 oC was 
slowly added n-BuLi (2.2 mmol) under an argon protective atmosphere, the reaction mixture 
was stirred at -78 oC for 30 minutes, then 3-(4-(4-methoxyphenyl)but-3-yn-1-yl)thiophenes 
210k (2.2 mmol) in 10 mL THF were added dropwise into the flask and the mixture was 
stirred at -78 oC for one hour. Lastly, N-methoxy-N-methylacetamides (2.2 mmol) was added 
into the mixture and the reaction was warmed to 0 oC and stirred for another one hour. After 
reaction completion, the mixture was quenched by 20 mL saturated NH4Cl solution and the 
aqueous phase was extracted with Et2O (3×20 mL). The collected organic phases were dried 
over Na2SO4 and concentrated under reduced pressure. The crude product was purified by 
column chromatography. 
1-(4-(4-(4-Methoxyphenyl)but-3-yn-1-yl)thiophen-2-yl)ethanone (210k’) 
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Yellow oil, Rf (hexane: DCM 7:3) = 0.09. 1H NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 1.4, 
1H), 7.40 – 7.34 (m, 1H), 7.31–7.25 (m, 2H), 6.83–6.75 (m, 2H), 3.77 (s, 3H), 2.89 (t, J = 7.1, 
2H), 2.67 (t, J = 7.1, 2H), 2.50 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 190.64, 159.18, 
144.12, 142.23, 133.47, 132.76, 129.82, 115.57, 113.83, 87.15, 81.63, 55.20, 29.52, 26.75, 
20.74; m/z (EI)(%): 285.1 (M+1, 10.2), 284.1 (M, 27.7), 283.1 (M-1, 97.2), 146.1 (11.1), 
145.1 (100), 102.1 (11.1); IR (KBr): = 2927, 1658, 1606, 1506, 1423, 1248, 1172, 1027, 
830 cm-1. 
To a solution of oxazolidin-2-ones 217 (57.6 mmol), CuCl2 (2.3 mmol) and Na2CO3 (23 
mmol) in 57.6 mL toluene were added pyridines (23 mmol) under an oxygen atmosphere, the 
mixture was heated up to 70 oC, then a but-3-yn-1-ylbenzene 214 solution (11.5 mmol 214 in 
57.6 mL toluene) was added dropwise into the flask for 4 hours by syringe and the reaction 
was stirred at 70 oC overnight. After the reaction cooled down to room temperature, the 
mixture was filtered through a plug of celite and the filter cake was washed with Et2O. The 
organic solvent was removed under reduced pressure, and the crude product was purified by 
column chromatography. 
3-(4-Phenylbut-1-yn-1-yl)oxazolidin-2-one (210l) 
 
Colorless oil, Rf (hexane: EtOAc 3:1) = 0.14. 1H NMR (400 MHz, CDCl3): δ = 7.31–7.25 (m, 
2H), 7.23–7.15 (m, 3H), 4.38 (dd, J = 8.7, 7.3, 2H), 3.81 (dd, J = 8.7, 7.3, 2H), 2.84 (t, J = 7.6, 
2H), 2.59 (dd, J = 9.4, 5.7, 2H); 13C NMR (100 MHz, CDCl3): δ = 156.51, 140.48, 128.44, 
128.34, 126.28, 70.74, 70.47, 62.78, 46.90, 35.15, 20.64; m/z (EI)(%): 216.2 (M+1, 51.8), 
229.2 (M, 58.0), 172.2 (61.1), 128.2 (100), 91.2 (68.3), 80.2 (43.1), 53.3 (60.8); IR (KBr): 
= 2918, 2268, 1763, 1482, 1414, 1202, 1112, 1032, 745, 700 cm-1. 
To a solution of phenols 218 (10 mmol) and K2CO3 (15 mmol) in 30 mL THF were 
added propargyl bromides 219 (12 mmol), the reaction was then heated up to reflux overnight. 
After the reaction cooled down to room temperature, the solvent was removed under reduced 
pressure, and the crude product was purified by column chromatography. 
1-Methoxy-4-(prop-2-yn-1-yloxy)benzene (220) 
 
Light yellow oil, Rf (hexane: EtOAc 15:1) = 0.36. 1H NMR (400 MHz, CDCl3): δ = 6.95–6.89 
(m, 2H), 6.87–6.80 (m, 2H), 4.63 (d, J = 2.4, 2H), 3.76 (s, 3H), 2.50 (dd, J = 3.4, 1.4, 1H); 13C 
NMR (100 MHz, CDCl3): δ = 154.41, 151.61, 116.07, 114.54, 78.86, 75.25, 56.53, 55.60; m/z 
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(EI)(%): 162.4 (M, 80.2), 161.6 (88.7), 160.7 (100), 159.9 (79.1), 158.3 (67.3); IR (KBr): = 
3286, 2946, 2325, 2118, 1502, 1455, 1213, 1028, 824, 707 cm-1. 
To a solution of 4-iodoanisoles 221 (5 mmol) and terminal alkynes 220 (10 mmol) in 5 
mL degassed Et3N were added Pd(PPh3)4 (0.25 mmol) and CuI (0.5 mmol) under an argon 
protective atmosphere, the reaction was then stirred at 60 oC for 3 hours. After the reaction 
cooled down to room temperature, the mixture was diluted with 30 mL EE and washed by 20 
mL 1N HCl and 20 mL saturated NaHCO3 solution. The aqueous phase was extracted with 
EE (2×30 mL), the collected organic phases were dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by column chromatography. 
1-Methoxy-4-(3-(4-methoxyphenoxy)prop-1-yn-1-yl)benzene (210a’) 
 
Yellow solid, Rf (hexane: EtOAc 10:1) = 0.33. 1H NMR (600 MHz, CDCl3): δ = 7.41–7.36 
(m, 2H), 7.01–6.95 (m, 2H), 6.88–6.84 (m, 2H), 6.84–6.81 (m, 2H), 4.85 (s, 2H), 3.80 (s, 3H), 
3.78 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 159.78, 154.26, 151.94, 133.27, 116.14, 
114.53, 114.35, 113.84, 86.93, 82.79, 57.54, 55.64, 55.22; m/z (EI)(%): 268.0 (M, 5.9), 145.1 
(100), 123.0 (9.6), 102.0 (20.1); IR (KBr): = 3393, 2226, 2067, 1602, 1501, 1451, 1217, 
1020, 822, 746 cm-1. 
To a solution of anilines 222 (50 mmol) and pyridines (60 mmol) in 50 mL DCM was 
added TsCl 223 (75 mmol) in portions, the reaction was then stirred at room temperature 
overnight. The reaction was quenched by 50 mL water and the aqueous phase was extracted 
with DCM (2×50 mL). The combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was recrystallized from 
DCM/hexane. 
4-Methyl-N-phenylbenzenesulfonamide (224) 
 
White solid, Rf (hexane: EtOAc 5:1) = 0.21. 1H NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 8.3, 
2H), 7.30–7.16 (m, 5H), 7.11–7.01 (m, 3H), 2.35 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 
143.83, 136.55, 135.94, 129.61, 129.23, 127.24, 125.14, 121.36, 21.49; m/z (EI)(%): 245.8 (M, 
41.8), 244.1 (100), 181.8 (32.0), 180.2 (33.4), 166.6 (22.8), 154.9 (26.8), 153.6 (37.8), 92.6 
(17.3), 91.4 (84.2), 90.6 (17.2), 65.5 (28.6); IR (KBr): = 3247, 1596, 1484, 1414, 1336, 
1290, 1153, 1089, 913, 813, 754, 693, 661 cm-1. 
To a solution of 4-methyl-N-phenylbenzenesulfonamides 224 (3 mmol), PPh3 (3.3 mmol) 
and 3-(4-methoxyphenyl)prop-2-yn-1-ols 225 (3.3 mmol) in 30 mL THF at 0 oC was added 
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DIAD (3.3 mmol) under an argon protective atmosphere, the reaction was then stirred at room 
temperature overnight. After reaction completion, the mixture was diluted with 30 mL Et2O 
and washed by 20 mL saturated brine, the aqueous phase was extracted with Et2O (2×20 mL). 
The combined organic phases were dried over Na2SO4 and concentrated under reduced 
pressure. The crude product was purified by column chromatography. 
N-(3-(4-Methoxyphenyl)prop-2-yn-1-yl)-4-methyl-N-phenylbenzenesulfonamide (210b’) 
 
White solid, Rf (hexane: EtOAc 5:1) = 0.26. 1H NMR (400 MHz, CDCl3): δ = 7.64–7.52 (m, 
2H), 7.36–7.27 (m, 5H), 7.17 (d, J = 8.0, 2H), 7.13–7.05 (m, 2H), 6.81–6.72 (m, 2H), 4.63 (s, 
2H), 3.78 (s, 3H), 2.35 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 159.66, 143.41, 139.82, 
135.98, 132.91, 129.19, 128.93, 128.46, 128.07, 128.02, 114.43, 113.78, 85.52, 82.16, 55.26, 
42.11, 21.50; m/z (EI)(%): 233.8 (4.0), 144.4 (100), 91.6 (6.7), 90.7 (7.5); IR (KBr): = 3056, 
2972, 2309, 2072, 1598, 1499, 1342, 1284, 1243, 1161, 1069, 824, 706 cm-1. 
N-(4-(4-Methoxyphenyl)but-3-yn-2-yl)-4-methyl-N-phenylbenzenesulfonamide (210c’) 
 
Light yellow oil, Rf (hexane: EtOAc 5:1) = 0.30. 1H NMR (600 MHz, CDCl3): δ = 7.64 (d, J 
= 8.3, 2H), 7.38–7.26 (m, 5H), 7.19 (d, J = 8.0, 2H), 7.11–7.04 (m, 2H), 6.82–6.77 (m, 2H), 
5.50 (q, J = 7.1, 1H), 3.80 (s, 3H), 2.37 (s, 3H), 1.34 (d, J = 7.1, 3H); 13C NMR (150 MHz, 
CDCl3): δ = 159.56, 143.16, 136.59, 135.97, 132.74, 131.46, 129.05, 128.68, 128.65, 128.19, 
114.49, 113.76, 86.79, 84.86, 55.26, 47.24, 21.82, 21.49; m/z (EI)(%): 405.1 (M, 5.8), 266.1 
(10.0), 160.1 (11.7), 159.0 (100), 91.1 (9.6); HRMS calcd. for C24H23O3N32S: 405.13932, 
found: 405.13950; IR (KBr): = 2937, 2086, 1601, 1502, 1454, 1345, 1244, 1163, 1096, 
1028, 909, 825, 728 cm-1. 
5.6.2 General Experiment for the Calcium-Catalyzed Carboarylation of Alkynes 
To a solution of but-1-yne-1,4-diyldibenzenes 210a (0.48 mmol) and 
4-(1-hydroxyethyl)phenols 209a (0.4 mmol) in 2 mL CH3NO2 were added Bu4NPF6 (0.01 
mmol) and Ca(NTf2)2 (0.02 mmol), the reaction was then stirred at 40 oC for 12 h. For the 
isolation of the product, 5 mL saturated NaHCO3 solution was added, and the aqueous phase 
was extracted with dichloromethane (2×10 mL). The combined organic phases were dried 
over Na2SO4 and concentrated in vacuo. The crude product was purified by column 
chromatography. 
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4-(1-(1-Phenyl-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211a)                               
 
White solid, Rf (Hex: EtOAc 5:1) = 0.32. 1H NMR (400 MHz, CDCl3): δ = 7.46 (t, J = 7.7, 
2H), 7.35 (dd, J = 19.1, 11.8, 3H), 7.15–7.01 (m, 5H), 6.74 (d, J = 8.6, 2H), 6.62 (d, J = 7.4, 
1H), 4.75 (s, 1H), 3.82 (q, J = 7.1, 1H), 2.79–2.68 (m, 2H), 2.28 (ddd, J = 17.1, 10.1, 7.1, 1H), 
2.09–1.98 (m, 1H), 1.36 (d, J = 7.1, 3H); 13C NMR (100 MHz, CDCl3): δ = 153.53, 142.01, 
139.85, 136.97, 136.43, 135.16, 133.66, 130.18, 128.53, 128.39, 126.92, 126.76, 126.16, 
125.91, 114.85, 39.96, 28.75, 23.11, 17.10; m/z (EI)(%): 327.2 (26.2), 326.2 (100), 312.2 
(12.5), 311.2 (49.7), 298.1 (4.5), 233.1 (4.4), 217.1 (30.4), 229.1 (12.0), 202.1 (12.0), 121.1 
(7.6), 107.1 (4.9), 91.1 (5.8), 71.1 (3.1); [M+H] HRMS calcd. for C24H23O: 327.17434, found: 
327.17432; IR (KBr): = 3375, 3025, 2934, 2882, 1602, 1506, 1443, 1366, 1226, 1176, 906, 
831, 730 cm-1.  
3-(1-(4-Methoxyphenyl)ethyl)-4-phenyl-1,2-dihydronaphthalene (211b) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.58. 1H NMR (400 MHz, CDCl3): δ = 7.45 (t, J = 7.8, 
2H), 7.40–7.25 (m, 3H), 7.16 (d, J = 8.6, 2H), 7.13–6.99 (m, 3H), 6.85–6.78 (m, 2H), 
6.65–6.57 (m, 1H), 3.82 (q, J = 7.1, 1H), 3.78 (s, 3H), 2.79–2.67 (m, 2H), 2.28 (ddd, J = 17.1, 
10.0, 7.3, 1H), 2.09–1.97 (m, 1H), 1.37 (d, J = 7.1, 3H); 13C NMR (100 MHz, CDCl3): δ = 
157.73, 142.07, 139.88, 137.00, 136.21, 135.17, 133.64, 130.18, 128.53, 128.18, 126.92, 
126.75, 126.15, 126.14, 125.90, 113.40, 55.18, 39.96, 28.77, 23.14, 17.12; m/z (EI)(%): 341.4 
(34.5), 340.4 (100), 326.3 (15.1), 325.3 (54.8), 312.3 (3.9), 263.3 (4.3), 249.2 (6.7), 247.2 
(6.3), 233.3 (10.5), 217.2 (41.9), 229.2 (15.7), 203.2 (13.5), 202.2 (13.6), 189.2 (4.6), 165.1 
(4.1), 135.2 (22.3), 121.2 (8.7), 105.2 (4.4), 91.2 (9.8); [M+Na] HRMS calcd. for C25H24ONa: 
363.17194, found: 363.17099; IR (KBr): = 3019, 2938, 2831, 2326, 2077, 1605, 1505, 
1451, 1243, 1177, 1034, 907, 829, 734 cm-1.  
4-Phenyl-3-(1-(p-Tolyl)ethyl)-1,2-dihydronaphthalene (211c) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.62. 1H NMR (400 MHz, CDCl3): δ = 7.45 (t, J = 7.7, 
2H), 7.34 (dd, J = 19.4, 11.9, 3H), 7.15 (d, J = 8.1, 2H), 7.13–7.00 (m, 5H), 6.62 (d, J = 7.3, 
1H), 3.84 (q, J = 7.1, 1H), 2.79–2.67 (m, 2H), 2.34–2.24 (m, 4H, Ar-CH3 and 1/2-CH2 ), 
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2.10–1.99 (m, 1H), 1.38 (d, J = 7.1, 3H); 13C NMR (100 MHz, CDCl3): δ = 141.97, 141.06, 
139.88, 137.00, 135.29, 135.20, 133.80, 130.19, 128.73, 128.52, 127.16, 126.92, 126.74, 
126.15, 126.14, 125.91, 40.37, 28.78, 23.21, 20.95, 17.02; m/z (EI)(%): 325.3 (61.5), 324.2 
(100), 310.3 (21.9), 309.3 (74.3), 296.3 (9.9), 233.2 (21.0), 232.2 (28.5), 231.2 (32.1), 218.2 
(23.3), 217.2 (83.5), 216.2 (23.8), 229.2 (46.1), 205.2 (45.0), 204.2 (16.9), 203.2 (35.8), 202.1 
(42.4), 189.1 (12.8), 178.1 (12.5), 165.1 (12.0), 119.1 (30.9), 117.1 (15.3), 115.1 (13.1), 105.1 
(17.9), 92.2 (9.8), 91.1 (36.2), 77.2 (6.9); HRMS calcd. for C25H24: 324.18725, found: 
324.18735; IR (KBr): = 3024, 2938, 1596, 1490, 1448, 1035, 904, 817, 738 cm-1. 
4-Methyl-N-(2-(1-(1-phenyl-3,4-dihydronaphthalen-2-  
yl)ethyl)phenyl)benzenesulfonamide (211d) 
Ph
211d
NHTs
 
White solid, Rf (Hex: EtOAc 10:1) = 0.43. 1H NMR (400 MHz, CDCl3): δ = 7.73 (s, 1H), 
7.65 (dd, J = 8.0, 1.2, 2H), 7.54 (s, 2H), 7.27 (s, 1H), 7.22–7.15 (m, 2H), 7.13–6.97 (m, 6H), 
6.84 (d, J = 8.0, 2H), 6.61 (d, J = 7.8, 1H), 6.47 (s, 1H), 3.24 (q, J = 6.9, 1H), 2.62 (ddd, J = 
15.3, 8.9, 6.3, 1H), 2.53–2.42 (m, 1H), 2.25 (s, 3H), 2.01 (ddd, J = 16.3, 8.2, 5.2, 1H), 
1.51–1.42 (m, 1H), 1.18 (d, J = 6.9, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.18, 139.09, 
138.43, 136.21, 135.70, 135.14, 135.08, 134.89, 133.93, 130.14, 129.98, 129.01, 127.74, 
127.49, 127.28, 126.99, 126.92, 126.80, 126.37, 126.07, 124.89, 122.32, 36.97, 28.41, 22.94, 
21.38, 18.87; m/z (EI)(%): 480.3 (4.0), 479.3 (10.5), 464.3 (2.8), 326.3 (3.8), 325.3 (29.0), 
324.2 (100), 309.3 (4.9), 245.2 (3.6), 232.2 (2.8), 231.2 (12.5), 229.1 (8.9), 193.1 (40.4), 
178.1 (4.3), 144.1 (3.6), 121.1 (5.5), 120.1 (60.9), 91.1 (10.7); [M+Na] HRMS calcd. for 
C31H29O2NSNa: 502.18112, found: 502.18127; IR (KBr): = 3330, 3062, 2971, 2934, 2879, 
2830, 1579, 1489, 1451, 1384, 1337, 1162, 1091, 907, 814, 762, 730, 708, 662, 632, 562 cm-1. 
4-Phenyl-3-(1-phenylethyl)-1,2-dihydronaphthalene (211e) 
 
Colorless oil, Rf (Hex: EtOAc 40:1) = 0.41. 1H NMR (600 MHz, CDCl3): δ = 7.46 (t, J = 7.8, 
2H), 7.40–7.23 (m, 7H), 7.18 (ddd, J = 8.5, 5.9, 2.2, 1H), 7.09 (ddd, J = 10.8, 8.5, 4.0, 2H), 
7.04 (dd, J = 10.6, 4.3, 1H), 6.63 (d, J = 7.6, 1H), 3.89 (q, J = 7.1, 1H), 2.79–2.69 (m, 2H), 
2.30 (ddd, J = 17.1, 10.4, 6.9, 1H), 2.04 (ddd, J = 15.9, 7.7, 6.5, 1H), 1.41 (d, J = 7.1, 3H); 
13C NMR (150 MHz, CDCl3): δ = 144.15, 141.78, 139.84, 136.95, 135.17, 133.96, 130.18, 
128.55, 128.03, 127.30, 126.93, 126.79, 126.20, 126.17, 125.94, 125.86, 40.77, 28.75, 23.22, 
16.92; m/z (EI)(%): 311.3 (24.4), 310.3 (100), 296.2 (7.0), 295.2 (29.2), 282.2 (5.8), 232.2 
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(6.9), 218.2 (8.7), 217.2 (41.0), 216.1 (7.0), 229.1 (16.3), 205.2 (26.2), 203.1 (19.0), 202.1 
(24.1), 189.1 (5.9), 178.1 (6.5), 165.1 (5.0), 115.1 (5.6), 105.1 (6.5), 91.1 (8.5), 78.2 (8.4); 
HRMS calcd. for C24H22: 310.17160, found: 310.17204; IR (KBr): = 3058, 3024, 2964, 
2933, 2880, 2830, 1598, 1487, 1446, 1031, 906, 763, 732, 669 cm-1. 
3-(1-(4-Chlorophenyl)ethyl)-4-phenyl-1,2-dihydronaphthalene (211f) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.61. 1H NMR (600 MHz, CDCl3): δ = 7.46 (t, J = 7.8, 
2H), 7.37 (dd, J = 10.7, 4.1, 1H), 7.29 (s, 2H), 7.24 (dd, J = 7.5, 5.8, 2H), 7.18 (d, J = 8.5, 2H), 
7.10 (dt, J = 15.4, 4.0, 2H), 7.04 (t, J = 7.4, 1H), 6.62 (d, J = 7.6, 1H), 3.85 (q, J = 7.0, 1H), 
2.80–2.67 (m, 2H), 2.28 (ddd, J = 17.3, 10.9, 6.6, 1H), 2.05–1.95 (m, 1H), 1.38 (d, J = 7.1, 
3H); 13C NMR (150 MHz, CDCl3): δ = 142.72, 141.05, 139.66, 136.74, 135.08, 134.31, 
131.63, 130.13, 130.01, 128.65, 128.13, 126.97, 126.91, 126.37, 126.23, 126.02, 40.33, 28.69, 
23.15, 16.92; m/z (EI)(%): 344.7 (2.4), 343.7 (8.5), 328.6 (3.3), 232.0 (5.5), 216.9 (24.0), 
229.9 (35.3), 214.6 (70.3), 213.3 (21.6), 212.7 (45.5), 204.9 (17.7), 204.0 (32.2), 203.0 (51.3), 
201.9 (62.0), 200.4 (100), 191.1 (10.6), 190.0 (15.7), 187.9 (39.1), 178.1 (15.3), 176.8 (20.6), 
175.5 (19.5), 165.1 (12.4), 164.1 (14.3), 162.8 (17.0), 140.4 (11.1), 139.2 (15.3), 138.5 (40.0), 
138.0 (17.5), 127.4 (16.2), 126.4 (12.5), 124.7 (23.4), 116.5 (11.7), 115.5 (18.8), 114.1 (29.8), 
111.4 (25.0), 103.5 (23.7), 102.2 (34.8), 91.1 (42.8), 77.4 (35.9); HRMS calcd. for C24H2135Cl: 
344.13263, found: 344.13257; IR (KBr): = 3059, 3023, 2965, 2933, 2881, 2830, 1597, 
1487, 1449, 1092, 1011, 906, 828, 769, 730, 702 cm-1. 
3-(1-(4-Methoxyphenyl)but-3-en-1-yl)-4-phenyl-1,2-dihydronaphthalene (211g) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.39. 1H NMR (400 MHz, CDCl3): δ = 7.42 (t, J = 7.4, 
2H), 7.36–7.31 (m, 1H), 7.25 (d, J = 6.5, 2H), 7.15–6.96 (m, 5H), 6.83–6.75 (m, 2H), 
6.60–6.52 (m, 1H), 5.71 (dd, J = 17.1, 10.0, 1H), 5.05–4.94 (m, 2H), 3.79–3.72 (m, 4H, 
-OCH3 and -CH), 2.73 (ddd, J = 16.2, 9.2, 6.3, 2H), 2.65–2.47 (m, 2H), 2.30 (ddd, J = 16.4, 
10.1, 6.4, 1H), 2.19–2.05 (m, 1H); 13C NMR (100 MHz, CDCl3): δ = 157.84, 139.70, 139.49, 
137.03, 136.99, 135.23, 134.98, 134.80, 130.87, 130.38, 128.51, 128.39, 126.87, 126.76, 
126.20, 126.13, 126.05, 116.00, 113.48, 55.18, 45.83, 36.00, 28.54, 23.21; m/z (EI)(%): 365.9 
(4.8), 326.5 (7.8), 325.8 (17.3), 324.4 (100), 217.8 (3.7), 216.9 (11.2), 216.1 (42.4), 214.8 
(24.8), 214.2 (20.7), 213.3 (35.8), 202.1 (17.2), 200.8 (13.0), 200.1 (9.7), 199.5 (15.3), 187.1 
(5.3), 175.6 (4.0), 119.7 (3.4), 91.3 (3.9); [M+Na] HRMS calcd. for C27H26ONa: 389.18759, 
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found: 389.18790; IR (KBr): = 3064, 3022, 2933, 2831, 1607, 1507, 1448, 1298, 1245, 
1177, 1035, 911, 827, 767, 700 cm-1. 
3-(1-(4-Methoxyphenyl)hept-2-yn-1-yl)-4-phenyl-1,2-dihydronaphthalene (211h) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.38. 1H NMR (400 MHz, CDCl3): δ = 7.55–7.23 (m, 
7H), 7.14–7.05 (m, 2H), 7.05–6.98 (m, 1H), 6.86–6.74 (m, 2H), 6.68–6.58 (m, 1H), 4.65 (s, 
1H), 3.77 (s, 3H), 2.75 (tdd, J = 15.2, 13.1, 6.6, 2H), 2.52 (ddd, J = 16.2, 11.2, 6.6, 1H), 2.27 
(td, J = 6.9, 2.3, 2H), 2.12 (ddd, J = 16.1, 7.4, 6.4, 1H), 1.62–1.39 (m, 4H), 0.93 (t, J = 7.2, 
3H); 13C NMR (100 MHz, CDCl3): δ = 158.24, 139.07, 137.84, 136.70, 135.39, 134.42, 
132.26, 130.52, 129.97, 128.69, 128.46, 127.05, 126.52, 126.19, 126.15, 113.45, 84.02, 79.07, 
55.22, 39.60, 31.16, 28.76, 23.89, 21.95, 18.60, 13.64; m/z (EI)(%): 408.1 (10.2), 406.5 (88.0), 
374.7 (15.6), 363.1 (22.0), 348.6 (100), 318.5 (11.5), 317.2 (18.7), 288.3 (11.9), 271.1 (9.3), 
255.0 (12.4), 253.0 (18.5), 251.7 (26.0), 239.9 (32.2), 238.5 (45.5), 237.2 (35.5), 225.0 (49.0), 
214.7 (43.4), 212.6 (41.3), 203.1 (32.1), 201.9 (48.1), 200.9 (51.7), 199.4 (65.2), 187.8 (15.1), 
170.9 (17.3), 158.8 (16.4), 143.1 (13.5), 127.3 (15.9), 121.0 (23.6), 119.8 (18.9), 114.2 (19.1), 
91.1 (17.1); [M+Na] HRMS calcd. for C30H30ONa: 429.21889, found: 429.21890; IR (KBr): 
= 3059, 3021, 2932, 2836, 1606, 1504, 1451, 1244, 1173, 1034, 834, 768, 701 cm-1. 
3-(1-(4-Methoxyphenyl)-3-phenylprop-2-yn-1-yl)-4-phenyl-1,2-dihydronaphthalene 
(211i) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.41. 1H NMR (600 MHz, CDCl3): δ = 7.59–7.27 (m, 
12H), 7.16–7.09 (m, 2H), 7.06 (td, J = 7.6, 1.7, 1H), 6.89–6.83 (m, 2H), 6.69 (d, J = 7.6, 1H), 
4.93 (s, 1H), 3.80 (s, 3H), 2.90–2.83 (m, 1H), 2.82–2.74 (m, 1H), 2.65 (ddd, J = 16.2, 11.5, 
6.4, 1H), 2.28–2.20 (m, 1H); 13C NMR (150 MHz, CDCl3): δ = 158.43, 138.93, 136.97, 
136.55, 135.37, 135.10, 131.69, 131.57, 130.57, 129.94, 128.84, 128.50, 128.23, 127.86, 
127.20, 127.11, 126.71, 126.30, 126.22, 123.68, 113.64, 89.07, 83.99, 55.24, 40.22, 28.76, 
24.03; m/z (EI)(%): 428.0 (15.1), 426.5 (100), 349.6 (12.3), 348.7 (15.0), 347.5 (14.6), 334.6 
(19.1), 333.2 (24.7), 319.5 (13.9), 318.5 (21.5), 317.5 (36.9), 316.5 (29.3), 315.4 (33.1), 303.4 
(29.8), 302.3 (39.0), 301.3 (27.6), 300.0 (19.8), 289.2 (20.5), 238.8 (23.8), 237.6 (19.2), 219.8 
(32.5), 218.6 (29.3), 217.6 (28.0), 229.8 (17.8), 214.4 (39.8), 213.4 (25.0), 212.7 (20.2), 203.9 
(21.7), 202.9 (30.1), 201.8 (51.6), 200.9 (25.7), 200.1 (42.6), 188.1 (24.6), 178.0 (21.7), 177.1 
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(24.4), 176.2 (27.2), 175.3 (27.3), 150.8 (16.4), 120.1 (10.4), 91.4 (12.7), 90.5 (8.7), 77.7 
(8.5); [M+H] HRMS calcd. for C32H27O: 427.20564, found: 427.20578; IR (KBr): = 3059, 
3024, 2935, 2891, 2832, 1603, 1504, 1445, 1245, 1174, 1034, 907, 836, 731, 697 cm-1. 
3-(1-(4-Methoxyphenyl)-2-methylpropyl)-4-phenyl-1,2-dihydronaphthalene (211j) 
Ph
211j
OCH3
 
White solid, Rf (Hex: EtOAc 30:1) = 0.54. 1H NMR (400 MHz, CDCl3): δ = 7.54–7.43 (m, 
2H), 7.40 (tt, J = 7.4, 1.3, 1H), 7.28–7.19 (m, 2H), 7.12–7.00 (m, 4H), 6.97 (td, J = 7.5, 1.5, 
1H), 6.83–6.74 (m, 2H), 6.51 (dd, J = 7.6, 1.0, 1H), 3.77 (s, 3H), 3.18 (d, J = 11.1, 1H), 
2.93–2.81 (m, 1H), 2.77–2.64 (m, 1H), 2.49 (ddd, J = 15.8, 7.9, 6.3, 1H), 2.40–2.20 (m, 2H), 
1.05 (d, J = 6.6, 3H), 0.67 (d, J = 6.4, 3H); 13C NMR (100 MHz, CDCl3): δ = 157.70, 140.12, 
140.06, 137.27, 135.24, 134.93, 134.21, 131.10, 130.86, 128.98, 128.41, 128.17, 126.72, 
126.66, 126.07, 125.98, 125.94, 113.46, 55.27, 55.13, 29.10, 28.65, 23.30, 21.84, 21.25; m/z 
(EI)(%): 368.4 (1.8), 326.4 (3.3), 325.3 (16.8), 324.4 (18.3), 230.4 (5.5), 217.7 (9.5), 216.8 
(47.8), 229.9 (71.7), 214.8 (91.4), 213.2 (100), 201.9 (38.9), 200.8 (53.8), 199.5 (48.1), 188.9 
(12.6), 162.5 (11.6), 121.3 (14.9), 120.7 (20.1), 119.9 (26.7), 114.2 (12.7), 107.1 (8.8), 91.5 
(17.3), 90.6 (18.3), 77.7 (9.4); [M+Na] HRMS calcd. for C27H28ONa: 391.20324, found: 
391.20377; IR (KBr): = 3058, 3022, 2955, 2833, 1607, 1508, 1456, 1242, 1176, 1036, 907, 
829, 766, 730, 704 cm-1. 
3-(Cyclohexyl(4-methoxyphenyl)methyl)-4-phenyl-1,2-dihydronaphthalene (211k) 
 
White solid, Rf (Hex: EtOAc 30:1) = 0.52. 1H NMR (400 MHz, CDCl3): δ = 7.49 (dt, J = 6.4, 
5.4, 2H), 7.44–7.36 (m, 1H), 7.24 (td, J = 8.2, 2.3, 2H), 7.12–7.07 (m, 1H), 7.07–7.00 (m, 3H), 
6.97 (td, J = 7.5, 1.6, 1H), 6.86–6.74 (m, 2H), 6.51 (dd, J = 7.6, 1.1, 1H), 3.78 (s, 3H), 3.24 (d, 
J = 11.0, 1H), 2.94–2.83 (m, 1H), 2.79-2.67 (m, 1H), 2.49 (ddd, J = 15.7, 7.9, 6.3, 1H), 
2.43–2.29 (m, 1H), 2.04–1.85 (m, 2H), 1.78 (d, J = 13.0, 1H), 1.69–1.53 (m, 2H), 1.50–1.41 
(m, 1H), 1.35–1.02 (m, 3H), 1.00–0.84 (m, 1H), 0.66–0.44 (m, 1H); 13C NMR (100 MHz, 
CDCl3): δ = 157.69, 140.05, 139.60, 137.26, 134.91, 134.77, 134.45, 131.09, 130.85, 129.06, 
128.39, 128.12, 126.70, 126.65, 126.05, 125.94, 125.87, 113.47, 55.12, 54.08, 38.87, 32.27, 
31.55, 28.64, 26.77, 26.50, 26.45, 23.40; m/z (EI)(%): 408.8 (1.5), 326.4 (3.4), 325.2 (21.0), 
324.3 (11.1), 323.4 (5.5), 216.7 (8.7), 229.9 (12.1), 214.7 (18.6), 213.7 (8.6), 202.9 (5.8), 
202.0 (12.7), 201.1 (12.6), 200.2 (11.5), 199.3 (6.0), 177.3 (5.2), 151.2 (3.0), 127.6 (5.8), 
121.4 (16.5), 120.6 (20.3), 119.8 (13.9), 107.9 (9.1), 91.5 (50.9), 90.7 (46.9), 82.8 (37.1), 77.6 
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(24.8), 55.7 (100); [M+Na] HRMS calcd. for C30H32ONa: 431.23454, found: 431.23450; IR 
(KBr): = 3021, 2924, 2847, 1606, 1505, 1448, 1244, 1177, 1035, 906, 832, 728 cm-1. 
3-(Cyclohex-2-en-1-yl)-4-phenyl-1,2-dihydronaphthalene (211l) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.46. 1H NMR (400 MHz, CDCl3): δ = 7.40 (dd, J = 
11.3, 4.4, 2H), 7.36–7.29 (m, 1H), 7.16 (dd, J = 13.0, 6.1, 3H), 7.07 (td, J = 7.3, 1.3, 1H), 7.01 
(td, J = 7.5, 1.3, 1H), 6.56 (dd, J = 7.6, 0.8, 1H), 5.78 (ddt, J = 9.7, 4.9, 2.5, 1H), 5.46 (d, J = 
10.0, 1H), 3.08 (ddd, J = 9.9, 5.9, 3.4, 1H), 2.90–2.75 (m, 2H), 2.36–2.26 (m, 2H), 2.07–1.88 
(m, 2H), 1.77–1.69 (m, 1H), 1.68–1.60 (m, 1H), 1.58–1.45 (m, 1H), 1.45–1.33 (m, 1H); 13C 
NMR (100 MHz, CDCl3): δ = 141.59, 139.78, 137.10, 135.40, 134.02, 130.24, 130.11, 128.57, 
128.33, 126.90, 126.58, 126.12, 125.96, 125.70, 40.24, 28.89, 27.76, 24.74, 23.97, 22.03; m/z 
(EI)(%): 288.3 (23.1), 287.3 (62.4), 286.2 (100), 285.1 (28.6), 271.3 (15.4), 259.2 (19.5), 
258.2 (40.8), 257.2 (25.1), 242.2 (33.4), 229.1 (29.8), 217.2 (31.1), 229.1 (35.0), 209.1 (35.5), 
205.1 (34.7), 203.1 (33.0), 195.1 (30.7), 191.1 (22.9), 181.1 (24.5), 179.1 (24.3), 169.1 (26.3), 
167.1 (38.7), 165.1 (37.6), 157.1 (17.9), 143.1 (19.9), 141.1 (12.4), 117.1 (9.7), 81.2 (10.0); 
HRMS calcd. for C22H22: 286.17160, found: 286.17127; IR (KBr): = 3020, 2926, 1597, 
1481, 1442, 1041, 966, 905, 714 cm-1. 
3-(Cyclopent-2-en-1-yl)-4-phenyl-1,2-dihydronaphthalene (211m) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.56. 1H NMR (400 MHz, CDCl3): δ = 7.40 (dd, J = 
10.2, 4.5, 2H), 7.32 (ddd, J = 6.3, 2.4, 1.2, 1H), 7.21–7.11 (m, 3H), 7.03 (dtd, J = 23.8, 7.4, 
1.2, 2H), 6.61–6.55 (m, 1H), 5.80 (dq, J = 4.7, 2.3, 1H), 5.49 (dq, J = 4.2, 2.1, 1H), 3.57 (tdd, 
J = 6.9, 4.7, 2.4, 1H), 2.82 (t, J = 7.8, 2H), 2.46–2.36 (m, 1H), 2.32–2.21 (m, 3H), 2.00–1.89 
(m, 1H), 1.72–1.62 (m, 1H); 13C NMR (100 MHz, CDCl3): δ = 140.70, 139.93, 137.05, 
135.29, 133.66, 133.57, 132.09, 130.36, 128.27, 126.92, 126.54, 126.11, 125.96, 125.68, 
49.13, 32.81, 29.09, 28.77, 23.39; m/z (EI)(%): 273.3 (24.0), 272.3 (100), 271.3 (11.3), 257.2 
(1.9), 243.2 (5.5), 229.2 (7.4), 229.2 (10.4), 202.2 (9.9), 189.1 (4.8), 165.1 (5.5), 128.1 (2.3), 
115.1 (2.8), 91.2 (7.3), 77.2 (4.7), 67.2 (16.5), 66.2 (7.3), 65.2 (4.9), 53.2 (2.6); HRMS calcd. 
for C21H20: 272.15595, found: 272.15588; IR (KBr): = 3051, 2934, 2886, 2841, 1596, 1483, 
1442, 1029, 739, 700 cm-1. 
4-(1-(1-(4-Methoxyphenyl)-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211n) 
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White solid, Rf (Hex: EtOAc 5:1) = 0.26. 1H NMR (400 MHz, CDCl3): δ = 7.20 (s, 2H), 
7.13–6.95 (m, 7H), 6.76–6.69 (m, 2H), 6.67–6.62 (m, 1H), 4.75 (s, 1H), 3.90–3.78 (m, 4H, 
-OCH3 and -CH), 2.78–2.63 (m, 2H), 2.31–2.19 (m, 1H), 2.07–1.95 (m, 1H), 1.35 (d, J = 7.1, 
3H); 13C NMR (100 MHz, CDCl3): δ = 158.35, 153.55, 142.25, 137.26, 136.52, 135.22, 
133.18, 132.01, 131.18, 128.38, 126.89, 126.14, 126.09, 125.90, 114.84, 113.97, 55.24, 39.93, 
28.76, 23.15, 17.09; m/z (EI)(%): 356.7 (6.1), 247.0 (9.2), 234.8 (10.0), 233.8 (14.3), 232.7 
(18.0), 231.8 (18.9), 217.7 (12.6), 214.4 (17.0), 201.8 (40.6), 200.8 (29.1), 199.9 (34.8), 190.0 
(24.0), 188.9 (34.9), 188.0 (33.5), 187.0 (24.5), 165.0 (25.4), 162.6 (22.7), 131.3 (22.4), 130.4 
(20.6), 127.4 (20.7), 121.3 (51.9), 120.7 (85.2), 119.7 (100), 117.5 (20.4), 115.5 (24.5), 114.0 
(23.2), 106.0 (46.8), 101.9 (28.5), 94.5 (65.6), 93.3 (79.6), 91.6 (24.7), 90.9 (88.7), 84.7 
(28.7), 83.5 (35.4), 82.6 (36.5), 77.3 (81.9), 65.9 (20.2); [M+Na] HRMS calcd. for 
C25H24O2Na: 379.16685, found: 379.16727; IR (KBr): = 3391, 2931, 1602, 1505, 1448, 
1365, 1228, 1171, 1025, 905, 824, 775, 729 cm-1.  
4-(1-(1-(2-Methoxyphenyl)-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211o) 
 
White solid, Rf (Hex: EtOAc 5:1) = 0.25 and 0.18 (three isomers). 1H NMR (600 MHz, 
CDCl3): δ = 7.39–7.32 (m, 1H), 7.22–7.14 (m, 2H), 7.10 (t, J = 8.0, 2H), 7.08–6.98 (m, 4H), 
6.75–6.68 (m, 2H), 6.58 (dd, J = 7.1, 3.5, 1H), 4.62 (d, J = 13.0, 1H), 3.77 (d, J = 6.2, 3H), 
3.70–3.64 (m, 1H), 2.78–2.67 (m, 2H), 2.37–2.13 (m, 1H), 2.08–1.93 (m, 1H), 1.34 (dd, J = 
7.1, 4.5, 3H); 13C NMR (150 MHz, CDCl3): δ = 157.89, 157.38, 153.48, 153.44, 142.62, 
142.50, 136.81, 136.73, 136.45, 136.23, 135.15, 135.00, 131.81, 131.78, 130.25, 129.36, 
128.70, 128.51, 128.44, 128.37, 128.34, 128.32, 126.92, 126.90, 126.21, 126.17, 125.96, 
125.94, 125.25, 125.01, 120.73, 120.63, 114.78, 114.64, 110.81, 110.78, 55.34, 55.17, 40.54, 
40.48, 28.79, 28.70, 23.17, 22.99, 16.97, 16.06; m/z (EI)(%): 357.7 (16.3), 356.6 (28.2), 356.1 
(100), 355.3 (47.8), 354.6 (21.5), 341.6 (24.6), 340.3 (41.8), 339.6 (10.1), 249.0 (11.5), 247.1 
(73.5), 244.8 (41.3), 243.6 (48.2), 234.0 (91.4), 232.8 (74.4), 231.8 (81.7), 230.5 (54.4), 229.9 
(22.4), 229.1 (39.8), 228.1 (19.0), 219.8 (21.3), 218.7 (33.5), 217.5 (40.8), 229.7 (22.0), 214.7 
(32.6), 213.7 (25.8), 212.3 (47.2), 202.1 (35.1), 200.9 (35.4), 199.4 (42.3), 189.0 (15.6), 187.6 
(15.0), 120.8 (54.3), 119.7 (18.5), 107.3 (20.6), 106.2 (15.7), 91.5 (11.3), 90.6 (10.2); [M+Na] 
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HRMS calcd. for C25H24O2Na: 379.16685, found: 379.16656; IR (KBr): = 3402,  3019, 
2936, 2833, 1598, 1495, 1447, 1235, 1176, 1113, 1028, 906, 831, 734 cm-1.  
1H NMR (600 MHz, CDCl3): δ = 7.34 (tt, J = 7.6, 3.8, 1H), 7.21–7.13 (m, 2H), 7.10 (dd, J = 
16.4, 7.7, 2H), 7.07–6.96 (m, 4H), 6.76–6.66 (m, 2H), 6.57 (dd, J = 7.2, 3.6, 1H), 4.54 (d, J = 
11.7, 1H), 3.77 (d, J = 3.8, 3H), 3.69–3.62 (m, 1H), 2.78–2.65 (m, 2H), 2.35–2.13 (m, 1H), 
2.06–1.91 (m, 1H), 1.33 (dd, J = 7.1, 4.3, 3H); 13C NMR (150 MHz, CDCl3): δ = 157.90, 
157.39, 153.48, 153.44, 142.61, 142.49, 136.84, 136.74, 136.45, 136.26, 135.16, 135.00, 
131.81, 131.79, 130.27, 129.37, 128.72, 128.51, 128.44, 128.37, 128.35, 126.92, 126.90, 
126.21, 126.17, 125.96, 125.93, 125.26, 125.02, 120.73, 120.63, 114.78, 114.63, 110.80, 
110.77, 55.34, 55.18, 40.55, 40.48, 28.80, 28.70, 23.18, 22.99, 16.98, 16.06; m/z (EI)(%): 
357.8 (18.5), 356.5 (100), 355.6 (39.1), 354.9 (67.4), 341.5 (19.3), 340.7 (42.2), 339.8 (23.1), 
248.0 (17.0), 247.0 (24.2), 245.1 (34.6), 243.7 (26.6), 234.8 (19.3), 234.0 (30.4), 232.8 (48.8), 
231.8 (43.4), 230.7 (23.9), 230.1 (19.1), 229.3 (14.5), 228.4 (10.8), 218.7 (16.1), 217.6 (14.1), 
216.7 (10.9), 214.6 (17.6), 213.5 (11.7), 212.2 (18.6), 201.9 (14.4), 200.8 (13.6), 199.6 (15.2), 
119.8 (10.7); [M+Na] HRMS calcd. for C25H24O2Na: 379.16685, found: 379.16653; IR (KBr): 
= 3403,  3018, 2934, 2834, 1598, 1495, 1447, 1234, 1176, 1114, 1029, 906, 831, 735 
cm-1.  
1H NMR (600 MHz, CDCl3): δ = 7.38–7.32 (m, 1H), 7.21–7.07 (m, 4H), 7.07–6.97 (m, 4H), 
6.74–6.68 (m, 2H), 6.60–6.53 (m, 1H), 4.55 (d, J = 11.8, 1H), 3.77 (d, J = 4.0, 3H), 3.69–3.62 
(m, 1H), 2.78–2.65 (m, 2H), 2.35–2.13 (m, 1H), 2.06–1.92 (m, 1H), 1.33 (dd, J = 7.1, 4.3, 
3H); 13C NMR (150 MHz, CDCl3): δ = 157.90, 157.39, 153.48, 153.44, 142.61, 142.50, 
136.84, 136.73, 136.45, 136.25, 135.15, 135.00, 131.81, 131.79, 130.27, 129.36, 128.72, 
128.51, 128.44, 128.37, 128.35, 128.32, 126.92, 126.90, 126.21, 126.17, 125.96, 125.93, 
125.26, 125.02, 120.73, 120.63, 114.78, 114.63, 110.80, 110.77, 55.34, 55.18, 40.55, 40.48, 
28.80, 28.70, 23.18, 22.99, 16.98, 16.06; m/z (EI)(%): 357.7 (12.9), 357.0 (12.4), 356.1 (100), 
355.2 (28.2), 341.2 (17.3), 340.7 (36.4), 248.0 (24.3), 245.9 (49.4), 244.9 (40.0), 243.5 (58.7), 
234.2 (51.4), 232.8 (57.7), 231.8 (64.3), 230.8 (57.8), 229.6 (82.4), 227.7 (24.0), 225.8 (17.9), 
219.8 (19.3), 219.0 (55.1), 217.8 (63.4), 216.7 (53.2), 229.7 (41.8), 214.7 (65.3), 213.7 (49.6), 
212.3 (79.4), 203.9 (19.1), 203.0 (27.7), 201.9 (78.6), 200.9 (61.6), 199.5 (89.3), 190.2 (25.7), 
189.1 (45.2), 188.3 (33.7), 187.0 (63.2), 178.1 (19.1), 177.2 (23.6), 176.4 (17.1), 175.5 (25.2), 
165.0 (20.2), 164.0 (30.9), 162.8 (27.5), 150.0 (19.6), 120.7 (74.7), 119.9 (34.1), 114.3 (18.1), 
106.9 (58.9), 94.5 (31.0), 93.5 (42.3), 91.3 (40.3), 90.6 (14.2), 77.7 (13.7), 77.2 (30.8); 
[M+Na] HRMS calcd. for C25H24O2Na: 379.16685, found: 379.16644; IR (KBr): = 3403,  
3018, 2934, 2834, 1598, 1495, 1447, 1234, 1176, 1113, 1028, 906, 831, 734 cm-1.  
4-(1-(3,4-Dihydro-[1,1'-binaphthalen]-2-yl)ethyl)phenol (211p) 
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White solid, Rf (Hex: EtOAc 5:1) = 0.22. 1H NMR (400 MHz, DMSO-d6): δ = 9.14 (d, J = 
17.5, 2H), 7.94 (dd, J = 13.2, 7.7, 4H), 7.78–7.55 (m, 4H), 7.55–7.32 (m, 6H), 7.13 (dd, J = 
6.7, 3.6, 2H), 7.07–6.93 (m, 4H), 6.90–6.73 (m, 4H), 6.71–6.61 (m, 2H), 6.59–6.48 (m, 2H), 
6.17 (ddd, J = 10.9, 7.7, 0.9, 2H), 3.47–3.34 (m, 2H), 2.91–2.65 (m, 4H), 2.40–2.20 (m, 2H), 
2.08–1.88 (m, 2H), 1.29 (d, J = 7.1, 3H), 1.11 (d, J = 7.1, 3H); 13C NMR (100 MHz, 
DMSO-d6): δ = 155.50, 155.41, 143.79, 143.28, 136.85, 136.55, 136.26, 134.59, 134.43, 
133.53, 133.44, 133.33, 133.18, 132.20, 131.81, 130.66, 130.41, 128.34, 127.97, 127.87, 
127.60, 127.51, 127.33, 127.00, 126.17, 126.03, 126.00, 125.84, 125.43, 124.92, 114.96, 
114.78, 40.38, 39.97, 28.14, 28.06, 22.86, 22.71, 17.16, 16.91; m/z (EI)(%): 376.9 (3.7), 361.6 
(2.4), 281.1 (8.5), 267.1 (20.6), 266.1 (24.1), 265.2 (21.0), 264.3 (20.0), 254.0 (23.8), 253.1 
(32.4), 252.2 (41.3), 251.0 (40.0), 250.0 (31.7), 248.9 (17.4), 238.9 (20.7), 238.0 (22.1), 237.1 
(15.3), 200.5 (16.1), 163.6 (18.3), 162.7 (15.0), 152.2 (14.3), 151.2 (16.4), 150.3 (14.3), 149.4 
(13.3), 141.4 (19.5), 140.4 (34.8), 139.4 (25.7), 132.8 (15.2), 131.5 (20.3), 130.6 (18.5), 129.6 
(21.4), 128.4 (32.1), 127.4 (46.8), 126.5 (52.5), 125.5 (29.4), 121.4 (67.5), 120.7 (97.7), 119.8 
(99.9), 118.6 (28.2), 117.5 (38.8), 116.6 (42.2), 115.7 (40.7), 114.8 (29.5), 113.9 (25.7), 107.6 
(40.8), 106.8 (78.5), 106.1 (38.4), 103.8 (17.6), 103.0 (22.5), 94.5 (67.8), 93.5 (55.8), 91.4 
(100), 90.5 (50.3), 77.8 (38.2), 77.0 (46.7), 66.0 (17.4); [M+Na] HRMS calcd. for C28H24ONa: 
399.17194, found: 399.17209; IR (KBr): = 3375,  3054, 2962, 2933, 2828, 1602, 1509, 
1439, 1367, 1227, 1174, 1042, 832, 777, 733 cm-1. 
4-(1-(1-(Thiophen-2-yl)-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211q) 
 
Colorless oil, Rf (Hex: EtOAc 5:1) = 0.31. 1H NMR (600 MHz, CDCl3): δ = 7.43–7.36 (m, 
1H), 7.19–7.12 (m, 3H), 7.12–7.05 (m, 3H), 6.99 (dd, J = 3.4, 1.0, 1H), 6.86–6.82 (m, 1H), 
6.78–6.72 (m, 2H), 4.68 (s, 1H), 4.03 (q, J = 7.1, 1H), 2.75–2.64 (m, 2H), 2.31–2.23 (m, 1H), 
2.02 (ddd, J = 16.1, 7.9, 6.3, 1H), 1.39 (d, J = 7.1, 3H); 13C NMR (150 MHz, CDCl3): δ = 
153.64, 146.75, 140.23, 136.74, 135.99, 134.79, 128.46, 127.54, 127.07, 126.88, 126.45, 
126.35, 125.93, 125.66, 125.51, 114.90, 40.35, 28.38, 23.47, 17.05; m/z (EI)(%): 334.5 (6.3), 
333.5 (27.5), 332.6 (46.5), 332.0 (100), 331.1 (73.3), 330.3 (41.8), 317.3 (32.4), 316.2 (28.3), 
315.3 (17.0), 302.5 (12.8), 237.9 (11.2), 236.7 (10.8), 232.8 (10.4), 231.7 (13.7), 230.5 (12.2), 
222.8 (14.2), 221.7 (15.5), 220.5 (17.0), 219.5 (12.5), 210.8 (11.0), 209.8 (14.7), 208.8 (17.3), 
207.8 (16.1), 206.7 (10.2), 164.8 (9.0), 163.6 (11.6), 119.7 (8.0); [M+Na] HRMS calcd. for 
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C22H20OSNa: 355.11271, found: 355.11249; IR (KBr): = 3369,  3024, 2939, 2882, 1606, 
1508, 1441, 1364, 1222, 1177, 1112, 1037, 907, 831, 726 cm-1. 
3-(2-(1-(4-Hydroxyphenyl)ethyl)-3,4-dihydronaphthalen-1-yl)oxazolidin-2-one (211r) 
 
White solid, Rf (Hex: EtOAc 1:1) = 0.43. 1H NMR (600 MHz, DMSO-d6): δ = 9.23 (d, J = 
35.2, 1H), 7.20 (td, J = 7.0, 1.3, 1H), 7.17–7.10 (m, 3H), 7.08 (d, J = 8.5, 1H), 7.02 (d, J = 7.6, 
1H), 6.72 (d, J = 8.5, 1H), 6.67 (d, J = 8.6, 1H), 4.62–4.45 (m, 2H), 4.04 (dq, J = 55.4, 7.0, 
1H), 3.90–3.79 (m, 1H), 3.73 (td, J = 8.8, 6.5, 1H), 2.67–2.43 (m, 2H), 2.27–2.08 (m, 1H), 
2.02–1.68 (m, 1H), 1.35 (dd, J = 27.6, 7.1, 3H); 13C NMR (150 MHz, DMSO-d6): δ = 156.93, 
156.88, 155.74, 155.71, 145.51, 144.76, 135.41, 135.32, 133.25, 132.09, 131.31, 131.08, 
128.41, 128.10, 127.55, 127.52, 127.15, 127.10, 126.67, 126.62, 126.42, 126.14, 121.79, 
121.70, 115.15, 114.83, 62.30, 62.21, 46.63, 46.09, 38.24, 37.73, 27.21, 27.05, 22.88, 22.84, 
16.92, 16.25; m/z (EI)(%): 335.3 (1.8), 261.8 (3.5), 247.9 (13.6), 247.2 (11.7), 245.6 (15.0), 
244.6 (14.1), 231.9 (10.9), 230.9 (13.0), 167.1 (10.6), 153.1 (10.3), 143.2 (10.8), 142.3 (10.9), 
130.5 (21.5), 129.5 (14.7), 128.4 (29.0), 127.4 (38.7), 126.6 (23.0), 125.8 (12.0), 121.3 (63.2), 
120.6 (41.1), 119.9 (100), 118.7 (25.6), 117.7 (20.9), 116.6 (22.6), 115.6 (48.1), 114.5 (49.8), 
107.6 (15.7), 107.0 (19.0), 106.1 (26.1), 104.5 (11.2), 103.5 (26.0), 102.8 (22.9), 102.2 (28.7), 
94.5 (37.9), 93.5 (67.7), 92.5 (13.2), 91.5 (71.8), 90.6 (56.9), 89.5 (24.5), 88.6 (26.4), 87.6 
(10.3), 78.7 (20.4), 77.7 (65.5), 76.9 (60.5), 66.9 (13.6), 65.9 (45.0), 65.1 (30.3), 64.0 (12.1), 
63.2 (11.0), 53.4 (11.5), 45.4 (15.1); [M+Na] HRMS calcd. for C21H21O3NNa: 358.14136, 
found: 358.14136; IR (KBr): = 3237, 2934, 1721, 1596, 1506, 1431, 1252, 1124, 1087, 
1033, 831, 760, 721, 674 cm-1.  
4-(1-(6-Methoxy-4-(4-methoxyphenyl)-2H-chromen-3-yl)ethyl)phenol (211a’) 
 
White solid, Rf (Hex: EtOAc 5:1) = 0.17. 1H NMR (600 MHz, CDCl3): δ = 7.21 (s, 2H), 7.07 
(t, J = 5.7, 2H), 6.99 (dd, J = 7.4, 1.5, 2H), 6.77 (d, J = 8.7, 1H), 6.74–6.69 (m, 2H), 6.64 (dd, 
J = 8.7, 3.0, 1H), 6.25 (d, J = 3.0, 1H), 5.09 (s, 1H), 4.62 (d, J = 13.9, 1H), 4.38 (d, J = 13.9, 
1H), 3.88–3.81 (m, 4H, -OCH3 and -CH), 3.63 (s, 3H), 1.37 (d, J = 7.2, 3H); 13C NMR (150 
MHz, CDCl3): δ = 158.81, 154.03, 153.97, 147.23, 135.49, 134.46, 130.92, 130.65, 128.95, 
128.26, 126.82, 115.80, 115.16, 114.12, 112.79, 112.27, 65.10, 55.67, 55.26, 38.26, 17.06; 
m/z (EI)(%): 390.2 (3.9), 389.1 (25.1), 388.2 (94.9), 387.2 (4.9), 373.1 (8.0), 294.1 (3.4), 
293.1 (9.1), 281.1 (5.6), 268.1 (34.8), 267.1 (100), 263.1 (10.9), 224.1 (6.8), 209.1 (3.9), 
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181.1 (4.3), 165.1 (6.3), 152.1 (5.6), 147.1 (5.3), 121.0 (50.5), 107.1 (6.5), 91.1 (7.6), 77.1 
(11.3); [M+Na] HRMS calcd. for C25H24O4Na: 411.15668, found: 411.15613; IR (KBr): = 
3415, 2960, 2839, 1605, 1509, 1485, 1271, 1242, 1216, 1179, 1031, 870, 837, 808, 733, 709 
cm-1.  
4-(1-(4-(4-Methoxyphenyl)-1-tosyl-1,2-dihydroquinolin-3-yl)ethyl)phenol (211b’) 
 
White solid, Rf (Hex: EtOAc 3:1) = 0.22. 1H NMR (600 MHz, DMSO-d6): δ = 9.31 (s, 1H), 
7.57 (d, J = 7.9, 1H), 7.25 (t, J = 7.6, 1H), 7.14 (d, J = 7.8, 2H), 7.09 (t, J = 7.5, 1H), 6.94 (d, 
J = 8.1, 2H), 6.87 (d, J = 8.2, 2H), 6.75 (t, J = 7.6, 4H), 6.52 (s, 1H), 6.42 (d, J = 7.7, 2H), 
4.30 (d, J = 18.0, 1H), 4.20 (d, J = 18.0, 1H), 3.76 (s, 3H), 3.44 (q, J = 6.9, 1H), 2.37 (s, 3H), 
1.17 (d, J = 7.1, 3H); 13C NMR (150 MHz, DMSO-d6): δ = 158.35, 156.01, 143.54, 137.65, 
135.13, 133.01, 132.57, 131.58, 130.34, 130.18, 129.09, 128.38, 128.31, 127.02, 126.82, 
126.62, 125.90, 125.66, 115.22, 114.07, 55.05, 44.57, 38.99, 20.92, 17.18; m/z (EI)(%): 391.0 
(1.0), 390.4 (1.2), 355.7 (3.0), 340.6 (1.7), 289.3 (4.3), 274.0 (5.8), 273.1 (8.1), 272.0 (12.4), 
271.0 (8.0), 270.0 (12.3), 244.9 (9.0), 243.9 (9.1), 243.0 (7.6), 242.0 (5.2), 235.8 (6.6), 234.9 
(8.4), 233.8 (9.1), 232.8 (6.5), 195.0 (5.7), 193.9 (16.0), 193.1 (48.2), 191.8 (100), 190.7 
(29.5), 190.0 (17.1), 189.1 (6.1), 184.0 (8.5), 183.2 (11.3), 181.4 (5.2), 170.9 (5.3), 170.1 
(6.0), 169.2 (7.8), 168.5 (15.0), 167.2 (17.4), 165.9 (25.7), 164.8 (18.7), 163.6 (9.5), 139.3 
(5.7), 138.3 (6.0), 121.2 (6.2), 119.8 (20.0), 114.1 (12.9), 105.5 (25.0), 104.1 (20.2), 103.1 
(5.6), 91.6 (9.4), 90.7 (21.5), 89.6 (17.2), 88.6 (11.6), 78.8 (9.1), 77.8 (13.8), 76.9 (6.7), 63.1 
(6.8), 51.6 (12.8); [M+Na] HRMS calcd. for C31H29O4NSNa: 534.17095, found: 534.17200; 
IR (KBr): = 3467, 3067, 3006, 2975, 1605, 1510, 1482, 1451, 1335, 1277, 1245, 1208, 
1153, 1087, 1028, 869, 826, 795, 765, 712, 661 cm-1.  
4-(1-(4-(4-Methoxyphenyl)-2-methyl-1-tosyl-1,2-dihydroquinolin-3-yl)ethyl)phenol 
(211c’) 
 
Light yellow solid, Rf (Hex: EtOAc 3:1) = 0.30. 1H NMR (600 MHz, CDCl3): δ = 7.81–7.76 
(m, 1H), 7.33–7.09 (m, 5H including one proton from CHCl3), 7.06 (dd, J = 14.9, 8.0, 2H), 
7.03–6.81 (m, 4H), 6.81–6.45 (m, 4H), 6.01–5.81 (m, 1H), 5.31 (s, 0.38H), 5.23 (q, J = 6.8, 
0.41H), 5.16 (s, 0.59H), 4.85 (q, J = 6.8, 0.64H), 3.84 (d, J = 10.6, 3H), 3.66 (dq, J = 109.1, 
7.4, 1H), 2.36 (d, J = 58.2, 3H), 1.36 (t, J = 6.8, 2.49H), 1.09 (d, J = 7.3, 1.89H), 0.44 (d, J = 
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6.8, 1.88H); 13C NMR (150 MHz, CDCl3): δ = 158.62, 158.58, 154.55, 154.37, 143.26, 
142.73, 142.56, 141.49, 136.57, 135.60, 135.17, 134.23, 132.02, 131.90, 131.86, 131.66, 
131.18, 131.04, 130.67, 130.44, 130.18, 129.96, 129.93, 129.61, 129.19, 128.90, 128.83, 
128.74, 127.42, 127.30, 127.23, 127.16, 126.71, 126.54, 126.38, 125.99, 125.64, 115.30, 
115.27, 114.25, 113.64, 113.40, 55.25, 50.42, 50.15, 40.37, 38.91, 21.47, 21.44, 21.38, 20.18, 
19.86, 18.27; m/z (EI)(%): 525.6 (1.5), 512.5 (3.2), 511.6 (12.3), 510.5 (37.1), 340.4 (9.0), 
250.3 (17.9), 247.3 (10.5), 245.2 (42.5), 218.3 (6.4), 217.3 (5.6), 204.2 (6.1), 203.3 (7.2), 
155.1 (24.4), 121.2 (56.3), 103.2 (9.1), 92.2 (10.3), 91.2 (100), 77.2 (14.8), 65.3 (19.1); 
[M+Na] HRMS calcd. for C32H31O4NSNa: 548.18660, found: 548.18658; IR (KBr): = 3441, 
2969, 1605, 1508, 1450, 1336, 1239, 1160, 1088, 1031, 905, 824, 729, 662 cm-1.  
4-(1-(9-Phenyl-6,7-dihydro-5H-benzo[7]annulen-8-yl)ethyl)phenol (211d’) 
 
Yellow oil, Rf (Hex: EtOAc 5:1) = 0.34. 1H NMR (600 MHz, CDCl3): δ = 7.42 (t, J = 7.5, 
2H), 7.37–7.30 (m, 3H), 7.24 (t, J = 7.5, 2H), 7.16 (t, J = 7.3, 1H), 7.10 (d, J = 7.3, 2H), 7.01 
(d, J = 8.1, 1H), 6.95 (d, J = 2.1, 1H), 6.69 (dd, J = 8.1, 2.3, 1H), 4.65 (s, 1H), 3.48 (q, J = 7.5, 
1H), 2.65–2.50 (m, 3H), 2.35 (ddd, J = 14.2, 9.4, 5.0, 1H), 1.92–1.84 (m, 1H), 1.81–1.73 (m, 
1H), 1.32 (d, J = 7.5, 3H); 13C NMR (150 MHz, CDCl3): δ = 153.31, 150.37, 147.21, 142.15, 
138.15, 137.18, 135.62, 129.10, 128.37, 128.34, 128.25, 126.94, 125.70, 119.92, 113.01, 
110.65, 44.59, 35.73, 31.62, 26.25, 16.01; m/z (EI)(%): 341.0 (4.3), 339.7 (43.6), 236.0 (24.9), 
234.9 (68.5), 233.8 (75.2), 232.5 (100), 222.8 (22.9), 221.9 (45.0), 220.8 (62.7), 219.6 (73.1), 
218.6 (47.5), 217.1 (62.1), 214.4 (11.0), 206.8 (9.8), 201.9 (20.0), 200.6 (26.1), 199.6 (14.5), 
191.0 (11.4), 190.0 (12.8), 188.9 (17.3), 187.7 (13.3), 176.4 (12.9), 154.9 (13.1), 91.5 (14.2), 
90.8 (24.9); [M+H] HRMS calcd. for C25H25O: 341.18999, found: 341.18948; IR (KBr): = 
3365, 3026, 2932, 2860, 1739, 1597, 1451, 1362, 1297, 1223, 1169, 1085, 1028, 904, 817, 
733, 699 cm-1.  
4-(1-(7-Methoxy-1-(4-methoxyphenyl)-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211s) 
 
Colorless oil, Rf (Hex: EtOAc 5:1) = 0.21. 1H NMR (400 MHz, CDCl3): δ = 7.18 (s, 2H), 7.07 
(t, J = 5.5, 2H), 7.03–6.91 (m, 3H), 6.76–6.66 (m, 2H), 6.61 (dd, J = 8.1, 2.7, 1H), 6.24 (d, J = 
2.6, 1H), 4.81 (s, 1H), 3.89–3.77 (m, 4H, –OCH3 and -CH), 3.63 (s, 3H), 2.70–2.55 (m, 2H), 
2.22 (ddd, J = 17.0, 10.4, 6.8, 1H), 1.98 (ddd, J = 15.9, 7.7, 6.4, 1H), 1.33 (d, J = 7.1, 3H); 
13C NMR (100 MHz, CDCl3): δ = 158.38, 158.03, 153.59, 142.93, 138.44, 136.42, 133.17, 
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131.80, 131.15, 128.37, 127.58, 127.45, 114.83, 114.00, 112.77, 110.43, 55.23, 55.19, 40.05, 
27.85, 23.57, 17.09; m/z (EI)(%): 389.4 (3.5), 388.3 (14.6), 387.3 (25.9), 386.3 (100), 385.3 
(13.4), 384.3 (44.1), 371.3 (22.2), 277.2 (10.3), 275.2 (22.4), 265.2 (12.7), 121.1 (17.4), 107.1 
(7.4); [M+H] HRMS calcd. for C26H27O3: 387.19547, found: 387.19528; IR (KBr): = 3406, 
2938, 2834, 1604, 1501, 1234, 1176, 1106, 1034, 907, 828, 729 cm-1. 
4-(1-(1-(4-Methoxyphenyl)-5-methyl-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211t) 
 
Colorless oil, Rf (Hex: EtOAc 5:1) = 0.22. 1H NMR (400 MHz, CDCl3): δ = 7.17 (s, 2H), 7.09 
(d, J = 8.4, 2H), 7.03–6.85 (m, 4H), 6.72 (d, J = 8.5, 2H), 6.51 (d, J = 6.9, 1H), 4.75 (s, 1H), 
3.91–3.74 (m, 4H, -OCH3 and -CH), 2.78–2.67 (m, 1H), 2.63–2.52 (m, 1H), 2.32–2.13 (m, 4H, 
Ar-CH3 and 1/2 -CH2), 2.01 (dt, J = 15.9, 6.2, 1H), 1.34 (d, J = 7.1, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 158.30, 153.55, 141.58, 137.13, 136.59, 134.20, 133.47, 133.36, 132.42, 131.21, 
128.38, 128.25, 125.46, 124.17, 114.81, 113.92, 55.23, 39.95, 24.51, 22.81, 19.56, 17.07; m/z 
(EI)(%): 371.4 (23.6), 370.3 (79.1), 356.3 (12.2), 355.3 (49.7), 276.2 (18.6), 262.2 (14.3), 
261.2 (38.6), 259.2 (13.5), 250.2 (11.4), 249.2 (38.1), 248.2 (13.1), 247.2 (26.7), 245.2 (18.5), 
244.2 (17.5), 239.2 (13.4), 237.2 (9.8), 236.2 (12.2), 235.2 (24.4), 234.2 (18.1), 233.2 (14.9), 
232.2 (12.2), 231.2 (19.0), 229.2 (14.6), 219.2 (12.4), 218.2 (12.6), 217.2 (13.1), 216.1 (14.9), 
229.1 (26.0), 203.1 (25.9), 202.1 (37.3), 191.1 (17.6), 190.1 (16.9), 189.1 (30.9), 185.2 (10.9), 
178.1 (15.5), 165.1 (19.1), 152.1 (11.6), 145.0 (15.1), 138.1 (10.9), 135.1 (10.5), 131.2 (24.5), 
129.1 (11.9), 128.1 (10.3), 122.1 (10.6), 121.1 (100), 119.1 (13.9), 115.1 (14.8), 108.1 (10.6), 
107.1 (48.2), 105.1 (29.4), 103.1 (17.4), 94.1 (28.9), 91.1 (29.4), 77.1 (35.5), 73.1 (10.2), 65.2 
(13.8); [M+H] HRMS calcd. for C26H27O2: 371.20056, found: 371.20056; IR (KBr): = 
3406, 2955, 2833, 1605, 1507, 1454, 1236, 1175, 1107, 1029, 907, 828, 729 cm-1. 
4-(1-(7-Bromo-1-(4-methoxyphenyl)-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211u) 
 
Yellow oil, Rf (Hex: EtOAc 5:1) = 0.24. 1H NMR (400 MHz, CDCl3): δ = 7.16 (dd, J = 7.9, 
2.0, 3H), 7.06 (d, J = 8.5, 2H), 6.96 (dd, J = 19.5, 8.3, 3H), 6.77–6.65 (m, 3H), 4.70 (s, 1H), 
3.86 (s, 3H), 3.82 (q, J = 7.1, 1H), 2.70–2.54 (m, 2H), 2.21 (ddd, J = 17.1, 10.6, 6.7, 1H), 
2.04–1.92 (m, 1H), 1.32 (d, J = 7.1, 3H); 13C NMR (100 MHz, CDCl3): δ = 158.58, 153.65, 
143.86, 139.39, 136.19, 134.02, 132.41, 131.13, 131.07, 128.78, 128.62, 128.36, 119.92, 
114.91, 114.24, 55.26, 40.01, 28.22, 23.06, 17.04; m/z (EI)(%): 437.1 (23.9), 436.1 (86.0), 
435.1 (26.9), 434.1 (100), 422.1 (10.7), 421.1 (43.1), 420.1 (11.4), 419.1 (44.0), 342.1 (14.7), 
341.1 (9.7), 340.1 (29.8), 327.0 (20.3), 325.0 (20.5), 313.0 (13.7), 265.1 (12.2), 247.1 (17.1), 
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245.1 (47.6), 244.1 (15.1), 239.1 (13.5), 235.1 (9.2), 234.1 (37.9), 233.1 (14.3), 232.1 (29.1), 
231.1 (26.6), 230.1 (9.3), 219.1 (13.9), 218.1 (9.4), 229.1 (22.3), 203.1 (21.4), 202.1 (27.5), 
191.1 (11.4), 190.1 (13.8), 189.0 (27.6), 165.0 (10.2), 121.0 (55.4), 107.0 (26.5), 94.0 (19.4), 
91.1 (13.1), 77.1 (16.4); [M+H] HRMS calcd. for C25H24O2Br: 435.09542, found: 435.09506; 
IR (KBr): = 3397, 2950, 2833, 1602, 1506, 1469, 1367, 1235, 1174, 1107, 1030, 905, 825, 
778, 729 cm-1.  
4-(1-(7-Fluoro-1-(4-methoxyphenyl)-3,4-dihydronaphthalen-2-yl)ethyl)phenol (211v) 
 
Yellow solid, Rf (Hex: EtOAc 5:1) = 0.22. 1H NMR (400 MHz, CDCl3): δ = 7.17 (s, 2H), 
7.08 (d, J = 8.4, 2H), 7.04–6.95 (m, 3H), 6.73 (dq, J = 5.3, 3.0, 3H), 6.34 (dd, J = 10.7, 2.7, 
1H), 4.80 (s, 1H), 3.89–3.79 (m, 4H, -OCH3 and -CH), 2.73–2.56 (m, 2H), 2.23 (ddd, J = 17.2, 
10.6, 6.7, 1H), 1.99 (ddd, J = 16.0, 7.7, 6.4, 1H), 1.34 (d, J = 7.1, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 162.81, 160.40, 158.55, 153.65, 143.61, 139.20, 139.13, 136.23, 132.74, 131.33, 
131.10, 130.57, 130.54, 128.37, 127.80, 127.72, 114.90, 114.17, 112.94, 112.71, 112.33, 
112.12, 55.27, 40.05, 27.93, 23.36, 17.06; 19F NMR (376 MHz, CDCl3): δ = -116.80 (dd, J = 
15.7, 9.3); m/z (EI)(%): 375.2 (25.7), 374.2 (100), 360.1 (8.2), 359.1 (33.7), 280.1 (11.8), 
265.0 (21.4), 253.0 (10.5), 251.1 (12.3), 249.0 (7.3), 233.0 (11.8), 220.0 (9.9), 135.0 (7.1), 
121.0 (26.1), 107.0 (13.4), 94.0 (6.9), 91.0 (6.2), 77.1 (8.8); [M+H] HRMS calcd. for 
C25H24O2F: 375.17548, found: 375.17569; IR (KBr): = 3401, 2948, 2834, 1604, 1449, 1359, 
1238, 1177, 1105, 1030, 979, 907, 818, 729 cm-1. 
4-(1-(1-(4-Methoxyphenyl)-3,4-dihydrophenanthren-2-yl)ethyl)phenol (211w) 
 
White solid, Rf (Hex: EtOAc 5:1) = 0.21. 1H NMR (400 MHz, CDCl3): δ = 7.99 (d, J = 8.5, 
1H), 7.71 (d, J = 8.0, 1H), 7.49 (d, J = 8.6, 1H), 7.43 (t, J = 7.6, 1H), 7.35 (t, J = 7.4, 1H), 
7.23–7.17 (m, 2H), 7.11 (d, J = 8.4, 2H), 6.98 (d, J = 8.6, 2H), 6.86 (d, J = 8.6, 1H), 6.71 (d, J 
= 8.5, 2H), 4.64 (s, 1H), 3.99–3.74 (m, 4H, -OCH3 and -CH), 3.25–3.13 (m, 1H), 3.05–2.93 
(m, 1H), 2.34 (ddd, J = 18.1, 11.6, 6.6, 1H), 2.18–2.07 (m, 1H), 1.37 (d, J = 7.1, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 158.43, 153.59, 141.85, 136.66, 134.14, 133.62, 132.45, 132.31, 
131.29, 130.98, 130.12, 128.42, 128.40, 125.84, 125.71, 124.99, 124.82, 123.51, 114.88, 
114.06, 55.26, 39.90, 23.85, 23.00, 17.21; m/z (EI)(%): 407.2 (28.6), 406.1 (100), 392.2 
(11.5), 391.2 (39.7), 378.1 (13.2), 297.1 (20.0), 285.1 (15.5), 283.1 (11.4), 265.0 (16.1), 253.1 
(16.5), 252.1 (17.4), 239.0 (21.1), 164.9 (10.9), 156.2 (20.6), 148.2 (9.4), 141.0 (25.5), 121.0 
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(27.3), 107.0 (19.3), 94.0 (10.5); [M+H] HRMS calcd. for C29H27O2: 407.20056, found: 
407.20020; IR (KBr): = 3401, 2952, 1603, 1504, 1449, 1367, 1230, 1026, 907, 821, 730 
cm-1.  
1-(6-(1-(4-Hydroxyphenyl)ethyl)-7-(4-methoxyphenyl)-4,5-dihydrobenzo[b]thiophen-2-yl
)ethanone (211x) 
 
Yellow solid, Rf (Hex: EtOAc 1:1) = 0.63. 1H NMR (400 MHz, CDCl3): δ = 7.41 (s, 1H), 
7.25 (s, 2H), 7.04 (d, J = 8.5, 2H), 6.95 (d, J = 8.8, 2H), 6.75 (t, J = 5.7, 2H), 5.35 (s, 1H), 
3.93–3.77 (m, 4H, -OCH3 and -CH), 2.64 (tdd, J = 15.7, 13.3, 7.7, 2H), 2.48–2.30 (m, 4H, 
-COCH3 and 1/2-CH2), 2.16–2.05 (m, 1H), 1.36 (d, J = 7.1, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 190.63, 159.13, 154.08, 149.71, 143.21, 139.97, 135.48, 134.46, 132.27, 130.64, 
130.42, 129.10, 128.31, 115.07, 114.20, 55.27, 39.65, 26.46, 24.14, 23.39, 17.34; m/z (EI)(%): 
406.1 (8.8), 405.2 (24.2), 404.2 (100), 390.1 (15.5), 389.1 (59.1), 373.1 (9.9), 361.1 (13.8), 
310.1 (17.9), 295.0 (28.9), 283.1 (9.4), 281.0 (9.7), 253.0 (10.7), 252.1 (13.7), 237.0 (10.5), 
221.0 (10.1), 208.0 (9.5), 165.0 (8.4), 121.0 (29.9), 107.0 (14.3), 94.0 (32.6), 91.0 (11.5), 77.1 
(13.6); [M+Na] HRMS calcd. for C25H24O3SNa: 427.13384, found: 427.13257; IR (KBr): = 
3226, 2945, 2832, 1607, 1510, 1413, 1243, 1181, 1025, 935, 828, 727 cm-1.  
4-Phenyl-1,2-dihydronaphthalene (226) 
 
Colorless oil, Rf (Hex: EtOAc 30:1) = 0.58. 
1H NMR (600 MHz, CDCl3): δ = 7.43–7.28 (m, 5H), 7.21 (d, J = 7.3, 1H), 7.17 (t, J = 7.3, 
1H), 7.12 (t, J = 7.5, 1H), 7.02 (d, J = 7.6, 1H), 6.10 (t, J = 4.7, 1H), 2.87 (t, J = 8.0, 2H), 2.42 
(td, J = 7.9, 4.8, 2H); 13C NMR (150 MHz, CDCl3): δ = 140.75, 139.86, 136.75, 135.07, 
128.72, 128.19, 127.63, 127.52, 127.04, 126.94, 126.17, 125.41, 28.28, 23.51; m/z (EI)(%): 
207.3 (19.6), 206.2 (100), 205.2 (20.5), 203.2 (8.8), 202.2 (8.4), 191.2 (18.7), 178.2 (6.9), 
165.2 (5.7), 128.2 (5.8), 91.2 (3.9), 77.2 (2.2); IR (KBr): = 3030, 2933, 2830, 2326, 2095, 
1900, 1593, 1481, 1443, 1354, 1031, 948, 830, 751 cm-1. 
5.7 Experiments for Al(OTf)3-Catalyzed Insertion of an Unactivated Alkyne 
into an Unstrained C-C σ Bond 
5.7.1 Experiments for Preparation of Substrates 
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To a solution of amines 233 (20 mmol) and pyridines (26 mmol) in 15 mL DCM was 
added TsCl 234 (22 mmol) in portions, the reaction was then stirred at room temperature 
overnight. The reaction mixture was washed by 15 mL 2N HCl and the aqueous phase was 
extracted with DCM (2×20 mL). The combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was recrystallized from 
DCM/hexane. 
N-(2-Acetylphenyl)-4-methylbenzenesulfonamide (235a) 
 
White solid, Rf (hexane: EtOAc 3:1) = 0.37. 1H NMR (400 MHz, CDCl3): δ = 11.45 (s, 1H), 
7.82–7.64 (m, 4H), 7.49–7.37 (m, 1H), 7.25–7.19 (m, 2H), 7.10–6.99 (m, 1H), 2.55 (s, 3H), 
2.36 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 202.4, 143.9, 140.1, 136.6, 134.9, 131.9, 
129.6, 127.3, 122.5, 122.3, 119.0, 28.1, 21.5; m/z (EI)(%): 290.3 (M+1, 39), 289.2 (M, 95), 
272.2 (23), 155.1 (20), 134.2 (100), 120.2 (31), 106.2 (51), 92.2 (29), 91.2 (96), 65.3 (43); IR 
(KBr): = 3057, 2182, 2111, 1936, 1816, 1640, 1587, 1493, 1455 cm-1. 
N-(2-Benzoylphenyl)-4-methylbenzenesulfonamide (235b) 
 
White solid, Rf (hexane: EtOAc 3:1) = 0.38. 1H NMR (400 MHz, CDCl3): δ = 9.97 (s, 1H), 
7.78 (dd, J = 8.3, 1.0 Hz, 1H), 7.57–7.47 (m, 4H), 7.41–7.34 (m, 5H), 7.11–7.05 (m, 1H), 
7.04–6.99 (m, 2H), 2.22 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 198.4, 143.6, 139.0, 137.6, 
135.9, 133.7, 133.0, 132.6, 129.8, 129.5, 128.0, 127.2, 126.2, 123.4, 123.1, 21.4; m/z (EI)(%): 
352.3 (M+1, 25), 351.3 (M, 100), 196.3 (89), 1953 (31), 167.3 (20), 91.3 (21); IR (KBr): = 
3242, 3056, 2922, 2657, 2326, 2100, 1998, 1920, 1640, 1593, 1482, 1447, 1390, 1287, 1213, 
1160, 1090, 938, 890, 810, 763, 699 cm-1. 
N-(2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (237a) 
 
White solid, Rf (hexane: EtOAc 3:1) = 0.13. 1H NMR (300 MHz, CDCl3): δ = 7.87 (s, 1H), 
7.62–7.66 (m, 2H), 7.41–7.45 (m, 2H), 7.18–7.30 (m, 3H), 7.05–7.12 (m, 2H), 4.39 (s, 2H), 
2.38 (s, 3H); 13C NMR (75 MHz, CDCl3): δ = 143.8, 136.9, 136.4, 131.6, 129.6, 129.3, 129.0, 
127.0, 125.3, 123.4, 63.9, 21.5; m/z (EI)(%): 277 (M, 30), 194 (20), 122 (100), 121 (32), 104 
(19), 94 (43), 93 (96), 92 (18), 91 (72), 77 (53), 65 (51); IR (KBr): = 3860, 3435, 3071, 
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2921, 2874, 2805, 2730, 2644, 2330, 2194, 2120, 2035, 1993, 1918, 1733, 1647, 1594, 1490, 
1456, 1410, 1314, 1220, 1183, 1149, 1090, 1029, 951, 926, 885, 843, 806, 760, 729, 714, 659 
cm-1. 
To a solution of N-(2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamides 237a (8 
mmol) in 40 mL DCM was added PCC (10.4 mmol), the reaction was then stirred at room 
temperature overnight. After reaction completion, the mixture was filtered through a plug of 
celite and the filter cake was washed with 50 mL DCM. The collected DCM was removed 
under reduced pressure and the crude product was purified by column chromatography. 
N-(2-Formylphenyl)-4-methylbenzenesulfonamide (238a) 
 
White solid, Rf (hexane: EtOAc 3:1) = 0.37. 1H NMR (300 MHz, CDCl3): δ = 10.79 (s, 1H), 
9.83 (d, J = 0.7 Hz, 1H), 7.77 (d, J = 8.5 Hz, 2H), 7.69 (d, J = 8.8 Hz, 1H), 7.59 (dd, J = 
7.7/1.6 Hz, 1H), 7.55–7.47 (m, 1H), 7.28–7.21 (m, 2H), 7.16 (td, J = 7.6, 1.0 Hz, 1H), 2.36 (s, 
3H); 13C NMR (100 MHz, CDCl3): δ = 194.9, 144.1, 140.0, 136.4, 136.1, 135.8, 129.7, 127.3, 
122.9, 121.9, 117.8, 21.5; m/z (EI)(%): 277.1 (M+2, 43), 275.2 (M, 4), 194.2 (32), 180.2 (21), 
122.2 (100), 121.2 (31), 120.2 (22), 94.3 (30), 93.2 (68), 91.2 (55), 77.2 (34), 65.3 (30); IR 
(KBr): = 3433, 3070, 2921, 2874, 2805, 2731, 2643, 2329, 2111, 1993, 1918, 1743, 1673, 
1594, 1492, 1457, 1410, 1314, 1290, 1220, 1149, 1090, 1030, 926, 886, 844, 806, 761, 713, 
684, 662 cm-1. 
N- (4-Chloro-2-formylphenyl)-4-methylbenzenesulfonamide (238b) 
 
White solid, Rf (hexane: EtOAc 3:1) = 0.55. 1H NMR (400 MHz, CDCl3): δ = 10.62 (s, 1H), 
9.77 (d, J = 0.7 Hz, 1H), 7.75 (d, J = 8.4 Hz, 2H), 7.68 (d, J = 8.9 Hz, 1H), 7.55 (d, J = 2.5 Hz, 
1H), 7.46 (dd, J = 8.9, 2.5 Hz, 1H), 7.27–7.23 (m, 2H), 2.38 (s, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 193.7, 144.5, 138.4, 136.1, 135.7, 135.1, 129.8, 128.4, 127.2, 122.8, 119.6, 21.5; 
m/z (EI)(%): 311.2 (M+2, 35), 310.2 (M+1, 23), 309.2 (M, 85), 156.2 (40), 155.2 (36), 154.2 
(100), 91.3 (84), 65.4 (23); IR (KBr): = 3177, 3051, 2927, 2857, 2749, 2322, 2169, 2107, 
2005, 1930, 1809, 1736, 1669, 1595, 1572, 1483, 1385, 1337, 1292, 1222, 1187, 1156, 1089, 
928, 866, 820, 720, 660 cm-1. 
To a solution of ketones 235 (5 mmol) in 20 mL EtOH at 0 oC was added NaBH4 (15 
mmol) in portions, the reaction was then warmed to room temperature and stirred for 2 h. 
After reaction completion, EtOH solvent was removed under reduced pressure, the residue 
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was washed by 20 mL saturated brine and the aqueous phase was extracted with Et2O (3×20 
mL). The collected organic phases were dried over Na2SO4 and concentrated under reduced 
pressure. The crude product was purified by column chromatography. 
N-(2-(1-Hydroxyethyl)phenyl)-4-methylbenzenesulfonamide (182a)                             
 
White solid, Rf (Hex: EtOAc 3:1) = 0.20. 1H NMR (600 MHz, CDCl3): δ = 8.43 (s, 1H), 
7.72–7.66 (m, 2H), 7.43 (dd, J = 8.1, 1.0 Hz, 1H), 7.24–7.20 (m, 2H), 7.20–7.16 (m, 1H), 
7.08 (dd, J = 7.7, 1.7 Hz, 1H), 7.04 (td, J = 7.5, 1.2 Hz, 1H), 4.84 (q, J = 6.6 Hz, 1H), 2.42 (s, 
1H), 2.37 (s, 3H), 1.36 (d, J = 6.7 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.71, 136.88, 
135.66, 133.99, 129.59, 128.48, 127.12, 126.97, 124.60, 121.79, 69.75, 22.81, 21.50; m/z 
(EI)(%): 293.3 (3.5), 292.2 (9.8), 291.2 (53.5), 136.2 (63.8), 118.1 (100), 91.1 (40.2); [M+Na] 
HRMS calcd. for C15H17NO3SNa: 314.08214, found: 314.08121; IR (KBr): = 3488, 3243, 
2977, 2972, 1549, 1496, 1330, 1159, 1091, 932, 759, 665, 564 cm-1.  
N-(2-(Hydroxy(phenyl)methyl)phenyl)-4-methylbenzenesulfonamide (182b) 
 
White solid, Rf (Hex: EtOAc 3:1) = 0.25. 1H NMR (400 MHz, CDCl3): δ = 8.01 (s, 1H), 
7.54–7.40 (m, 3H), 7.36–7.27 (m, 3H), 7.22 (td, J = 7.9, 1.5 Hz, 1H), 7.19–7.08 (m, 4H), 7.02 
(td, J = 7.5, 1.2 Hz, 1H), 6.92 (dd, J = 7.7, 1.5 Hz, 1H), 5.67 (s, 1H), 2.73 (s, 1H), 2.38 (s, 3H); 
13C NMR (100 MHz, CDCl3): δ = 143.58, 141.00, 136.43, 135.75, 133.11, 129.52, 129.04, 
128.92, 128.57, 127.77, 127.15, 126.28, 124.54, 121.98, 74.57, 21.49; m/z (EI)(%): 354.2 
(2.3), 353.2 (10.5), 199.2 (15.5), 198.2 (100), 196.1 (25.8), 180.2 (86.5), 179.2 (45.0), 120.2 
(27.2); [M+Na] HRMS calcd. for C20H19NO3SNa: 376.09779, found: 376.09778; IR (KBr): 
= 3441, 3104, 1596, 1454, 1320, 1152, 1090, 998, 925, 820, 693 cm-1.  
To a solution of organometallic reagents R-M 198 (10.5 mmol) in 20 mLTHF at 0 oC 
were added aldehydes 238 (5 mmol) slowly under an argon protective atmosphere, the 
reaction was then heated under reflux for 30 minutes. After the reaction cooled down to room 
temperature, it was quenched by 20 mL saturated NH4Cl solution and the aqueous phase was 
extracted with Et2O (2×30 mL). The collected organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography. 
N-(2-(1-Hydroxyprop-2-yn-1-yl)phenyl)-4-methylbenzenesulfonamide (182c) 
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Yellow oil, Rf (Hex: EtOAc 3:1) = 0.17. 1H NMR (600 MHz, CDCl3): δ = 7.74 (s, 1H), 7.66 
(d, J = 8.3 Hz, 2H), 7.52 (dd, J = 7.7, 1.3 Hz, 1H), 7.37 (d, J = 7.9 Hz, 1H), 7.30–7.24 (m, 
1H), 7.22 (d, J = 8.1 Hz, 2H), 7.14 (td, J = 7.5, 1.0 Hz, 1H), 5.30 (dd, J = 5.7, 1.7 Hz, 1H), 
2.85 (s, 1H), 2.67 (d, J = 2.3 Hz, 1H), 2.38 (s, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.97, 
136.61, 135.28, 130.91, 129.77, 129.67, 128.26, 127.18, 125.49, 123.37, 81.28, 76.61, 62.53, 
21.54; m/z (EI)(%): 303.7 (4.1), 302.7 (16.5), 301.6 (98.0),300.4 (100), 284.0 (53.8), 218.9 
(37.8), 204.7 (30.9), 146.7 (19.8); [M+Na] HRMS calcd. for C16H15NO3SNa: 324.06649, 
found: 324.06543; IR (KBr): = 3453, 3284, 2925, 1596, 1490, 1401, 1326, 1161, 1022, 923, 
818, 671, 558 cm-1.  
N-(2-(1-Hydroxybut-3-en-1-yl)phenyl)-4-methylbenzenesulfonamide (182d) 
 
White solid, Rf (Hex: EtOAc 3:1) = 0.26. 1H NMR (600 MHz, CDCl3): δ = 8.43 (s, 1H), 
7.74–7.62 (m, 2H), 7.46 (d, J = 8.0 Hz, 1H), 7.23 (dd, J = 8.5, 0.6 Hz, 2H), 7.21–7.17 (m, 1H), 
7.06–7.02 (m, 2H), 5.73–5.53 (m, 1H), 5.17–5.00 (m, 2H), 4.70–4.60 (m, 1H), 2.52 (s, 1H), 
2.37 (s, 3H), 2.35–2.25 (m, 2H); 13C NMR (150 MHz, CDCl3): δ = 143.73, 136.97, 135.81, 
133.69, 131.99, 129.61, 128.57, 127.78, 127.11, 124.45, 121.81, 119.22, 73.35, 41.27, 21.49; 
m/z (EI)(%): 319.7 (1.3), 318.7 (5.0), 317.0 (41.4),  300.7 (21.0), 275.9 (100), 247 (20.5), 
155.1 (38.2); [M+Na] HRMS calcd. for C17H19NO3SNa: 340.09779, found: 340.09805; IR 
(KBr): = 3474, 3146, 2934, 1740, 1593, 1438, 1318, 1152, 1048, 920, 762, 696 cm-1. 
N-(4-Chloro-2-(1-hydroxyethyl)phenyl)-4-methylbenzenesulfonamide (182e) 
 
Yellow oil, Rf (Hex: EtOAc 3:1) = 0.18. 1H NMR (400 MHz, CDCl3): δ = 8.34 (s, 1H), 
7.68–7.60 (m, 2H), 7.36 (d, J = 8.7 Hz, 1H), 7.24–7.19 (m, 2H), 7.13 (dd, J = 8.7, 2.5 Hz, 1H), 
7.05 (d, J = 2.4 Hz, 1H), 4.76 (q, J = 6.6 Hz, 1H), 2.47 (s, 1H), 2.37 (s, 3H), 1.32 (d, J = 6.6 
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 144.01, 136.56, 135.99, 134.20, 130.10, 129.71, 
128.37, 127.12, 127.07, 123.37, 69.23, 22.75, 21.52; m/z (EI)(%): 329.1 (2.2), 328.1 (6.6), 
327.1 (36.0), 326.1 (17.4), 325.1 (100), 310.1 (25.9), 309.1 (17.4), 308.1 (69.8), 307.1 (19.5), 
243.1 (8.1), 172.1 (14.8), 171.1 (10.1), 170.1 (46.1), 169.1 (19.4), 155.1 (18.0), 154.1 (41.3), 
153.1 (28.1), 152.1 (86.6), 151.1 (9.2), 128.1 (11.0), 117.1 (50.3), 107.2 (8.3), 93.2 (8.9), 91.2 
(45.0), 89.2 (12.0), 65.2 (19.1); [M+Na] HRMS calcd. for C15H16NO3ClSNa: 348.04316, 
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found: 348.04272; IR (KBr): = 3487, 3247, 2927, 1597, 1448, 1389, 1330, 1160, 1091, 
1013, 906, 816, 733, 670, 571, 548 cm-1.  
To a solution of N-(2-acetylphenyl)-4-methylbenzenesulfonamides 235a (5 mmol) and 
K2CO3 (15 mmol) in 15 mL CH3CN was added (1-bromoethyl)benzenes 243 (10 mmol), the 
reaction was then heated up to reflux overnight. After reaction completion, the slovent was 
removed under reduced pressure, then the residue was dissolved in 20 mL EtOH and NaBH4 
(15 mmol) was added in portions at 0 oC. The reaction was warmed to room temperature and 
stirred for 2 h. After reaction completion, EtOH was removed under reduced pressure, the 
residue was washed by 20 mL saturated brine and the aqueous phase was extracted with Et2O 
(3×20 mL). The combined organic phases were dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by column chromatography. 
N-(2-(1-Hydroxyethyl)phenyl)-4-methyl-N-(1-phenylethyl)benzenesulfonamide (245) 
 
White solid, Rf (Hex: EtOAc 3:1) = 0.39. 1H NMR (400 MHz, CDCl3): δ = 7.75–7.59 (m, 2H), 
7.46 (ddd, J = 14.5, 8.9, 4.9 Hz, 1H), 7.41–7.08 (m, 9H), 7.08–6.98 (m, 2H), 6.94–6.81 (m, 
1H), 6.72 (dd, J = 56.6, 7.8 Hz, 1H), 5.98–5.25 (m, 2H), 4.41 (dq, J = 19.2, 6.5 Hz, 1H), 3.07 
(s, 1H), 2.45 (s, 3H), 1.50 (dt, J = 15.8, 7.6 Hz, 2H), 1.32 (dd, J = 13.7, 7.2 Hz, 3H), 1.21 (d, J 
= 6.4 Hz, 2H), 0.57 (d, J = 6.5 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 149.23, 148.07, 
143.58, 143.46, 143.30, 139.88, 139.57, 138.90, 138.08, 137.44, 137.16, 132.65, 132.03, 
131.97, 131.36, 130.81, 130.57, 129.76, 129.64, 129.56, 129.23, 129.13, 128.50, 128.43, 
128.38, 128.22, 128.17, 128.09, 128.06, 128.00, 127.87, 127.77, 127.70, 127.60, 127.54, 
127.08, 126.89, 65.05, 63.53, 63.00, 59.38, 58.53, 58.34, 23.34, 21.56, 21.49, 21.45, 20.05, 
19.88, 18.19, 17.73; m/z (EI)(%): 379.4 (1.7), 378.3 (7.1), 274.2 (4.3),  239.3 (10.7) 222.2 
(11.2), 206.2 (11.0), 194.2 (8.5), 180.1 (13.8), 155.0 (75.4), 106.2 (10.1), 105.1 (100), 104.1 
(20.5), 91.2 (41.8), 89.1 (12.9), 77.2 (15.1), 45.5 (17.0); [M+Na] HRMS calcd. for 
C23H25NO3SNa: 418.14474, found: 418.14484; IR (KBr): = 3566, 2975, 2934, 1739, 1594, 
1485, 1451, 1331, 1154, 1078, 996, 906, 770, 701cm-1.  
To a solution of 4-methyl-N-phenylbenzenesulfonamides 224 (5 mmol) in 10 mL 
ethoxyethene 250 was added Pd(PPh3)4 (0.025 mmol) under an argon protective atmosphere, 
the reaction was then heated up to 100 oC and stirred overnight. The crude product was 
purified by column chromatography. 
N-(1-Ethoxyethyl)-4-methyl-N-phenylbenzenesulfonamide (251) 
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Colorless oil, Rf (Hex: EtOAc 5:1) = 0.42. 1H NMR (600 MHz, CDCl3): δ = 7.53 (d, J = 8.3 
Hz, 2H), 7.34–7.26 (m, 3H), 7.22 (d, J = 8.1 Hz, 2H), 7.01–6.96 (m, 2H), 5.68 (q, J = 6.0 Hz, 
1H), 3.84 (dq, J = 9.4, 7.1 Hz, 1H), 3.63 (dq, J = 9.4, 7.0 Hz, 1H), 2.41 (s, 3H), 1.21 (t, J = 
7.0 Hz, 3H), 1.12 (d, J = 6.1 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.19, 137.69, 
134.42, 131.96, 129.22, 128.64, 128.57, 127.52, 84.86, 63.49, 21.49, 20.72, 14.89; m/z 
(EI)(%): 319.2 (1.0), 276.1 (1.3), 275.1 (4.1) 274.1 (15.7), 249.1 (6.1), 248.1 (15.9), 247.1 
(100), 183.1 (3.6), 182.1 (8.8), 168.1 (6.8), 155.0 (13.5), 119.1 (3.9), 104.1 (6.8), 91.1 (20.6), 
77.1 (8.8), 73.1 (45.2), 65.1 (7.1), 45.3 (27.4); [M+Na] HRMS calcd. for C17H21NO3SNa: 
342.11344, found: 342.11343; IR (KBr): = 2980, 2932, 2880, 2088, 1595, 1490, 1450, 
1378, 1339, 1233, 1163, 1087, 1049, 996, 905, 814, 698, 661cm-1. 
5.7.2 General Experiment for the Al(OTf)3-Catalyzed Insertion of an Unactivated 
Alkyne into an Unstrained C-C σ Bond 
Al(OTf)3 (14.3 mg, 0.03 mmol, 10 mol%) was suspended in 1.5 mL DCE, alcohols (0.3 
mmol), alkynes (0.36 mmol) and Bu4NPF6 (5.8 mg, 0.015 mmol, 5 mol%) were then added at 
room temperature and the reaction was stirred at 40 oC for 12 h. After reaction completion, 5 
mL saturated NaHCO3 solution was added and the aqueous phase was extracted with 
dichloromethane (3×10 mL). The combined organic phase was dried over anhydrous Na2SO4 
and concentrated in vacuo. The crude product was purified by column chromatography. 
2,3-Dimethyl-4-phenyl-1-tosyl-1,2-dihydroquinoline (184a) 
 
White solid, Rf (Hex: EtOAc 10:1) = 0.35. 1H NMR (600 MHz, CDCl3): δ = 7.77 (dd, J = 8.0, 
1.1 Hz, 1H), 7.32–7.27 (m, 2H), 7.28–7.19 (m, 4H), 7.12 (d, J = 8.0 Hz, 2H), 7.04 (td, J = 7.6, 
1.3 Hz, 1H), 6.49 (dd, J = 7.8, 1.4 Hz, 1H), 4.80 (q, J = 6.9 Hz, 1H), 2.38 (s, 3H), 1.51 (s, 3H), 
1.22 (d, J = 6.9 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.32, 137.16, 136.02, 134.10, 
131.34, 130.72, 129.69, 129.05, 128.21, 128.07, 126.96, 126.37, 125.48, 55.56, 21.36, 18.68, 
17.98; m/z (EI)(%): 391.4 (1.2), 390.4 (3.9), 389.4 (13.6), 375.3 (26.2), 374.3 (100), 234.3 
(26), 218.2 (11.5), 155.1 (21.7), 120.1 (13.9), 91.1 (35.7); [M+Na] HRMS calcd. for 
C24H23NO2SNa: 412.13417, found: 412.13315; IR (KBr): = 3056, 2971, 2925, 2864, 1739, 
1595, 1483, 1444, 1343, 1160, 1089, 763, 665 cm-1.  
2-Methyl-3-pentyl-4-phenyl-1-tosyl-1,2-dihydroquinoline (184b) 
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Colorless oil, Rf (Hex: EtOAc 10:1) = 0.40. 1H NMR (600 MHz, CDCl3): δ = 7.74 (dd, J = 
8.0, 1.2 Hz, 1H), 7.23–7.21 (m, 2H), 7.20–7.15 (m, 3H), 7.05–7.02 (m, 2H), 6.98–6.95 (m, 
1H), 6.42 (dd, J = 7.8, 1.4 Hz, 1H), 5.84 (s, 1H), 4.83 (q, J = 6.9 Hz, 1H), 2.31 (s, 3H), 1.74 
(ddd, J = 13.6, 11.2, 5.2 Hz, 1H), 1.66 (ddd, J = 13.6, 11.0, 5.3 Hz, 1H), 1.24–1.18 (m, 1H), 
1.16 (d, J = 6.9 Hz, 3H), 1.11–0.94 (m, 5H), 0.73 (t, J = 7.3 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ = 143.22, 138.75, 137.34, 136.32, 131.63, 131.58, 131.00, 128.98, 128.10, 127.54, 
127.25, 127.05, 126.96, 126.19, 125.83, 53.66, 32.48, 31.97, 28.04, 22.21, 21.39, 19.14, 13.87; 
m/z (EI)(%): 447.3 (1.2), 446.3 (3.9), 445.3 (11.4), 432.3 (8.7), 431.3 (28.5), 430.3 (100), 
290.2 (5.0), 220.2 (10.8), 155.0 (16.1), 91.1 (15.3); [M+Na] HRMS calcd. for C28H31NO2SNa: 
468.19677, found: 468.19650; IR (KBr): = 3063, 2928, 2858, 1596, 1481, 1344, 1161, 
1089, 897, 759, 689 cm-1.  
3-(3-Bromopropyl)-2-methyl-4-phenyl-1-tosyl-1,2-dihydroquinoline (184c) 
 
Colorless oil, Rf (Hex: EtOAc 10:1) = 0.22. 1H NMR (400 MHz, CDCl3): δ = 7.74 (dd, J = 
8.0, 1.1 Hz, 1H), 7.31–7.11 (m, 7H), 7.07 (d, J = 8.0 Hz, 2H), 7.01–6.96 (m, 1H), 6.48–6.38 
(m, 1H), 5.88 (s, 1H), 4.80 (q, J = 6.8 Hz, 1H), 3.02 (t, J = 6.8 Hz, 2H), 2.33 (s, 3H), 
1.96–1.88 (m, 1H), 1.82 (ddd, J = 13.5, 10.8, 4.9 Hz, 1H), 1.76–1.67 (m, 1H), 1.61–1.50 (m, 
1H), 1.17 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.45, 136.85, 136.66, 
136.33, 132.29, 131.64, 131.24, 129.15, 128.36, 127.56, 127.45, 127.27, 127.17, 126.29, 
125.97, 53.49, 32.86, 31.45, 30.99, 21.43, 18.99; m/z (EI)(%): 498.4 (1.0), 497.4 (3.2), 496.5 
(2.6), 495.3 (3.2), 483.3 (19.0), 482.3 (71.0), 481.4 (55.9), 480.1 (100), 479.4 (14.5), 341.7 
(10.5), 340.7 (14.3), 260.8, (9.9), 231.3 (17.5), 218.9 (23.1), 217.9 (52.5), 216.6 (32.2), 229.8 
(25.6), 155.5 (24.6), 154.4 (18.8); [M+Na] HRMS calcd. for  C26H26BrNO2SNa: 518.07598, 
found: 518.07727; IR (KBr): = 2934, 1590, 1468, 1334, 1161, 1084, 888, 757, 684 cm-1.  
2,3-Dimethyl-4-(p-Tolyl)-1-tosyl-1,2-dihydroquinoline (184d) 
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White solid, Rf (Hex: EtOAc 10:1) = 0.31. 1H NMR (400 MHz, CDCl3): δ = 7.68 (dd, J = 8.0, 
1.1 Hz, 1H), 7.25–7.18 (m, 2H), 7.18–7.13 (m, 1H), 7.03 (d, J = 8.0 Hz, 2H), 6.97 (ddd, J = 
12.7, 6.2, 2.4 Hz, 3H), 6.43 (dd, J = 7.8, 1.4 Hz, 1H), 4.72 (q, J = 6.9 Hz, 1H), 2.30 (s, 3H), 
2.26 (s, 3H), 1.43 (s, 3H), 1.13 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.28, 
136.56, 136.01, 134.08, 133.96, 131.51, 131.35, 130.60, 129.55, 129.01, 128.78, 128.18, 
126.96, 126.86, 126.34, 125.50, 55.59, 21.37, 21.13, 18.69, 17.97; m/z (EI)(%): 405.6 (0.8), 
404.6 (2.8), 403.6 (12.1), 402.7 (13.1), 389.7 (17.5), 388.4 (100), 387.4 (92.1), 262.9 (11.4), 
262.0 (18.2), 261.0 (12.7), 248.8 (26.0), 247.9 (22.5), 245.9 (19.4), 232.9 (18.2), 231.8 (16.7), 
216.5 (15.7), 189.7 (5.8), 155.5 (9.5), 154.4 (6.8); [M+Na] HRMS calcd. for C25H25NO2SNa: 
426.14982, found: 426.14981; IR (KBr): = 3063, 2973, 2924,  2866, 1596, 1448, 1445, 
1343, 1163, 1090, 895, 813, 763, 732, 665 cm-1.  
4-([1,1'-Biphenyl]-4-yl)-2-methyl-3-pentyl-1-tosyl-1,2-dihydroquinoline (184e) 
 
White solid, Rf (Hex: EtOAc 10:1) = 0.35. 1H NMR (600 MHz, CDCl3): δ = 7.83 (dd, J = 8.0, 
1.0 Hz, 1H), 7.65–7.59 (m, 2H), 7.46 (t, J = 7.7 Hz, 4H), 7.36 (dd, J = 10.6, 4.2 Hz, 1H), 7.32 
(d, J = 8.2 Hz, 2H), 7.26 (td, J = 8.0, 1.4 Hz, 1H), 7.13 (d, J = 8.0 Hz, 2H), 7.07 (td, J = 7.7, 
1.2 Hz, 1H), 6.59 (dd, J = 7.8, 1.3 Hz, 1H), 6.00 (s, 1H), 4.93 (q, J = 6.8 Hz, 1H), 2.40 (s, 3H), 
1.88 (ddd, J = 13.6, 11.2, 5.4 Hz, 1H), 1.80 (ddd, J = 13.6, 11.1, 5.3 Hz, 1H), 1.37–1.28 (m, 
1H), 1.26 (d, J = 6.9 Hz, 3H), 1.22–1.14 (m, 3H), 1.14–1.05 (m, 2H), 0.82 (t, J = 7.3 Hz, 3H); 
13C NMR (150 MHz, CDCl3): δ = 143.24, 140.61, 139.77, 138.93, 136.35, 136.32, 131.65, 
131.61, 130.68, 130.00, 128.99, 128.78, 127.60, 127.36, 127.27, 127.12, 126.95, 126.78, 
126.24, 125.88, 53.73, 32.59, 31.98, 28.07, 22.23, 21.44, 19.16, 13.88; m/z (EI)(%): 523.6 
(0.7), 522.7 (2.5), 521.7 (6.3), 508.6 (11.6), 507.5 (38.5), 506.6 (100), 366.5 (7.2), 351.4 (6.4), 
308.3 (9.8), 296.4 (21.0), 295.3 (8.2), 294.3 (29.8), 293.3 (11.5), 217.3 (3.8), 155.1 (11.9), 
91.2 (11.6); [M+Na] HRMS calcd. for C34H35NO2SNa: 544.22807, found: 544.22791; IR 
(KBr): = 3061, 3029,  2930, 2859,  1597, 1483, 1449, 1348, 1238, 1165, 1089, 987, 905, 
761, 731, 694, 663 cm-1.  
4-(4-Chlorophenyl)-2,3-dimethyl-1-tosyl-1,2-dihydroquinoline (184f) 
 
White solid, Rf (Hex: EtOAc 10:1) = 0.28. 1H NMR (400 MHz, CDCl3): δ = 7.70 (dd, J = 8.0, 
1.0 Hz, 1H), 7.24–7.18 (m, 3H), 7.18–7.11 (m, 2H), 7.04 (d, J = 8.0 Hz, 2H), 6.99 (td, J = 7.6, 
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1.3 Hz, 1H), 6.39 (dd, J = 7.8, 1.4 Hz, 1H), 4.73 (q, J = 6.9 Hz, 1H), 2.31 (s, 3H), 1.44 (s, 3H), 
1.13 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.35, 136.03, 135.59, 134.68, 
132.97, 131.38, 131.08, 130.96, 129.70, 129.03, 128.37, 127.22, 127.00, 126.49, 125.28, 
55.55, 21.39, 18.67, 17.91; m/z (EI)(%): 427.2 (0.8), 426.2 (2.8), 425.2 (9.8), 424.2 (7.4), 
423.2 (24.7), 411.2 (9.8), 410.1 (40.1), 409.2 (25.0), 408.1 (100), 270.1 (12.6), 268.1 (39.5), 
217.1 (10.6), 155.0 (20.9), 91.1 (22.1); [M+Na] HRMS calcd. for C24H22ClNO2SNa: 
446.09520, found: 446.09558; IR (KBr): = 3060, 2971, 1594, 1484, 1446, 1343, 1162, 
1090, 1022, 893, 818, 763, 667 cm-1.  
1-(4-(2-Methyl-3-pentyl-1-tosyl-1,2-dihydroquinolin-4-yl)phenyl)propan-2-one (184g) 
 
Colorless oil, Rf (Hex: EtOAc 5:1) = 0.20. 1H NMR (400 MHz, CDCl3): δ = 7.79 (dd, J = 8.0, 
1.0 Hz, 1H), 7.29–7.19 (m, 3H), 7.04 (ddd, J = 12.7, 8.8, 4.6 Hz, 5H), 6.47 (dd, J = 7.8, 1.4 
Hz, 1H), 5.87 (s, 1H), 4.88 (q, J = 6.8 Hz, 1H), 3.67 (s, 2H), 2.36 (s, 3H), 2.16 (s, 3H), 
1.83–1.66 (m, 2H), 1.30–1.23 (m, 1H), 1.21 (d, J = 6.9 Hz, 3H), 1.18–0.96 (m, 5H), 0.78 (t, J 
= 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 206.20, 143.22, 138.98, 136.30, 136.11, 
132.94, 131.56, 131.50, 130.58, 129.92, 129.20, 128.97, 127.57, 127.25, 127.11, 126.21, 
125.77, 53.63, 50.57, 32.42, 31.94, 29.40, 28.00, 22.17, 21.41, 19.10, 13.86; m/z (EI)(%): 
503.4 (0.8), 502.3 (2.5), 501.3 (5.6), 489. 4 (2.1), 488.3 (10.0), 487.3 (31.4), 486.3 (100), 
346.3 (5.9), 276.2 (9.6), 232.2 (7.6), 155.1 (10.5), 91.2 (8.5); [M+Na] HRMS calcd. for 
C31H35NO3SNa: 524.22299, found: 524.22321; IR (KBr): = 2931, 2863, 1715, 1597, 1451, 
1346, 1161, 1092, 887, 815, 763, 665 cm-1.  
2-Ethynyl-3-methyl-4-phenyl-1-tosyl-1,2-dihydroquinoline (184h)  
 
White solid, Rf (Hex: EtOAc 10:1) = 0.22. 1H NMR (400 MHz, CDCl3): δ = 7.74 (d, J = 8.0 
Hz, 1H), 7.25–7.16 (m, 6H), 7.06 (d, J = 8.5 Hz, 2H), 7.01 (t, J = 7.6 Hz, 1H), 6.47 (d, J = 7.7 
Hz, 1H), 5.52 (d, J = 2.4 Hz, 1H), 2.32 (s, 3H), 2.16 (dd, J = 2.4, 0.7 Hz, 1H), 1.58 (s, 3H); 
13C NMR (100 MHz, CDCl3): δ = 143.82, 136.46, 135.70, 132.30, 131.70, 131.03, 129.56, 
129.22, 129.17, 128.14, 127.64, 127.47, 127.30, 127.05, 126.77, 126.03, 79.45, 71.94, 51.59, 
21.41, 18.36; m/z (EI)(%): 401.5 (1.9), 400.5 (6.6), 399.4 (30.3), 398.5 (21.3), 397.7 (7.7), 
243.8 (56.8), 242.8 (100), 241.6 (94.0), 240.8(26.4), 240.0 (19.5), 239.9 (11.3); [M+Na] 
HRMS calcd. for C25H21NO2SNa: 422.11852, found: 422.11746; IR (KBr): = 3283, 2922, 
2856, 1595, 1480, 1446, 1338, 1166, 1068, 957, 865, 764, 704, 664 cm-1.  
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2-Allyl-3-methyl-4-phenyl-1-tosyl-1,2-dihydroquinoline (184i) 
 
White solid, Rf (Hex: EtOAc 10:1) = 0.26. 1H NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 8.0 
Hz, 1H), 7.22 (d, J = 8.1 Hz, 2H), 7.17 (t, J = 5.8 Hz, 4H), 7.04 (d, J = 8.1 Hz, 2H), 6.98 (t, J 
= 7.6 Hz, 1H), 6.42 (d, J = 7.7 Hz, 1H), 5.84 (ddt, J = 17.1, 10.1, 7.1 Hz, 1H), 5.01 (dd, J = 
29.4, 13.6 Hz, 2H), 4.65 (dd, J = 9.4, 4.9 Hz, 1H), 2.31 (s, 3H), 2.21 (dt, J = 12.1, 5.9 Hz, 1H), 
2.16–2.04 (m, 1H), 1.46 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.33, 137.19, 136.23, 
133.81, 132.66, 131.71, 131.56, 131.46, 129.67, 129.05, 128.11, 127.11, 127.04, 126.95, 
126.40, 125.57, 117.74, 59.53, 35.91, 21.37, 19.37; m/z (EI)(%): 376.6 (4.4),375.7 (11.6), 
374.7 (31.4), 374.0 (100), 373.4 (18.1), 219.0 (12.9), 217.8 (19.0), 216.7 (9.9), 154.8 (5.6), 
90.9 (5.4); [M+Na] HRMS calcd. for C26H25NO2SNa: 438.14982, found: 438.14951; IR 
(KBr): = 3065, 2983, 2918, 1595, 1482, 1442, 1345, 1164, 1083, 979, 913, 883, 813, 760, 
703, 667 cm-1.  
3-Methyl-2,4-diphenyl-1-tosyl-1,2-dihydroquinoline (184j) 
 
White solid, Rf (Hex: EtOAc 10:1) = 0.30. 1H NMR (400 MHz, CDCl3): δ = 7.53 (dd, J = 8.0, 
1.1 Hz, 1H), 7.30 (dd, J = 8.1, 2.2 Hz, 4H), 7.22 (dt, J = 4.1, 2.4 Hz, 3H), 7.20–7.13 (m, 3H), 
7.09 (d, J = 8.0 Hz, 2H), 7.08–7.03 (m, 1H), 6.92 (td, J = 7.6, 1.3 Hz, 1H), 6.45 (dd, J = 7.8, 
1.4 Hz, 1H), 5.77 (s, 1H), 2.34 (s, 3H), 1.50 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.51, 
137.11, 137.06, 136.04, 133.62, 131.76, 131.58, 130.75, 129.65, 129.18, 128.52, 128.24, 
128.06, 127.87, 127.22, 127.05, 126.41, 125.46, 61.77, 21.42, 19.67; m/z (EI)(%): 454.3 (0.6), 
453.2 (2.9), 452.2 (9.9), 451.2 (29.8), 375.2 (14.8), 374.2 (54.3), 297.2 (25.3), 296.2 (100), 
294.2 (23.5), 280.2 (55), 218.2 (12.4), 217.2 (17.9), 155.1 (13.2), 91.2 (25.3); [M+K] HRMS 
calcd. for C29H25NO2SK: 490.12376, found: 490.12372; IR (KBr): = 3026, 2921, 1740, 
1594, 1484, 1336, 1164, 1062, 911, 813, 764, 668 cm-1.  
6-Chloro-2,3-dimethyl-4-phenyl-1-tosyl-1,2-dihydroquinoline (184k) 
 
White solid, Rf (Hex: EtOAc 10:1) = 0.31. 1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 8.6 
Hz, 1H), 7.32–7.28 (m, 2H), 7.28–7.22 (m, 3H), 7.19 (dd, J = 8.6, 2.4 Hz, 1H), 7.14 (d, J = 
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8.0 Hz, 2H), 6.44 (d, J = 2.4 Hz, 1H), 4.78 (q, J = 6.9 Hz, 1H), 2.38 (s, 3H), 1.48 (s, 3H), 1.19 
(d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 143.63, 136.34, 135.82, 132.82, 132.11, 
130.03, 129.92, 129.51, 129.24, 128.34, 127.34, 126.94, 125.29, 55.58, 21.41, 18.80, 18.02; 
m/z (EI)(%): 427.1 (1.1), 426.1 (3.8), 425.1 (13.8), 424.1 (10.6), 423.1 (37.0), 410.1 (37.0), 
409.1 (24.1), 408.1 (100), 270.1 (24.8), 269.1 (15.4), 268.1 (77.8), 218.1 (12.9), 217.1 (15.9), 
155.0 (39.3), 91.1 (41.8); [M+Na] HRMS calcd. for C24H22NO2ClSNa: 446.09520, found: 
446.09521; IR (KBr): = 3073, 2966, 2924, 1594,  1475, 1343, 1163, 1090, 890, 816, 748, 
670 cm-1.  
3,4-Dimethyl-2-phenyl-1-tosyl-1,4-dihydroquinoline (184a’) 
 
Colorless oil, Rf (Hex: EtOAc 10:1) = 0.35. 1H NMR (400 MHz, CDCl3): δ = 7.73 (dd, J = 
7.9, 1.3 Hz, 1H), 7.38–7.24 (m, 8H), 7.24–7.18 (m, 1H), 7.10 (dd, J = 8.6, 0.6 Hz, 2H), 7.05 
(dd, J = 7.5, 1.3 Hz, 1H), 3.06 (s, 1H), 2.34 (s, 3H), 1.79 (s, 3H), 0.93–0.76 (m, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 143.39, 137.98, 136.43, 129.70, 129.04, 127.90, 127.61, 127.18, 
126.37, 126.15, 125.05, 21.44; m/z (EI)(%): 390.5 (0.8), 389.4 (3.9), 374.3 (2.1), 250.2 (1.0), 
235.3 (9.7), 234.0 (100), 232.1 (9.8), 219.3 (1.9), 218.3 (7.9), 217.2 (8.3), 216.2 (2.3); [M+Na] 
HRMS calcd. for C24H23NO2SNa: 412.13417, found: 412.13367; IR (KBr): = 2929, 1595, 
1485, 1447, 1358, 1216, 1163, 1088, 1013, 913, 815, 756, 666 cm-1.  
N,N'-((Oxybis(ethane-1,1-diyl))bis(2,1-phenylene))bis(4-methylbenzenesulfonamide) 
(241) 
 
Colorless oil (diastereoisomers), Rf (Hex: EtOAc 3:1) = 0.30. 1H NMR (600 MHz, CDCl3): δ 
= 8.13 (s, 1H), 7.70 (d, J = 8.3 Hz, 2H), 7.53 (d, J = 8.2 Hz, 1H), 7.22–7.18 (m, 2H), 
7.18–7.15 (m, 1H), 6.91 (td, J = 7.5, 0.9 Hz, 1H), 6.71 (dd, J = 7.6, 1.2 Hz, 1H), 4.25 (q, J = 
6.7 Hz, 1H), 2.32 (s, 3H), 1.16 (d, J = 6.8 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.98, 
136.83, 135.64, 129.72, 129.32, 129.05, 128.91, 127.16, 124.18, 120.15, 76.37, 21.79, 21.53; 
m/z (EI)(%): 564.3 (1.3), 291.1 (6.8), 274.1 (32.0), 273.1 (32.3), 210.1 (6.4),  120.1 (14.2), 
119.1(40.5), 118.1 (100), 117.0 (19.9), 91.1 (47.5), 65.1 (19.6); [M+Na] HRMS calcd. for 
C30H32N2O5S2Na: 587.16448, found: 587.16284; IR (KBr): = 3265, 3065, 2977, 2928, 
1730, 1595, 1495, 1450, 1405, 1334, 1281, 1161, 1090, 916, 816, 760, 733, 664, 564 cm-1.  
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N,N'-((Oxybis(ethane-1,1-diyl))bis(2,1-phenylene))bis(4-methylbenzenesulfonamide) 
(241) 
 
Colorless oil (diastereoisomers), Rf (Hex: EtOAc 3:1) = 0.30. 1H NMR (600 MHz, CDCl3): δ 
= 7.72 (s, 1H), 7.60 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 7.7 Hz, 1H), 7.22 (d, J = 8.0 Hz, 2H), 
7.19–7.14 (m, 1H), 7.02 (dtd, J = 9.3, 7.6, 1.3 Hz, 2H), 4.63 (q, J = 6.6 Hz, 1H), 2.37 (s, 3H), 
1.32 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ = 143.75, 136.93, 134.95, 132.57, 
129.67, 128.71, 128.01, 127.15, 124.89, 121.70, 74.99, 21.52, 20.86; m/z (EI)(%): 564.6 (2.5), 
292.3 (6.4), 291.2 (33.1), 275.2 (20.7), 274.2 (99.2), 273.2 (85.4), 210.2 (10.6),  136.1 (20.5), 
120.2(11.1), 119.2 (28.4), 118.1 (100), 117.1 (21.7), 91.2 (28.2); [M+Na] HRMS calcd. for 
C30H32N2O5S2Na: 587.16448, found: 587.16461; IR (KBr): = 3262, 2977, 2927, 1595, 
1495, 1451, 1400, 1329, 1281, 1156, 1090, 1067, 912, 814, 758, 733, 661 cm-1.  
(E)-2-Methyl-1-phenyl-2-buten-1-one (252) 
 
Colorless oil, Rf (Hex: EtOAc 10:1) = 0.61. 1H NMR (400 MHz, CDCl3): δ = 7.63–7.54 (m, 
2H), 7.49–7.42 (m, 1H), 7.41–7.33 (m, 2H), 6.38 (qq, J = 6.9, 1.3 Hz, 1H), 1.96–1.92 (m, 3H), 
1.85 (ddd, J = 6.9, 2.1, 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 198.82, 141.45, 138.76, 
137.57, 131.15, 129.11, 127.92, 14.70, 12.07; m/z (EI)(%): 160.9 (37.2), 159.9 (55.7), 158.9 
(22.8), 144.8 (36.2), 131.9 (67.6), 116.9 (16.5), 104.8 (100), 82.8 (13.1), 76.9 (54.4), 55.0 
(17.8),51.0 (24.7); [M+Na] HRMS calcd. for C11H12ONa: 183.07804, found: 183.07806; IR 
(KBr): = 3048, 2927, 2328, 2093, 1640, 1442, 1380, 1275, 1167, 1022, 870, 782, 701 cm-1. 
5.8 Experiments for a Novel Approach to 2H-Chromenes through 
Al(OTf)3-Catalyzed Unstrained C-C σ Bond Activation 
5.8.1 General Experiment for the synthesis of 2H-Chromenes through 
Al(OTf)3-Catalyzed Unstrained C-C σ Bond Activation 
To a suspension of 10 mol% Al(OTf)3 (19.0 mg, 0.04 mmol) in 4 mL dried DCE, 
4-bromo-2-(1-hydroxyethyl)phenols 164b (86.8 mg, 0.4 mmol), 1-phenyl-1-propynes 229 
(69.7 mg, 0.6 mmol), Bu4NSbF6 (9.6 mg, 0.02 mmol) and NH4PF6 (9.8 mg, 0.06 mmol) were 
added, the reaction was then stirred at 40 oC for 12 h. After reaction completion, the reaction 
was quenched by addition of 5 mL saturated NaHCO3 solution and the aqueous phase was 
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extracted with dichloromethane (3×10 mL). The combined organic phases were dried over 
Na2SO4 and the crude product was purified by column chromatography. 
6-Bromo-2,3-dimethyl-4-phenyl-2H-chromene (169a) 
                            
White solid, Rf (pentane: EtOAc 40:1) = 0.52. 1H NMR (300 MHz, CDCl3): δ = 7.47–7.33 (m, 
3H), 7.15 (dd, J = 8.5, 2.4, 3H), 6.72 (d, J = 8.5, 1H), 6.67 (d, J = 2.4, 1H), 4.86 (q, J = 6.5, 
1H), 1.66–1.63 (m, 3H), 1.43 (d, J = 6.6, 3H); 13C NMR (150 MHz, CDCl3): δ = 150.50, 
136.51, 132.53, 130.61, 129.73, 129.17, 128.63, 127.84, 127.45, 126.40, 117.94, 113.05, 
75.41, 18.65, 17.09; m/z (EI)(%): 316.2 (5.4), 314.1 (4.7), 301.1 (17.1), 299.1 (17.6), 145.0 
(42.0), 105.0 (51.6), 77.1 (100), 57.2 (65.6); HRMS calcd. for C17H15O79Br: 314.03008, found: 
314.02876; IR (KBr): = 2920, 1744, 1471, 1382, 1234, 1087, 929, 817, 757, 700 cm-1. 
7-Bromo-2,3-dimethyl-4-phenyl-2H-chromene (169b) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.61. 1H NMR (300 MHz, CDCl3): δ = 7.45–7.32 
(m, 3H), 7.15 (d, J = 6.4, 2H), 7.00 (d, J = 2.0, 1H), 6.85 (dd, J = 8.2, 2.0, 1H), 6.42 (d, J = 
8.2, 1H), 4.86 (q, J = 6.6, 1H), 1.63 (d, J = 0.5, 3H), 1.43 (d, J = 6.6, 3H); 13C NMR (150 
MHz, CDCl3): δ = 152.27, 136.79, 131.44, 129.85, 129.36, 128.51, 127.32, 126.51, 123.76, 
123.52, 120.71, 119.33, 75.69, 18.75, 17.04; m/z (EI)(%): 316.0 (9.9), 314.0 (9.5), 288.0 
(49.7), 277.0 (100), 275.0 (53.0), 261.0 (59.2), 152.1 (30.0), 105.1 (31.6), 77.2 (27.9); 
[M-CH3] HRMS calcd. for C16H12O79Br: 299.00660, found: 299.00535; IR (KBr): = 2976, 
1750, 1590, 1479, 1408, 1228, 1074, 932, 857, 809, 755, 700 cm-1. 
6-Chloro-2,3-dimethyl-4-phenyl-2H-chromene (169c)  
 
White solid, Rf (pentane: EtOAc 40:1) = 0.46. 1H NMR (600 MHz, CDCl3): δ = 7.43 (t, J = 
7.7, 2H), 7.39–7.34 (m, 1H), 7.15 (d, J = 2.0, 2H), 7.01 (dd, J = 8.5, 2.5, 1H), 6.77 (d, J = 8.5, 
1H), 6.53 (d, J = 2.5, 1H), 4.88–4.82 (m, 1H), 1.64 (s, 3H), 1.42 (d, J = 6.5, 3H); 13C NMR 
(150 MHz, CDCl3): δ = 149.96, 136.55, 132.52, 129.84, 129.26, 128.61, 127.63, 127.44, 
125.88, 125.65, 125.00, 117.41, 75.43, 18.61, 17.09; m/z (CI)(%): 272.0 (10.3), 271.1 (18.6), 
270.0 (36.0), 85.1 (61.9), 83.1 (100); IR (KBr): = 2974, 2922, 1476, 1235, 1080, 934, 814, 
762, 699 cm-1. 
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7-Chloro-2,3-dimethyl-4-phenyl-2H-chromene (169d)  
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.48. 1H NMR (600 MHz, CDCl3): δ = 7.42 (t, J = 
7.6, 2H), 7.35 (dd, J = 10.6, 4.3, 1H), 7.15 (s, 2H), 6.85 (d, J = 2.1, 1H), 6.70 (dd, J = 8.3, 2.1, 
1H), 6.48 (d, J = 8.3, 1H), 4.86 (q, J = 6.5, 1H), 1.64 (s, 3H), 1.43 (d, J = 6.5, 3H); 13C NMR 
(150 MHz, CDCl3): δ = 152.19, 136.87, 132.91, 131.19, 129.87, 129.31, 128.51, 127.31, 
126.19, 123.10, 120.82, 116.47, 75.66, 18.75, 16.99; m/z (EI)(%): 271.1 (5.5), 270.1 (4.8), 
233.2 (62.5), 231.2 (37.1), 155.2 (26.3), 105.2 (37.0), 77.3 (100), 51.3 (51.0); [M-CH3] 
HRMS calcd. for C16H12O35Cl: 255.05712, found: 255.05669; IR (KBr): = 2975, 1596, 
1566, 1482, 1412, 1231, 1077, 1002, 938, 859, 810, 758, 701 cm-1. 
2-Butyl-6-chloro-3-methyl-4-phenyl-2H-chromene (169e)  
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.52. 1H NMR (400 MHz, CDCl3): δ = 7.45–7.31 
(m, 3H), 7.14 (d, J = 5.9, 2H), 6.99 (dd, J = 8.5, 2.5, 1H), 6.76 (d, J = 8.5, 1H), 6.51 (d, J = 
2.5, 1H), 4.64 (dd, J = 9.6, 2.4, 1H), 1.86–1.74 (m, 1H), 1.63 (s, 3H), 1.61–1.51 (m, 2H), 
1.48–1.25 (m, 3H), 0.90 (t, J = 7.2, 3H); 13C NMR (150 MHz, CDCl3): δ = 149.99, 136.63, 
131.94, 129.85, 129.53, 128.60, 127.62, 127.42, 126.21, 125.55, 124.96, 117.38, 79.41, 32.03, 
27.67, 22.47, 17.52, 14.03; m/z (CI)(%): 313.0 (1.1), 271.0 (33.6), 259.0 (33.7), 242.0 (31.3), 
235.0 (35.6), 233.0 (100), 105.1 (16.7), 103.1 (31.5); HRMS calcd. for C20H21O35Cl: 
312.12754, found: 312.12711; IR (KBr): = 3052, 2937, 1724, 1598, 1472, 1239, 1167, 
1094, 818, 757, 703 cm-1. 
2-Allyl-6-chloro-3-methyl-4-phenyl-2H-chromene (169f) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.43. 1H NMR (400 MHz, CDCl3): δ = 7.42 (t, J = 
7.4, 2H), 7.38–7.32 (m, 1H), 7.13 (d, J = 6.0, 2H), 7.00 (dd, J = 8.5, 2.5, 1H), 6.75 (d, J = 8.5, 
1H), 6.52 (d, J = 2.5, 1H), 5.97–5.84 (m, 1H), 5.12 (d, J = 1.1, 1H), 5.10–5.06 (m, 1H), 4.73 
(dd, J = 8.4, 3.9, 1H), 2.61–2.50 (m, 1H), 2.45–2.36 (m, 1H), 1.65 (s, 3H); 13C NMR (150 
MHz, CDCl3): δ = 149.86, 136.46, 133.68, 130.96, 130.19, 129.70, 128.63, 127.79, 127.50, 
126.04, 125.72, 125.03, 117.85, 117.46, 78.78, 37.18, 17.65; m/z (CI)(%): 298.0 (10.2), 297.0 
(40.0), 296.0 (9.4), 271.0 (51.4), 259.0 (44.0), 255.0 (51.2), 235.0 (37.0), 233.0 (100), 121.1 
 Experimental part 107 
 
 
(23.5), 105.1 (43.2); HRMS calcd. for C19H17O35Cl: 296.09624, found: 296.09553; IR (KBr): 
= 3063, 2922, 1866, 1638, 1475, 1241, 1047, 919, 817, 761, 701 cm-1. 
6-Chloro-2-ethynyl-3-methyl-4-phenyl-2H-chromene (169g) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.42. 1H NMR (400 MHz, CDCl3): δ = 7.44 (dd, J = 
11.1, 4.7, 2H), 7.40–7.35 (m, 1H), 7.17 (s, 2H), 7.06 (dd, J = 8.5, 2.5, 1H), 6.87 (d, J = 8.5, 
1H), 6.59 (d, J = 2.5, 1H), 5.39 (dd, J = 2.2, 0.6, 1H), 2.49 (d, J = 2.3, 1H), 1.76 (s, 3H); 13C 
NMR (150 MHz, CDCl3): δ = 149.43, 135.70, 130.48, 129.67, 128.67, 128.02, 127.94, 127.76, 
126.79, 125.65, 125.44, 117.67, 80.04, 74.28, 68.68, 16.86; m/z (EI)(%): 282.0 (20.5), 281.0 
(17.1), 280.0 (60.9), 279.0 (15.6), 266.9 (33.8), 266.0 (20.6), 265.0 (100), 244.0 (18.7), 229.0 
(24.5), 202.9 (31.6), 202.0 (33.2), 189.0 (14.3); IR (KBr): = 3289, 3056, 2915, 2328, 2106, 
1593, 1474, 1233, 1031, 896, 817, 705 cm-1. 
6-Chloro-3-methyl-4-phenyl-2-(phenylethynyl)-2H-chromene (169h) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.40. 1H NMR (400 MHz, CDCl3): δ = 7.47–7.35 
(m, 5H), 7.33–7.25 (m, 3H), 7.19 (d, J = 2.6, 2H), 7.05 (dd, J = 8.5, 2.5, 1H), 6.88 (d, J = 8.5, 
1H), 6.60 (d, J = 2.5, 1H), 5.64 (s, 1H), 1.81 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 
149.73, 135.92, 131.97, 130.34, 129.75, 128.73, 128.66, 128.28, 128.23, 127.91, 127.70, 
126.55, 125.76, 125.38, 122.10, 117.68, 86.17, 85.25, 69.46, 17.07; m/z (EI)(%): 358.0 (20.2), 
356.0 (55.3), 341.0 (100), 279.0 (28.0), 152.5 (15.8); HRMS calcd. for C24H17O35Cl: 
356.09624, found: 356.09626; IR (KBr): = 3063, 2922, 2287, 2225, 1591, 1476, 1228, 
1108, 1027, 900, 820, 754, 695 cm-1. 
6-Chloro-2-isopropyl-3-methyl-4-phenyl-2H-chromene (169i) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.61. 1H NMR (400 MHz, CDCl3): δ = 7.42 (t, J = 
7.4, 2H), 7.38–7.32 (m, 1H), 7.15 (s, 2H), 6.97 (dd, J = 8.5, 2.6, 1H), 6.73 (d, J = 8.5, 1H), 
6.48 (d, J = 2.5, 1H), 4.50 (d, J = 5.3, 1H), 2.14–2.01 (m, 1H), 1.64 (s, 3H), 1.07 (d, J = 6.9, 
3H), 0.98 (d, J = 6.8, 3H); 13C NMR (100 MHz, CDCl3): δ = 151.51, 136.85, 130.71, 130.17, 
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129.34, 128.64, 127.69, 127.45, 125.89, 125.13, 125.02, 116.48, 84.21, 32.23, 19.22, 18.75, 
17.27; m/z (CI)(%): 300.2 (31.7), 299.2 (99.5), 273.2 (34.6), 271.2 (100); HRMS calcd. for 
C19H19O35Cl: 298.11189, found: 298.11133; IR (KBr): = 3419, 2964, 1729, 1600, 1471, 
1393, 1241, 1100, 939, 819, 756, 702 cm-1. 
6-Chloro-2-cyclohexyl-3-methyl-4-phenyl-2H-chromene (169j) 
 
Colorless oil, Rf (pentane) = 0.23. 1H NMR (400 MHz, CDCl3): δ = 7.41 (t, J = 7.5, 2H), 
7.37–7.31 (m, 1H), 7.15 (s, 2H), 6.97 (dd, J = 8.5, 2.6, 1H), 6.72 (d, J = 8.5, 1H), 6.48 (d, J = 
2.5, 1H), 4.50 (d, J = 5.3, 1H), 1.92 (d, J = 10.8, 1H), 1.73 (dddd, J = 11.2, 7.4, 5.4, 2.8, 4H), 
1.64 (s, 4H, -CH3 and 1/2-CH2), 1.38 (qd, J = 12.2, 3.4, 1H), 1.29–1.00 (m, 4H); 13C NMR 
(100 MHz, CDCl3): δ = 151.47, 136.90, 130.72, 129.86, 128.61, 127.67, 127.44, 126.06, 
125.14, 125.05, 116.59, 83.75, 41.93, 29.56, 27.69, 26.38, 26.32, 26.13, 18.91; m/z (CI)(%): 
339.2 (100), 338.2 (24.5), 337.2 (9.6), 273.2 (7.0), 271.1 (20.7); HRMS calcd. for 
C22H23O35Cl: 338.14319, found: 338.14307; IR (KBr): = 3059, 2929, 1725, 1603, 1469, 
1242, 1086, 1014, 901, 820, 717 cm-1. 
6-Bromo-3-methyl-2,4-diphenyl-2H-chromene (169k) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.31. 1H NMR (400 MHz, CDCl3): δ = 7.50–7.41 
(m, 4H), 7.41–7.30 (m, 4H), 7.24 (s, 2H), 7.10 (dd, J = 8.5, 2.4, 1H), 6.72 (d, J = 2.4, 1H), 
6.62 (d, J = 8.5, 1H), 5.72 (s, 1H), 1.55 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 150.57, 
138.67, 136.23, 130.90, 130.63, 129.78, 128.84, 128.76, 127.88, 127.68, 127.64, 126.07, 
117.82, 113.08, 81.04, 17.81; m/z (EI)(%): 378.0 (57.7), 375.9 (61.0), 362.9 (100), 361.0 
(93.3), 300.9 (28.6), 298.9 (29.3), 104.8 (31.2), 76.9 (15.0); HRMS calcd. for C22H17O79Br: 
376.04573, found: 376.04566; IR (KBr): = 3062, 3030, 1595, 1475, 1396, 1234, 1025, 907, 
815, 730, 700 cm-1.  
2,3-Dimethyl-4-phenyl-2H-chromene (169l) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.36. 1H NMR (400 MHz, CDCl3): δ = 7.43–7.37 
(m, 2H), 7.36–7.31 (m, 1H), 7.16 (d, J = 6.7, 2H), 7.08–7.02 (m, 1H), 6.85–6.80 (m, 1H), 
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6.76–6.69 (m, 1H), 6.56 (dt, J = 5.8, 2.9, 1H), 4.85 (q, J = 6.5, 1H), 1.64 (d, J = 0.5, 3H), 1.43 
(d, J = 6.5, 3H); 13C NMR (100 MHz, CDCl3): δ = 151.39, 137.37, 131.05, 129.95, 128.38, 
128.00, 127.09, 125.37, 124.46, 120.72, 116.13, 75.22, 18.68, 17.01; m/z (EI)(%): 236.8 
(28.5), 235.7 (32.7), 221.9 (71.0), 221.0 (75.8), 220.1 (100), 205.8 (52.0), 189.8 (85.4), 176.6 
(60.7), 163.6 (69.3); [M+1] HRMS calcd. for C17H17O: 237.12739, found: 237.12738; IR 
(KBr): = 3056, 2973, 2923, 1594, 1483, 1375, 1232, 1089, 1013, 756, 702 cm-1.   
3-Methyl-2,4-diphenyl-2H-chromene (169m)  
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.35. 1H NMR (600 MHz, CDCl3): δ = 7.47 (dd, J = 
16.1, 7.8, 4H), 7.40–7.31 (m, 4H), 7.27 (d, J = 16.5, 2H), 7.07–7.00 (m, 1H), 6.74 (dd, J = 
16.4, 7.9, 2H), 6.63 (dd, J = 7.6, 1.2, 1H), 5.74 (s, 1H), 1.57 (s, 3H); 13C NMR (150 MHz, 
CDCl3): δ = 151.51, 139.29, 137.10, 131.40, 129.93, 128.66, 128.60, 128.49, 128.31, 127.71, 
127.27, 125.42, 124.07, 120.76, 115.98, 80.96, 17.73; m/z (EI)(%): 299.1 (13.6), 298.2 (47.8), 
284.1 (23.2), 283.1 (100), 221.1 (34.9); HRMS calcd. for C22H18O: 298.13522, found: 
298.13514; IR (KBr): = 3057, 2920, 1597, 1578, 1483, 1446, 1234, 1050, 749, 698 cm-1. 
3,6-Dimethyl-2,4-diphenyl-2H-chromene (169n) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.46. 1H NMR (400 MHz, CDCl3): δ = 7.49–7.41 
(m, 4H), 7.39 (dd, J = 5.0, 3.6, 1H), 7.36–7.29 (m, 3H), 7.27 (dd, J = 8.9, 3.8, 2H), 6.82 (dd, J 
= 8.1, 2.0, 1H), 6.64 (d, J = 8.1, 1H), 6.41 (d, J = 1.9, 1H), 5.68 (s, 1H), 2.10 (s, 3H), 1.54 (s, 
3H); 13C NMR (100 MHz, CDCl3): δ = 149.28, 139.34, 137.24, 131.52, 129.95, 129.90, 
128.77, 128.63, 128.52, 128.48, 128.43, 127.72, 127.21, 125.83, 123.84, 115.74, 80.84, 20.70, 
17.79; m/z (EI)(%): 313.0 (16.5), 312.0 (58.3), 297.0 (100), 235.0 (39.6), 104.8 (31.6); HRMS 
calcd. for C23H20O: 312.15087, found: 312.15067; IR (KBr): = 3033, 2918, 1600, 1488, 
1236, 1005, 913, 823, 705 cm-1. 
6-Bromo-2-methyl-3-pentyl-4-phenyl-2H-chromene (169o)  
 
Light yellow oil, Rf (pentane: EtOAc 40:1) = 0.59. 1H NMR (600 MHz, CDCl3): δ = 7.42 (s, 
2H), 7.36 (td, J = 7.4, 1.2, 1H), 7.23–7.01 (m, 3H), 6.72 (d, J = 8.5, 1H), 6.63 (d, J = 2.4, 1H), 
4.91 (q, J = 6.5, 1H), 2.09 (ddd, J = 13.6, 9.9, 6.6, 1H), 1.85–1.79 (m, 1H), 1.43–1.36 (m, 4H, 
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-CH3 and 1/2-CH2), 1.35–1.28 (m, 1H), 1.20–1.08 (m, 4H), 0.79 (dd, J = 9.0, 5.0, 3H); 13C 
NMR (150 MHz, CDCl3): δ = 150.34, 137.10, 136.52, 130.64, 130.07, 129.67, 129.37, 128.65, 
128.49, 128.06, 127.41, 126.86, 118.02, 113.07, 73.31, 31.56, 30.48, 28.08, 22.23, 18.88, 
13.84; m/z (EI)(%): 372.1 (16.9), 370.1 (16.5), 357.1 (35.0), 355.1 (34.5), 301.0 (34.9), 299.0 
(38.6), 277.0 (29.3), 219.1 (29.3), 105.1 (39.5), 99.1 (100), 77.2 (38.0), 71.3 (41.0); [M-CH3] 
HRMS calcd. for C20H20O79Br: 355.06920, found: 355.06760; IR (KBr): = 2935, 1600, 
1468, 1383, 1234, 1104, 910, 817, 707 cm-1. 
6-Bromo-3-(3-bromopropyl)-2-methyl-4-phenyl-2H-chromene (169p) 
 
Colorless oil, Rf (pentane: EtOAc 40:1) = 0.39. 1H NMR (400 MHz, CDCl3): δ = 7.49–7.34 
(m, 3H), 7.16 (dd, J = 8.5, 2.4, 2H), 7.08 (s, 1H), 6.72 (d, J = 8.5, 1H), 6.62 (d, J = 2.4, 1H), 
4.89 (q, J = 6.5, 1H), 3.27 (dt, J = 9.9, 6.4, 1H), 3.16 (dt, J = 9.9, 6.7, 1H), 2.24 (ddd, J = 13.3, 
9.3, 6.7, 1H), 1.98 (ddd, J = 9.6, 7.2, 3.6, 1H), 1.93–1.80 (m, 2H), 1.40 (d, J = 6.5, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 150.33, 136.02, 134.88, 131.06, 130.70, 129.89, 129.45, 128.89, 
128.71, 128.20, 127.71, 126.46, 118.13, 113.18, 73.21, 32.83, 31.54, 29.13, 18.82; m/z 
(EI)(%): 422.0 (5.1), 406.9 (34.2), 301.0 (56.5), 299.0 (58.9), 276.9 (100), 261.0 (63.7), 151.0 
(98.3), 105.1 (87.3), 77.2 (97.2); HRMS calcd. for C19H18O79Br2: 419.97189, found: 
419.97116; IR (KBr): = 2968, 1593, 1475, 1233, 1118, 1073, 911, 817, 734, 702 cm-1.  
6-Bromo-2,3-dimethyl-4-(p-Tolyl)-2H-chromene (169q) 
 
White solid, Rf (pentane: EtOAc 40:1) = 0.42. 1H NMR (300 MHz, CDCl3): δ = 7.26–7.20 (m, 
2H), 7.14 (dd, J = 8.5, 2.4, 1H), 7.03 (d, J = 7.5, 2H), 6.70 (t, J = 5.7, 2H), 4.84 (q, J = 6.5, 
1H), 2.41 (s, 3H), 1.64 (s, 3H), 1.41 (d, J = 6.6, 3H); 13C NMR (150 MHz, CDCl3): δ = 
150.54, 137.06, 133.40, 132.40, 130.51, 129.68, 129.32, 129.06, 127.87, 126.57, 117.89, 
113.03, 75.45, 21.27, 18.65, 17.12; m/z (EI)(%): 330.0 (25.3), 328.9 (12.5), 328.0 (26.3), 
315.0 (94.5), 313.0 (100), 277.0 (38.2), 275.0 (37.1), 165.0 (33.2), 119.0 (41.3), 116.1 (26.4), 
91.1 (40.9); [M+1] HRMS calcd. for C18H18O79Br: 329.05355, found: 329.05273; IR (KBr): 
= 3023, 2975, 2921, 1511, 1474, 1236, 1170, 1082, 932, 810, 730 cm-1.  
4-((1,1'-Biphenyl)-4-yl)-6-bromo-2-methyl-3-pentyl-2H-chromene (169r) 
 Experimental part 111 
 
 
 
Light yellow oil, Rf (pentane: EtOAc 40:1) = 0.44. 1H NMR (400 MHz, CDCl3): δ = 7.67 
(ddd, J = 6.1, 4.2, 2.1, 4H), 7.52–7.42 (m, 2H), 7.41–7.32 (m, 1H), 7.24 (s, 1H), 7.17 (dd, J = 
8.5, 2.4, 2H), 6.73 (dd, J = 8.6, 5.5, 2H), 4.93 (q, J = 6.5, 1H), 2.15 (ddd, J = 13.6, 9.7, 6.8, 
1H), 1.91–1.81 (m, 1H), 1.47–1.27 (m, 5H, -CH3 and –CH2), 1.23–1.07 (m, 4H), 0.79 (dd, J = 
8.5, 5.6, 3H); 13C NMR (100 MHz, CDCl3): δ = 150.37, 140.65, 140.13, 137.29, 135.48, 
130.69, 130.49, 130.15, 129.02, 128.80, 128.06, 127.38, 127.04, 126.81, 118.07, 113.11, 
73.32, 31.55, 30.53, 28.12, 22.25, 18.87, 13.85; m/z (EI)(%): 448.1 (5.1), 446.1 (5.1), 431.1 
(14.9), 377.0 (22.0), 181.1 (37.4), 154.1 (68.4), 152.1 (75.3), 99.1 (100), 77.2 (46.5), 71.3 
(76.6), 55.2 (54.1); HRMS calcd. for C27H27O79Br: 446.12398, found: 446.12319; IR (KBr): 
= 3036, 2934, 1599, 1471, 1392, 1236, 1100, 1034, 910, 819, 734 cm-1. 
2,2'-(Oxybis(ethane-1,1-diyl))bis(4-bromophenol) (266) 
 
Colorless oil, Rf (pentane: EtOAc 5:1) = 0.32. 1H NMR (400 MHz, CDCl3): δ = 7.30 (dd, J = 
8.6, 2.4, 1H), 7.23 (s, 1H), 7.02 (d, J = 2.4, 1H), 6.79 (d, J = 8.6, 1H), 4.54 (q, J = 6.7, 1H), 
1.52 (d, J = 6.7, 3H); 13C NMR (100 MHz, CDCl3): δ = 154.00, 132.31, 130.50, 127.36, 
119.05, 112.28, 76.78, 22.19; m/z (EI)(%): 417.8 (14.6), 415.8 (28.8), 413.8 (16.6), 399.8 
(15.4), 398.7 (11.6), 397.8 (28.8), 395.8 (16.0), 217.9 (44.7), 229.9 (47.2), 200.9 (97.5), 199.9 
(68.9), 198.9 (100), 197.8 (63.0), 120.0 (55.4), 102.0 (22.1), 91.1 (50.6); HRMS calcd. for 
C16H16O379Br2: 413.94607, found: 413.94560; IR (KBr): = 3385, 2975, 1589, 1469, 1351, 
1231, 1070, 903, 814, 732 cm-1.
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